var title_f41_3_42032="Dermatitis herpetiformis papules and vesicles";
var content_f41_3_42032=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatitis herpetiformis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple inflammatory papules and vesicles are present near the elbow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott Florell, MD, Department of Dermatology, University of Utah.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42032=[""].join("\n");
var outline_f41_3_42032=null;
var title_f41_3_42033="SGA meconium stained";
var content_f41_3_42033=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Meconium-stained small gestational age (SGA) infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 256px; height: 398px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The infant has the characteristic appearance of an SGA infant. Note the loose, peeling skin, decreased subcutaneous tissue and muscle mass, and meconium staining.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of George T Mandy, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42033=[""].join("\n");
var outline_f41_3_42033=null;
var title_f41_3_42034="X-ray hamstring avulsion fracture of the ischial tuberosity";
var content_f41_3_42034=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    X-ray hamstring avulsion fracture of the ischial tuberosity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 454px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An AP radiograph of the pelvis of the left hip demonstrates an avulsion fracture of the left ischial tuberosity (arrow). A well corticated bone fragment is seen (arrowhead) adjacent to the left femoral neck presumably relating to a chronic hamstring complex avulsion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph Farnam, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42034=[""].join("\n");
var outline_f41_3_42034=null;
var title_f41_3_42035="Lichen simplex chronicus1";
var content_f41_3_42035=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Vulvar lichen simplex chronicus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42035=[""].join("\n");
var outline_f41_3_42035=null;
var title_f41_3_42036="Culdocentesis";
var content_f41_3_42036=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Culdocentesis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 392px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Mann, WJ, Stovall, TG. Gynecologic Surgery. Churchill Livingstone, New York 1996. Copyright &copy; 1996 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42036=[""].join("\n");
var outline_f41_3_42036=null;
var title_f41_3_42037="Injectable soft tissue filler treatment sites";
var content_f41_3_42037=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 543px\">",
"   <div class=\"ttl\">",
"    Potential sites for treatment with injectable soft tissue fillers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 523px; height: 561px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAIxAgsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKQsKAFopNwppfFAD6KhMoHehZge9AE1FRmUe1KJAaAH0UgNLQAUUgOaWgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooJxQKACiioZ50iQszAAUAS5pjSqvUiuT1fxVbWecyDj3rjtV+ISxhghB9MVnKrGJag2eqT30UYyzAfjWZca1bxklpVx9a8OvvG97dFtshC9qxzrlwzEvKxJ9TWLxCeiNVQZ7vc+L7OHI8wmqcnjK3POcfjXibao8g5Y1DLfynjccVP1hlKgeyP41gMm3P41ai8W2/GX/WvDPtL9dxo+3yjo5qHiGivYHvB8UwN91xV2x8RQOQDIAfrXz8L6bGQ5/OpIdVnSQEyN+dNYpA8Oz6Xi1a2K5Myj8alXVLZvuyqfxr50fxDclMK7Z+tRR69fRtkSN+dV9bjexP1Z2ufTEd3G3RhUvmqe9fPeneNdQgkG9yV710lt8QsnEoK+9aqvFmboyR7D5i+tKHB715dB48gP3n/Wtiy8XW8rKBIOa0VREezZ3YIorLsNRjuEDKwOa0VcN0NVciw+iiimAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUx3Cgk02aQRqSxxXC+MfGEGnQSJG48zHrUykoq7KjFy2NLxH4sttLyrON/pmvMPEPxBnut8UR2p7Vwuu63PqN08kkhOTxWSZc9TXn1a8paLY7adBLVmtearcXTHzJGI+tZc8pPUmmb896jl55rFPXU2suhNG5x1p+45qvEeKkJpXHYsRvTmbmqyNzT2aqvcksFvlqDcS9PzlKiiGZKhlIvLwlQFvmqWU4SqsZy+Khdxl+EZ61KcE8U2MYSpIV3NmpT1Gx6pgVHKewqZ/lFVJH5qkxC79o61Nb3zxuCrkYqgxJNAFaKfKLluei+GvFpgKxzMR75r0rR/EMVwq/OPzr52Qsh4rTsNYubRhsc4HbNbwxJhPD3Ppu3u45VBDCrQYHpXiXh/xc+5RI5/OvQNM8TQzbQzDNdkKqkjlnScTrqKgt7hZkDKc1PWxkFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFBOKACmu4Rck1FPcxwqWdgAK4Hxb4zjg3RWxBb19Kxq1o09y4wctix468RpZ2rpG4DnjivBNcv5r2Zi7k89619c1SW+lZpHJrBkAPavOq4lSZ3UqNkZjIxNAjNXSntS7B6Vj7S5ty2KRQiggkVcKD0ppjGKXMOxVTjipDSsmDQVOKpO4WGd6R34oIINMbpWiRDZIkvGM0sUmJKqEkGhHO7NDQI2JGylQQn95UBmO3GafA3zCs7WRRsJygq1CAFqnA2QKthsLWQyG4b0qt7mpZOSTVOaTBwKpajHkgtgVPFHnmorSPecmtAKFFEtAuQMlREYNWGOaaYyRmnFiYRSNGcg4rV0/WZbdwd54rGcYFQkmtVUsQ4XPYfDvjYIESXp65r0XRtWi1CIMjA18vQTujDBIr0LwR4p+xSCOU5U98120azkctWjbY91BorF0vWIruNWjYMprYRgwyK600zlasOooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiimSyKikscCgBxIA5rJ1bVobOMl3AxWR4j8TQ2aMqsM15P4i8Ry3sjKrnbXBiMbGn7sdWdFKg5as3vFPi95C0Vu2QeM15/cSyzOS7Ek0MxY5JyaaXArx5VZTd2ejCmoohMJbqaT7MKlMoFMMw9am5oRmBaQwCnGcetJ560+ZoLIYbcUxrapxMvrR5o9aaqBYpNbmozGVrQLA0nlhq0jO5LRlOvNRFM1qyWuelQ/ZTngVvCRnJGRKnNQ4IraktT6VXezbPStdyDM3kVYgk5FE1uR1FRBCpqWM3LR84q8W+WseyfFXzJx1rJx1KuNmk2g1TjBkkFSXDZFJZDMgo2HuatvHsQUSP2FOzhKgYgdahK+oMevXJpXlAFU5bjHAqLzcnmrsSTyyZqu0gpk0wAqk8/JwapDL4lxTo7tomDKSDWZ9opDNmtY6aoh67nqXgfxQUuEikfCnrk17lpNytxArA5BFfH1rdvbzK6kjBr334a+JBdWkccj5KjHWuylI5asOx6qKKjhcOoI71JXWcoUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRSE8UANdgqkmuF8aeJFtVaJH59jWr4t1tNOtHwRuI4rw/WdRkvbh2diQTXFi63KuWJ00Kd3djdW1SW7lYljg1l555oY03NeNy3Z6KVh5bioJZMdKec1C6ZNVyqIyBpGNNO41PtVetBdBQrvZCbKxVqjcsoqy7rUDnNUoNk8yIPMcd6BK471IVz2pyxZ7U/ZC5h0MzZ5q9A+6ooLQtjArWtNNdsYWrjTDnGwqCBkVYjtA5HFXoNMfIyDWraaY4x8tXGNhN3MZdMLD7tObRiR92u3s9NyvK1ZNgo4xVrQnc8yuNDY5wtZN3ozIT8tewNpyntVG70hX/gBoumGx5Eto8bcqaWVGC16RP4eDDhayNR0FkjJC07XFc4KQnNT2Zw9XbmwZHIIqHyGj5xUSjctMts/FVJ396C5qrM5JqFCwXGu/NML1G2etQyS44FUoiuLO/vVZjSO5PNMwTVWQEgp4FRgYpd2KoQpBrqPA+rvp+oIA5Ck1ywfNWLKTZOp960hJoTVz638M6mt7ZxuPSt8HNeP/AA41gNaxxlugr1a0l3oDnNd9OV0efONmWqKKK0ICiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiikNAAaq6hcCCBnJ6CrVcZ4+1MWlmUVsMaicuVXKhHmdjzjx1q7XV26qx2g4riXkOat6jOZ52Ynqao4ya8OtUc5Hq04cqHDJp4AHWhRgUyVwBUxLYSOAKqyTYNNlc1AQXrRQXUhyYST54qPexNSLbkmp0tT6VqklsQ7lcZNSxxMe1aFvYM5AC1u2GhvIAdtUI52O1LdjVqKwY9BXY2vh88ZWte10Fdw3LSsgscdYac24ZQ11mm2I2gMlb9vpEaAfKKvxWSoOBSWgGVBYpkfLWnb2iKPuirCwBT0qdUp3GRJAo6CkeHNWlFKVp7kmeYu1KIAR0q26CnKtQkNszntgB0qpe2KyREYraKZNNkjBXFUtBHnd7oW+QkLxWXfaCyxkha9Oe2UnpVeeyR0IwKVyjxe50542I2n8qpNp7s3CmvWb3REck7aonQlA+7QmDPKLy0aPtWTLE27pXquqaBuBKrXNXegOuflpgcbHAXPSrkdkMc1eltGt3IK1WlnZelS79BgbNcc1BNaAA0jXb1E9y7DBoVxFdo9rU5Bg5pA+TzUqkGrQjsvBWqNa3KDPBNfQ3hq8W6tkIPOK+VNPnMMykHHNe6fDfWPMiSMtk9K7KMjmrR6nq46UUyJtyA07o3sa6jlFoopAckj0oAWiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKSloFADJDtQk9hXinxL1Tz79okPC8V7HqcgisZnPACk1816/dm51GZ85BY1w42dkorqdWFhd3M88nmk4FRM5qKRiRXm8p3pkk1wFHBqo0xakKEnJNAQVokkTqxUBc1ftbQv2pbC2MjDiut0nSGYqSvFVa4bGVaaLJLjC5rVtPDjlhleK7PTbBYkAKitaK3QdqtIls5mw8OogBKity305IwAFArURAKdtpskqJbKO1WEiA7VIBThUXGAUClxS0oouIQClxRS+tACUopKUUwEaigmm0XAfTTRSGgLDSKaV9akoNIZWeMHqKheEelXSKYy0gMia2Vs5FZ13YIwPyiugkSqs0dAzz3WtHDZIX9K42+0p1Y/KSK9juLYPnIrGu9KRgTtoUgaPIzabD8wppt4z6V2es6RyxVa469gkt3Oc1Vm9UTcZ9jU9KT7ER0psd0V4arkNwp9KnVFFJoXjIOK7DwJq7WN+gc/KSBWSFSVMHFNji8mQMnBFa0q3K9SJwuj6l0S6W5tEdWBBHWtKvKPhx4iyiW0rc9BzXqcLh1BBzmvShJSWh584uL1JKKKKskKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoopHOFJoAx/FbldAvSDj92efwr5luJMyt9a+jvHEhXwpfuDg+Wa+bwmSWavNxvxI78J8LGVG7YqSV8cCq7c1xnUIz0kZJYUhUmprWEsw4q0kSzoPD8RklXAyK9M0q32xKSK5TwhY9CRXfQoEUVr0IJY0AFTLTU6U8DmkBItPxTFp26k2ICKBRmipGOFFApaYgooJABJOAKz7jW9Ktji51OxhPTElwi/wAzVwpzm7QVwNCgVzsvjjwrFjd4i0k55+W7Rv5GqUnxL8HRrubXrQj/AGdzH8gK645ZjZ/DRk/+3X/kLmXc680lcYfil4L/AOg7D/36k/8AiaWP4neDZH2rr1uD/tI6j8ytW8nzBf8ALif/AIDL/IOZdzsaO1ctF8QvCMpIXxBYDHPzSbf51cg8YeGp9oi8QaQzN0X7ZGD+Wc1lLLsXD4qUl/26/wDIOZG7RVG31fTbjH2fULOXPI2Tq38jV0EEZByD6VyyhKDtJWGFIRS0VIyN14qCSPirVMYcUAZskdVZYsjFarrVeSPilYZzeoWisjDFcH4gsMFm216lcQg5rnda00SxtxTjKwNHjV4mxj2qBJSp610WuaW8UjHFc3LGUNaWuQmX7a+KkAmte1nEo61yobBq9Y3JjYZPFZuPYu52ujXbWd7HIpIwe1fQPha9F5p8b5ySBXzVa3Svgg17f8L7vzbEJnp2rpws3ezObERVrnodFFFegcYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUVyf3eB3qWo5R8hoA8++LmpGy0JLUdZzg/SvDmctwK9O+Nl4Jbqytl/hBY15kAFHNeTiXeoz0qCtBEbJxzURGKnL5qFsk8VijW4+FdxxXQ6LppnkXisvT4RvXdXoHhyKMbcAVUVqJs3NGsBbRDjmthelRRcAU8GrbJJkqUYrF8Qw6pc6PPFoN1Daai2PLmmTeq8jPGD2z2NcaPh1rep4PiPxtqs6ty8Np+4T+ZB/75ruwmFw9WDqV66hra1pOX3JWt6tCba2R3+o6zpmmLnUtRs7Qf9N5lT+ZrldS+K/g+wJU6qLhx/DbxO/642/rUem/CXwhZvvk097yXOd9zMzZ/AEA/lXWaboOkaXj+ztLsbUjvDAqH8wK6f+Eil/z8qP8A7dgv/b2L3mcN/wALTlvj/wASDwjr2oA9HaHy0/76G79aX+3/AIlahzYeFdO09D0a8uQ5H4Bgf0r0sClFH9pYSn/Bwsf+3nKX6pfgHK+55p/Y3xOvv+PrxLpOnKeq2lv5hA+rL/WlHw41y6P/ABNfH2tyg9Vt8wD8gxH6V6XSin/buJj/AAowh/hhBfjZv8RciPNB8GfD0nOoXus37dT9ougefwUf5NaFv8JPBUH/ADBvMPrJcSn9N2K7C81Owss/bL61t8dfNmVP5msS68e+E7XPm+IdNP8A1znWT/0HNbRzPOsSrU6lRr+7zfoLlihkXw98JRAhfD+nnP8Aei3fzq9H4Q8Nxtuj8PaOjDutlED/AOg1z1x8W/BUOR/bHmMO0dtKf124qk3xp8JBisUl/M2cAR2xy30yRV/Uc9rauFV+vN+oXijs/wDhGdC/6Ammf+Akf+FMk8LeH5E2yaFpTr6NZxkfyrjv+FzeHf8Any1r/wABB/8AFUf8Lo8Kr/r11KA9hJbYJ/I0v7JzrpTn+Ic0TqJfBHhaUDd4d0gY/u2iL/IVSn+G/hCbO/QLMZ5+QFP5EVlw/GPwXJt36jNFnrvtZOPyBq9B8UfBk+NmuwjP9+KRP/QlFDw2fUfs1V/4GF4sq3Hwi8FzHI0gxknOUuZR+m7FUT8GfDkfNndaxZn1gugOfXlTXV23jfwvc48rxDpWTjAa6RSc+xIrUtdV0+7x9lvrSfPTy5lbP5GolmmdUFadSov8Tl+o+WLPPz8Mb+3GNL8ceIbcDoskxkH5AgelB8L/ABDss/2f41guh6Xdmoz+OGPevTDSGsf7fxcv4nLP/FCD/wDbb/iHIjzQ3XxTsOJNP0DVVHXyZDGx/Fio/SmH4h6/Yf8AId8C6rEqjLS2jeev6DA/OvTTTWNH9q4eppWwsH/h5ov8JW/AfK+jPPbD4teFLt/LuLq4sJuhju4GUg+5GQPzrrNP1TT9VhMumXttdx92glVwPrg8VNqel6fqcezUrG1u06YniVwPzFYujeC9A0PVpNS0nT1tbp4zExR227SQThScDoOlZ15ZZUpt0ozhPorqUfvtFr8RrmNeRapXMQdCMVfeoHGa8dlnBeJbMBGIFeaajGVlYYr2rXLbfC3FeV67DsmbIxW0HdWIkrM5dhUkYqSRRmmAEdKdguaFpL5fevZfgzfGeeSMHO2vEEavVfgTKU12ZCflZK0o6TRnVXus+gR0ooFFeicAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAAajfmM09zhSab1jNAHgXxWl3eJCufuqK4WR+cV1vxQ3jxXc789sfSuPxk8149XWbPUp6QQq1ZhQdTUUaFjVoDaMVmyy1aj5xiu/wDDSARAnrXC6emXFdvokm1ABVRE9TplcdqlQ5qpHkirUIobCxYjFTqKjQVMopCZmav4g0fRcf2tqdnZsV3BJplVmHqF6noelclffF/wjbNstrq5v5eyWtuxJPoN2AfzrptW8JaDrGopf6ppdtd3SIIw8y7vlBJAx0PU9q07DTbHT02WFlbWq4xiCJUH6CvXoTy2nTTqwnOfVXUV+Um/wIfMeef8LH1q/wD+QD4G1m4Vj8sl1+4X65wQfzpftvxT1HAh0vQtJQ955TIw/wC+Sw/SvTcUta/2ph6f8DCwX+Lmk/xdvwFyvqzzFfCXj/UAP7V8cLar3WxtB+QYbT+NL/wqWG751vxR4i1A9w1zhT+BDfzr0yij+38bH+E4w/wwjH8Ur/iHIjz+y+D/AIMtsF9MkuGHea4kP6AgfpW3a+A/ClrjyvD2mHH/AD0gWT/0LNdLUNzdW9qu65nihHrI4X+dc9TNswxDtOtN/wDbz/zDlS6Fe20XS7b/AI9tNsof+ucCr/IVeRVRQqKFUdABgViXHi7w5bZ8/X9KQj+E3cefyzms6b4j+EISwbX7I7eTsYt/IHNQsFjq+vs5y+TYXSOtoriv+FpeDP8AoOw/9+pP/iabH8VvBUgJXXIxg4+aGUfzWr/sbMP+gef/AIDL/IOZdzr5rK0nDefawSBuW3xg5/Os+48MaBcE/aNE0uXJyd9pG38xWInxQ8GuwUa7bgn+8jgfmVq1D8QfCU33PEGnDnHzzBf51awOZ0dqdSPykgvFjbn4d+EbgESeH7Bf+ucez/0HFZN18IPBc+SulvATnmK5k/kWIrqIPFHh+4OLfXNKlOcfJdxtz+BrTguILhd1vNHKvXKMGH6VX9pZphv+XtSPzkg5Ys83Hwe0iDnTNY16wI6CG7AA/wDHc/rSf8K/8T2pzpvxA1QY6LdR+d+pb69q9NptV/rBmD+OfN/ijGX/AKUmHIjzM6d8UbAZh1nRNTUfwzwmNj/3yoH60g8U+PdPYDVfBkd2uQPM0+5H57csfzxXphppo/teE/42Gpy9E4v/AMkcfyHy+ZFksoJBUkZweory74v/ABOm8CxCO20K9u5nACXUqFbUE9t45J/2ePrXqbVTvbeG6t5ILqKOaCQFXjkUMrD0IPBFePFpO7Q2m1ZHmvw78X3154Qsb3VbLWNQvbsNPJNBa5i+YnCpzwqjA+oJ710R8T5/5geu/wDgJ/8AXrT0HRbLw/p32DS42islkd44d2Vi3HJVfRcknHbPHGBV+lJxbbSHFO25yV34lhZCsuka5GfQ6fI36qCK4LxPqNvJuZLDVl/3rCUfzWvZ5BkGuU8TW+YWOKINX2CSZ4ZNqUYcj7NfD62z/wCFImpx45tr7/wGf/CtvVI9s7Y9aqQn58GtrozsyomoRE/8et/+Fq/+Fdt8NPEdtpfiKB5bfVQpOCI9NuJT+SIc1kwIOCK6fwbN5OvWh77wKSmlJA4txZ7evjzSMD/Q/En/AITmo/8Axinw+ONJllSNbTxEGdgoLeHtQUZPqTDgD3NdHCSY0+lSLyor1Dzzhvi14yu/Bdj4durOCKZL/W7bT7gPDJMwhk3lzGiHcX+XgANn0NczpXxkjOseK01SzmNnY6jZ6dpdvDZyQ3dzLOrEIyTFcNlTjIQYH0r0vxB4e0vxCunrrFr9oFheR39t+8ZPLnjzsf5SM4yeDkeorkNO0PwF4tvvE6WNm95NNextqU6i5RDcw5CmObhQ6c/6psjPPWgCje/GzQrUwQDR/ENxqUl5cWDada2qTXEU8ChnQqshByGGCpYdeRg08fFSGy0rxLql/YX91Z6RqL2cwgt4LZrcBUIDebc/vDlwMrgk8bB36TT/AIe+GNPvNOu7XTCt1YXE13BM9xK7+dKoWSR2ZiZGYADL7ulZ/iTwB4MFlqGo6vZTxQR3Umt3EsV7cxlZ1Qbph5bg5CrwB07DJoAo6n8XtI01JWudG10G1s4r/UEEMQbT4pWATzQZAc852pvIHUUjfGLQRqhtVsdWe3GqQ6Qb5Y4jCJ5V3RnHmb9pHfb25xxVy38EeCfF2l2OrJbXN/aXdpGEnkvboNdwZ3oJtzhpQDggS7sdPatKX4d+FpZJnbSl3TahFqj7Z5VBuYxhHADYGB/CPl9qAOQ8IfFi8u9A8Qap4i0R7aHTtXmsEeO4tLdNqnAVmmuQPMX+IghTkbc84ZYfE7/hKPGHw6bw1cTw6Lq8mpxXtvPFHvdoIQygsN2MMc5RsHPeuj1j4deC4LTUL6+sJ4IBdHWJmivblBFOoLGeNUcbHxnJQAnA64FO8F+E/BctloOu+GrNnggM97p9w005INyoErkSNk7gBww47YoA7miiigAooooAKKKKACiiigAooooAKKKKACiiigBG5FIOlOPSmA8UAfP3xe/5G2THTaK4pFya7v4voP8AhLGA/uDNcWq4ryK3xs9Ol8CHxqAKcBubFIKngTJFYGpfsU+YYrtNDtzsDEVzuk2251yK7rT4hHEAB0q4iLCJgAVaiWo1qxGKQMmSpBTB0pwqiB9Zusa7pOioratqVpZhhlRNKqlvoDyfwrRzWNrXhfQ9cvIbvV9Mt7yeFdiNKucLnOMdDz610Yb2HtF9Yvy/3bX/AB0E79DmL/4weEbV9lvd3F/L2S1t2Yk+gLYB/Oqn/CyNbvzjQfAusXCN92S6/cKffOCP1r0Cw02w05Nmn2VrarjGIIlQY/AVbzXp/XMtpfwsM5f45v8AKKj+ZNpdzzT7b8VNR4i0zQdJU955TIw/FWYfpQPCfj+//wCQn44S2U9VsrRePoflP416VmjPNL+25w/g0acPSCf4y5mHIea/8Kp+1nOs+LfEV9nqPtO1T7YO7jrxVi2+Dfg+Nt09pdXTHkma6fJ/75Ir0QGlzSfEOZNWjWcf8Pu/+k2DkXY4+3+Gng63x5eg2pxj/WFn/wDQia0YfBnhiHHl+HdIBByCbOMkH6kZrfzSGuSeZ4yp8daT9ZP/ADHyrsZP/CNaF/0BdM/8BI/8Ke/h7RZNvmaPpzbRgZtUOB6dK06TNY/Wq387+9jsjIk8L+H5EKyaHpTKeoa0jIP6VUm8DeFZvv8Ah3Shxj5LVE/kBXRZoq447Ew+GpJfNhZHGXHwv8GXGd+hQDP9ySRP/QWFZlx8GvCEjboLa7tWzkGG5bI+m7NejUZrqp55mVP4cRP/AMCf+YuWPY8zPwoS250nxX4jssdALrIH5BeKQ+DPHFlzpvj2WX0W7tFb9SW/lXpuaQkVr/rBjX/EcZ/4oQl+cQ5EeZlfipp/Ifw9qq+hDIx/9BAr0DTHu5NNtX1KKOG9aJTNHG25VfHIB9M1aJppauTF4761FJ0oRa6xVr+utvwGlYRqgkqVmqCRq4Ciu/WmZ5pzmmCpZSJFGazNdtw9o5xzitRKi1BA1q49qcQZ4ZrcSx3bg+tZflKTla2/FURW8k9c1zXnMjYrR3MzUt32nBroPC741uzI/wCegrmIX8we9b3hZ9uuWeenmCpW6B7H1NbH/R4/90VKvSo7bm3jP+yKlr2UeYIwDKVOcEY4OD+dfPvh7wF4x0Hw3awww6uIX16e51OxtNYKXFzaknyzHIZgFOTlsOjNxuJIr6DooA8G8PeC/iLe6r4Zi8S65r1npkFvO109nqi+YD526GKU5PmNtGCwB443etGw8I/E2W51dNevdVumnttRgdY5Y3srvzInEP37v91htu3bAuM4YkfMOo8d+P8AU/DPjjxNG14F0nTfD8F+kRs1uNsrXOwtt3xs2V4x5gA6/XWb4v6NFqpsZtO1fYmqRaPJeCKLyVuJF3JkeYX2nnkKcY57ZAPPrDwR8TNI0X7D4eur2yVvC1tBsn1ESxxagkyeYkQLnyyYgwDKAmT1zyNCHQ/iJb+G7i2EGtX7z6jFII7q+aCS0i2MHMTR6iXmXOPkknTB5AP8PSwfHbwfPrcunRtevs+0hJ0WN1kMCF3AjVzKMgHaWRQxBwTXT/Dvx5p3jyxnu9JgmigiCHMtxbSMd4JAKwyuUIxyHCnnpwcAHkSeFfidceGdGsdf/tjUIY7XULe4gt9VSKV5XJFvJM4mXzI8EZXe3TkHv7D8KtJvdC+HHhzS9Vh8i/tLKOKaLerbGA5GVJB/A11VFABRRRQAUUUUAFFVdVv7bStMvNRv5PKs7SF7iaTaW2IilmOACTgA8AZrD8MeO/D3ie8W10e9me4e2W8jjntJrdpIGOBKglRd6EkfMuRzQB01FFFABRRRQAUUVgeIPFVjoWuaFpd5FdPcaxJLHbtCgZVMce9t3Oeg4wCc0Ab9FVtOvItQsorqBLhIpRlVuIHgkHOOUcBl/ECrNAA3Q1CDhsVK3SqzkhgR0pMZ4l8XU/4qgn1jFcP0r0r4yWIW/t7wf8tBtP4V5zHEWPtXkV9KjuelRd4IagLGtGyhJIJpIYAo5q7CyqQK573NTc0eM71AFdbANqAVz3h1PMct6V0gHPFarRCJUNWYzVZB0qRnCLmkDLO4UeYB3rEnvnyVjBY98dqqS3F4VOAR9Kok6MzqD1FL5wx1riLme/hYkb2Hpmqkms3MONxI9jQB6GJR60nnD1rz4eJZCO4I96ki8WBSPMBI9qdgPQFkz3p24etcjb+KbZiM52n3rTtNZtbmTbHKN3oaWoG7mlDVTWYGqei67p+tQSS6bcxzeVI0MyA/NFIpwUdeqkEdDSCxrs4VSzEBQMknsKq6Vqdlq9il5plzHc2r5CyRnIODg/qKxfH2o/2d4K1u6Bw6WkgU5/iYbV/Uiqnwpsv7O+HmhQYwWtxMf+2hL/8As1egsJH6i8U3rzqKXybf3afeT1sbt3run2uuWWjzz7dQvUeSCLaTuCjJ5xgcA/lR4l1q28PaHdarfLK1tbKGcRLuY5IAwOO5FcL4yPlfGHwPMvLMlzGQemNhH/sxrt/EenprGgajpz4xdW7xZ9CVIB/A4NbVMLQoPCznflmk5f8Agcou3yQau5dsbyK+sbe7tm3QTxrLG3qrAEH8jXN32r+LbKyuLqXQdBMcEbSsF1mYkhRk4/0XrxWV8FdUa++H9lFMT59i72cgPYqcqPwUqK6bxPIP+Ec1X/r0l/8AQDXNjsN9TxdTDvXlk19z3+Ybq5oabefbtNtLvZs8+FJdmc7dyg4z361Y31zuiX0dv4b0suwGLSL/ANAFU7zxRFEdq/MxGfl7CuN7lI6wyCo5J1XqRXAyeKLg8ogAPqao3GuXEjNulIUjoDRYLHoj6hCP4xVb+1YWcqHH515tNqEjfLGGJ+uaWC5mLBtnz9Miq5R2PSXvox1cD0pFuA/euHT7ZKd3lucdCeKsRXV9GxyrflmldDsdeHzThXOWmpyk/vUxWvbXaygEGpaA0ENEo3RsPamRtmpG5U00B4140Gy+kBHeuJmPzV3PxDUrqDelcI+STmtCCzaTBTzXW+Cws/iGzBxjeDXD8qa3/CFw6a9ZbTz5gFCWqYnsz6+h4iT6Cn1XsmJtIy3XaKnX7or1keYLRRRQBzWv+BfDmv3WoXGr6d9om1CzWwuW8+RPMgV96phWGPm5yMH3qCT4deFpJJXfS8tLqEWqOftEvNzGMJJ97sO3Q9wa6yigDlrXwFoFndXU9hFqFj9peSSSKz1S6t4S8gIZhEkgRWOc5Cgg4IwQDVzw34T0fw5dX91pVvMLu/KG6ubi6luZptgwu6SVmYgDgDOK3aKACiiigAooooAKKKKAMbxnpc+ueDtd0m0aNLm/sJ7WJpSQgZ42UFiATjJ5wDXl83wZnb4dz2MmpG98UyaFFosc91IBbWyKVYpHsiU7Ny/eYM5GMnrXtNFAHheu/BSVYrGLQoNKubNdLntJLPU7mZo4LyXBN7ExWQmTI6ELwBgitTw98M9W0jxPDf6omj+KVFtYwx3eqSMtxp7QoFd4AYpFJJG8cocgZJ617BRQB85WvwM8RQWWrQy6jbXN7dWd1ai/a+EYufNyVM8S2u9yCRy0zkY44+Wty5+DV3pY0CTwqunI9vp13aahHdXc+JJriBY2mRyrk4K52kKMDjGePcaKAPn2x+DPiG1k8Lup0NrnTLe3tZ57qYXkJRH3N5dvLakoxzgMsqHvxXpfjvwnfeIPFXhHU7OW2SDSJbmSdZWYMwkhMa7cKQeTzkjj1rt6KAPnOD4Eay+kC1v5dDuJY/CzaPCzM7CO7+1NKsoJj4UK2Nw+bOeMVpaz8HfEOoeJYNTutUS9CwWQRvtwt5rSSBAreXI1rMxVmBb5THnPzbuo96ooA8i8BfDjV/D3xBvNbmTSo9PufPkkDSLe3bSyNnK3BtopEUAfdLuP5121/wCHNTubqaaLxhr1rG7FlghhsSkY/uqXtmbA9yT710zdKPSgDx/4neEdSXRBcyeLdduhE44lhsgBn/dtwa8qXSbxemv6n/37tv8A41X0/wCK7P7f4evYMZJjJH1HNeJeH9DOpyuZGZIo2wcDkn0rzMYmpq3U7sM046nH/wBnXvT/AISDVP8Av3bf/GaWPTL1mCjxBqnX/nnbf/Ga9ak8GadLCQiyRt/eVyT+vFclfaPNpF75cvzqTlHA4Yf41zpSjqzfRljw9oGoNCSvirWo+P4YrP8ArAa2l8PanjP/AAl+u/8Afmy/+R6n8OtkEeorejGarmYcqOeXw7qf/Q4a9/35sf8A5Hpx8Nak/Xxhr3/fmx/+R66VVp54oUmDSOW/4RfUB08X67/35sf/AJGpreHNRAwfF+u4/wCuNj/8j107vgVXkkpObBROYm8OX5BB8W64frDZf/I9Zd74VupU+fxRrLH3is/6QV108oAyTWNe6hFHxuyfShSfQrlRxt14OvFO6PxHqp+sdt/8ZrKuPDOqxMc63qbD1CW3/wAart3vZW5it5HHsKZ9qk/5aW8g/CtFJrcOSJ5+dKv0wP7d1QHt+7t//jVSR2eowurDxDqqt6iO2/8AjVdtJ9mmbDptPuMVDc6TFMqtC2Mc0+a5PIZ2lz6qzoj+KtZUHg4itP6wVyHhr4eeJNT8d6j4li1y+0eyluGZJ8ILm7UHG4oiqgDYzyvf7p612KabOk3CnaD19a7SwLR2yIx7d6FNxTsS6ak9TnPjLcSr4Eh0xJnnuL66htQ74DOc7snaAOqjoAOa9Gs0S1tILeLiOFFjUegAwP5V5p4wtLrVfGfhK2S3leyt5nu5pQpKApgqCeg6Y/GvQ1lNenjpKGAw1CL1fPN/N8q/CP4lxXvNnD/EFtnxH8ASpw5muEJ9sJx+pr0bzBXmnxA3N4+8AnBwLifn8I69DJxxSzJ3weD/AMEv/TkxRWrPOvAjf2N8RfF+iHIimddQgXsA33sf99qP+A11viif/intUGf+XWX/ANANYOtaBet8RNK16xMYgS3e2uwWwSuCVwO/J/QVd8Sy/wDEg1LPX7NL/wCgmpzWtTxNWlXhK7lCPN5SS5Xf15b/ADCKsmjnPtsjaTpsWflFtFn/AL5FV4oZJZCFU9eTUWn+DvD9xpWnytplpua3jLfIOTtHNT/8Ip4bgU/8Sq0J9TGK812YKLLK6ZI52twDzmp49JDcMQAPSsaTQNAY7YtGtGI9IhUkfhHTpVzHodkP+2YppJFWfY6SLT4Fh2hMH1q7CkUZG1FyPauT/wCEM09QC2h2Z/7ZCg+GNEhGZtDtB/2yFGncq7O2V1OMVJhG7VxkPhnw5IMjSLL/AL9irUXhHw6xH/Ensj/2zFS7C1Z0/lID0FSRoFIK1zn/AAhvhzH/ACBrL/v2Kkj8G+HO+i2P/foUe73FqdVC3NWh0rk4vBXhonnRbH/v0KsjwT4Zx/yA7D/v0KSS7ibZxXxPjKXYOOK8+BHeu9+JPg/Q7W2R7TSrWI99kYFecR6FpxAzZw8/7NaaGepcKgjitTwiv/FS2A9ZVH61kw+GbGX/AFenxt9EzXQ+AvB2mXniyzhudNgkhDbnVo+CPenFJtCk2kz6xhJSGNcfw1YT7i/SuSj+HfhBkBHh3Ten/PEU8fDvwhgZ8O6bn/riK9Q84seK/F1l4dvNLsHt7y/1XU3ZLOws0VpZdgy7ZdlRVUEElmArI1H4gix1vw5p9zo15Z/2tc3FvK186wm28qHzC3G5XXtkNjg8nFT+O/BDeI9V0jWNN1N9L1nTBLHFN5ZkSSKVdsiOqujcgcMrqVPIOa5yD4Vap5Ohte+M766v9Lub24S7kieRx58RjVUMkrlRHwRuLZxzQBteLvifoWkeCtZ8QaFfaZ4gbTER5Lazv42OGdUGWXdt+9np2retPF/h650mbUU13SfsduQtzML2MxwOf4XbOFPscV5TN8CL28ttcGqeMJby81XTI9OluZLWV2yk6S+afMnbk7Nu1SqjOQB0OjqPwVk1U6le6l4jc61d39nfLPa2z28MZtY2jjXy1m39HbLCQNnBBGOQDpPFXxLstIvtAj0uK21i01a2v7hLu3u1KL9lh83AKhg277ucjHXnpV3w/wDEXw/qGh6HeapqulaRf6raQ3Udhc38YkAkHAAbaW5yAcc4rlIfgzHGuk+Xqltbmy/tIuILaZlma8gERYma4kYFcbj8xDei8k53iL4IajrPhqz0FvGlymmW2nW9kkDW0nlrJEQfOVEnVSW29JA+OxHGAD1uDxBo1xqr6Zb6vp0upIWVrRLlGmUqAWBQHIIBBPHGa5aH4jQf8JHr2l3OnmNdM1G105ZvtcK+a08e8NiVkAx02qWY9gelTeEPh9Y+H/FniHxDKba91DVbrz45mtFWW2UqFMYkySQcZOMfSsbWfhT/AGlrmq6j/bPl/btZsNX8v7LnZ9mXb5ed/O7+9gY9DQB21n4q8PXuojT7LXtJuL9mZRbRXkbykr94bAc5GDnjjFJaeLPDt4b0Wev6TcGyUtdCK8jf7OAcEvg/KAQeuK86j+CsOyxSbW2ZLfV7zVGKWuxnW4XaYw287SP73OcDgVT0j4FQ6fptxZTahp+oo1i2nRSXtreOywmUSbGAvAmBg8RrHhsMMcggHrWia5pOvW73Gh6pYalBG/lvJZ3CTKrYzglSQDgjj3rRrlPh14WvfCek3NnqGu3OrmWdpYvN37LZMACKPzHkfaMfxO1dXQAUUUUAFFFFABRRRQAUUUUAFFFFADZPu04UjdKM0ANkAZGB6Ec15zawxWhlEKgR72I/E16LcZ8mTHXaf5V5dqVz9ms/l+8eBXJiuh1YbqbtrcK2ADWf4qsRdaexUfOnzr+Fc9Z3lzbXEZmYlHPftXYs4ntR34rltpZnRszl/DZJzx2rpIhzXPaRGbfUZ4Wx8p4+ldFF1rFGhMBgU2Q4FSdqguDgGgCrNKBWfcXGMgVYkG5uTRHbwgksQacY3BySM1ba4u26lUq7a6DbRvvmwze9VNT8QW9gDHCPMkHZe1YLDXdabcjvHGTwF44+tdMaLZhKtY7wR2Vsv7yWKMD1IFRtc6Uw5ubc5/2hXki6TeajrkmnpI8kynHzOcZrkPHsOs+C9YgttRijMU4yjRnIIojBSvYlza3PoaTT9PuxlVicnupFZV5oRgy1qxx/dNeV6NfXsC21xZzyRtJj5M16FZ+LJocJqkBHbeo/mKlQ5tYmiqcrSkPAZG2uuGFSo471NPcW9/EJLV1bPORVMElqyasdKZNqk19DpNxJpFvHc3wUeVDI+xWOR1P0zXMRRfEq9wRJoWnA9sM5H6MM12VryBXLy/Du51O7ml1TxXrUkUjllhgk8pUBOQAORxx27V7OU4ihTjKNfkXW8oOb9Evh08+5nUT6DBoHxEkIZ/FVhGw6KtkjBfoSmaR9H+I8PKeJdMuO+JbYJ+Hyp0rlfGXh7wn4Z1CGwP8Awkmo3rRGeSO1uATFEM5dvl9ifoMnHFdBoXw+0TWNHt9V8M+IdftophlStyMqw6hgACGB469vxr6Ot7OlQjiKjioS2bw8Lfg21fW3cyTu7fqdN4e/4SCOynHid7CS4D4je03YK475A71R8TSE6LqP/XvJ/wCgmuhFpLZaTFa+e9zNFEE86c5aRgMbmI9e9cPqVr4lubO4t2bRwJkaMkebkZGK+Hr1FVrSmrLXorL5LobdLFzR3P8AYWn46/Zo/wD0EU+Ozku5OcgZ6Vd0mwNvYWsDYd4oljyO+ABmtKWaDS4TLckK2Mhe9Zr3naJTdlqTaZoSKAWArZ/4l1jHm5nijx6sBXGpqmqazKEsFaC3PG7ua5PWLGebW3tHMkrocYJzk1vKmqavJnN7VzdonqbeIfD27Z9vh3e5pwbTdQBFvcQyewYV85+O/wC2/Cl3EbzTvKt5uY2Yda3vD7Ne2drdIHgkkxnacGicYxs3oTGcm9NT1y90QD5ojt+lVEhmtWxJyPUVjm913QnVZ2a5tuuHGTj2NdLY6jbanCrxd/vKeoNTOk4mkKqkMU7qmXg4qw1sAMrULLisWrGydyaJuRVqM5wKpR9atxdaQHNfEG387TCccivPPBmhNrOsxwNkQL80hHZR/j0r1HxiudLf6VH8LdKS30w3bD95cEn6KCQP1yatK7sZydjqbLSbSwtFit4UiQD7qjH5+tQW8dra6vBePEuVO0uBztqTVdRSBsFgB71mrci6Q4NaXs7oztdanpqAAcdKdVPRpPN0q1c8nywD9RxVyvSTurnA1Z2CiiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAA9KTFKeKap+ZvSgBswJjcDnKkYryLUQZL+CE8jOSK9gPavLrq13eJ5lxgR5/nXLiVszpw73KmswDyflGMCtLSJzJZR5Pbmo9VjJhIAqLRgUiKHsa5DqJxBjVzIBwyc/WtZVA5qGNAX3Ec1YrJ7lIcOlQXC5U1OKa4yMVIzDud4+7WPfC5ZGVGIzXVSQA9qrSWgI6VcZcuo9GcdoFtHDO6365lJyC/Q16BpbxeVtG0ZrGezjcbJ4wyA/iKfBbXELD7JKkkY/gk4P512wrp6HJUo9jjtcWfw94wkvFDCCVtyyDtWT40WLxTdQXd9IJDCMIOwr027hN7CYb/T5GX2wwrF/wCEXsC+UsbkD04A/nWMoNX5Hoy4tO3MtUcV4Z0mXUNVtoIFxHGwZm7ACvR/EthayptKLuAxkVNbW4sIyltDHAvqTkn8qo3siku077kAJZmOAB70Q/dqy3ZTg6ru9jn7OyW0QvbzhXB5jxwa1oFE1usiqRu6iuQvPH+hJeG00jT7vWbleosoi6/n3+oBFb/hDxNaeJILkW0M1rPasEntpk2vGTnHHpwfyrrxWU46jR9vVpOMVbV+e11uk+jaN4zjsjds4iAOK2bdeBmqtrHhaugrFGztwqgk/QV5i1BnnnwxjXV/G/jTX5QH/wBK+wQN6InB/MBKb8OY/wDhHvHfivwuOLTcuoWidlRsbgPpuQf8Bqz8AUY+BXupPv3d7NOx9Twv/stR+Jx/Zvxs8MXoJVNQs5bN8dyu5h+rLX2mKl7XGYzAfZULJedJJq3yi/vZzrRJ/wBana3yZU1izRDdXRXY+U1iXH3q+JOhE+kxKJXYrnauQPU1g3Edtf3MkmpsVm34EZ4CjPSta2lkhbcuKfcTLNy8WW7E81pTqKGgnFyZoaX9nt0VIgqr2xXG+LIpNN8TJqcCZiYgk+4rfiCbgWUqP9g4NT3VjHdwsqXKMjcGOdf61vOaqxtszCNJ0nfdHJ+Np7LxnaWy3+zy4TvCjrmsbSdOE+pWtraL8isM4HAArrm8HBmytqrg/wDPOfitPT9Pm0uMrbaXtb+8ZBz+NR7KdSSc3oPmjBNQRe1sQG1McigqBjmuK0y2dNQeW1YrGD07Gukksru9YvfSJDHn7itkkfWrEFnGhCwphB0rpqT7GVOnbckjLNGM9aSRM1c8naBxTZErjep1IrRpU8a4NIqYqRBU2GZPiiIzWQjXqxwPrWzYIlhp0cKYCxoEH4Cqd9H5lxarjgSBj+HP9KXU5THbSHPQVcSJGFdBtR1B9xPlrwKdpDGG6kt2J+U8Zqxo0Xybj1JzUTJs1xf9oUyT1Lw6ANGtsehP6mtGqmkoYtNtkPBEYz+VW69OGkUefLdhRRRVEhRRRQAUUUUAFFFFABRRRQAUUUUAQX90ljY3N3KGMcETSsF6kKMnHvxXnHhf41eGPEseiHTotREuq3zWCQyRxh4JAm8GQBzhSvIIzn8DXomq2n2/TLyz3+X9oheLfjO3cpGcd+teRab8CLPTtW8H6pZ61JDf6HCIbiVLUYvdoIjfaWIRlDEZO7IwO1AHpOn+MfDGpC5OneI9FuxbRmWcwX0UnlIOrNhvlHuaavjXwq2mPqS+JtEOnJL5DXQv4vKEmM7C+7G7HOM5rzEfA+9ub6e81zxQmt3E1hJYSHUbS4lWVGlEgLD7UCuMEARmMA4OMg51LP4TanbDR7o+LprnVNJvprqza8tpLi2hjkjEZhEbzGQqABtJlJH40AdtJ410Qa1YabDfWc7Xdu90s0d9bbUiUE7ypkEjKQrfMisODkjFXYvE+gS7PK1zS332xvV23cZ3QA4Mo55TII3dPevI9K+Fl9p3inwrplvFdPoWjWGoxXGqTSRL58l0vSKMOzLgseGUDjqepr3/AMCJ/wCxZIrrXZr9bfQTosENjYrDK6ifzkbdJPtLZ4IJUEdxQB6zH458Jy2c93F4o0J7W3KCaZdQhKRl87QzbsDODjPXBrO1Hx/YR674TstJNrqtpr888C3ttdqyReVGXJG0ENnGMZGK868N/DrxlqN34qv73U5PDFzqUunrC9vGqvLFbRMjK6Qzt5atlfuTbuM5HSt7wj8Hf+EevNDn/tz7R/ZmrXmqbPsrDzPPiCeXlpWYbcZ3EsT39aAOh1j4hWtl8S9O8GwLYvdT2xu7ia4vhD5S7gAirtYvIRlgh2/KM5xTfGXxM0bRPBOseINEutO186YYhLb2l8hwXlVMMy7tv3s8jtR4k+HkOv8AjK/1u51GWKC88Py6A9tFHhgryFzKJN3XnG3b+PauPv8A4Gy6npV7bX/iRDcyaRa6Lbywaf5aRwQTJKGdPNO+Q+WBuyoGeB2oA7Hx58RdM8ManoumRSWd/ql/qltp8tkt4qTW6TEjzmTBbA44IGdw5Fdbe6pp2nyLHfX9pbOw3BZplQkeuCa8yv8A4QS3HiCW8g16OOxl8RweJGgex3zebH1j83zANhycfJke/f02+0rTr+RZL6wtLl1G0NNCrkD0BIoArN4j0P8A6DOm/wDgUn+NcXdaxoza5eyrqun4Z8A/aU54+vrmu0PhzQ/+gNpv/gKn+Fcnc+H9HXVrxRpWn4DcD7MnHH0rnxPwq5vQ3ZmahrujhT/xM7E/S4T/ABqjaa7pQ5OpWPP/AE3T/GjX9H0pGVU0yxXJ7W6f4VUj0rS8xxrplkWY/wDPBP8ACuPQ6tToodd0jbn+1bD/AMCE/wAaf/b+kf8AQVsP/AhP8aig0LSRGAdLsCf+vdP8Kc2h6Rn/AJBVh/4Dp/hWcuUtXJBr+kZ/5Cth/wCBCf404a/o/wD0FbD/AMCU/wAaiGhaR/0CrD/wHT/CnDQtIx/yCrD/AMB0/wAKS5R6kh13RyP+Qrp//gQn+NMbW9H/AOgrYf8AgQn+NOGh6Of+YVYf+Ayf4Up0HR/+gVYf+Ayf4UWQtSq+saOf+YpYf+BCf41EdY0kcrqth/4EJ/jTdYXwno0YfVYtFswRkCaONS30GMn8K5iTxt8M0cq02nEj+7pzkfmI8V24fLcXiVzUKM5Lyi3+SFzW3OrHiHTwMDVrH/wIT/GuIsfi7pC+Jr/Qdcu4rC7gmKxXBkBtp0PKMHzhTtIyDwDnntXR6NqXgTWnVNOk0SWVvuxmJEc/RWAP6Vj6f8INBbxPf6/r1tDqF3cTFobYoBbW8Y4RQmMMQoGSeCe3es6lGeHk4YiLi+zVn+Im27ctjrppYvsbXklxH9lVDIZtw2BQMls9MY715jBb3/xOvpGWSWy8IQSbRt+WS8YfyH8vc9N74srJdv4d8IacRbR6tPtmMa4CQx4JAH45x/s4713aw6d4f0ZF3Q2WnWkYUF2Cqij1J/ya9jCy/s3DQxEFetVvydeWKduZL+Zu6Xa192im+Z26GZY6XpfhzS3W1ggsrKBC7kDAAA5Zj347muN+FCPquo+IvEskZjt9SuAlspGCY0yM/qB9QaqajfX3xR1A6do3nWnhOFx9qvSpVrojnYoPb2/E9hXpthY2+n2cFrZxLFbwIEjReigUYvmy/DTpV3evWtzLdximpWf96TSduiWurCPvO62RaiXAxUWtP5Oh6jJu27LaRt2emFPNTpVLxT/yKutf9eU3/otq8PCx5q0F5r8ypbGB8DItnww0c7SpczMc9/3z4P5YrP8AjD/ous+CNS6C31ZI2b0VyuR+SVt/Bgf8Wy0L/rk//oxqyP2gh5fgq1uh9611CGYeuQGH9a+povm4imn9qpNf+Bcy/Uxv7h3d2PkNcZf69p0XiCDRhcLJqcwL+RH8zIgGSz/3R256k8V0XijT/wC19Jnsxe3lkJR/r7OXy5F/3W5rwfwx8LtR8KeO3mOoXd1pl7E8f223fy5o3yGAkHOQdpGR3xnFfJqEXe71NOaSasj223XdVoW4YdK5e28Nc/8AIb1wfS7/APrVpw+Fdy/8h3Xv/Az/AOtUcqfUtt9jVa1x0pjW5AqoPCOR/wAh3Xv/AAM/+tR/wiAI/wCQ7r3/AIGf/Wosu4ud9iwI5F+6xH0pGWZ+GdyPc1XPg0H/AJjmvf8AgX/9alHg0D/mOa9/4Gf/AFquK8yXPyLsFsQRnpV+KMjjtWMPB4H/ADHde/8AAz/61PHhED/mPa//AOBn/wBjV3XcltvobjL8tV3Wsl/CfH/Ie1//AMDP/rVC3hP/AKjuvf8AgZ/9apaXcabNgLTlGBWCfCmP+Y7r3/gX/wDWpp8LY/5juvf+Bn/1qVl3Ku+x0O0EgkcjpWfqa74dueprNPhfCE/27r3/AIGf/WrNuvDoKH/id64cet3/APWqkl3JbfY6XTYNiACkntd2t2eByzbaw9K8Oecv/Ic10Y44u/8A61aMXhENqtmP7d17PmLg/a+R9OKpJXIbaR60owOOlLXKDwb/ANTH4k/8Dv8A7GtHRNA/sq6ef+1tXvdyFPLvLnzEHIOQMDnjr7mvTPPHSeJ9AiXUWk1zS0XTWC3pa7jAtSTgCXn5CTwN2K11YMoZSCpGQRyCK+XviB8HvFupL421TQrZk1LU9WkQWxuYwt9YN5bKeWwpWRNwDYOM+wPY6l4d+IzeKnktJtSB/tK1ktLuPUlSxgsVTEkMltvG989/LbPXcKAPcaK+f7bw78UhH4kSxn1JZ7i0la0v9WvtkqStKD5SQxXU0A/dggPsjIJ/Ptvg1pPijSl1b/hKbjV3SbyWgg1BkkELBSJPLf7VcOwJ2k7iuD0GCQAD0qiiigAooooAKKKKACiiigAooooAKKKKACivNvFGuavd/FzSvCFnq0uh2Eulyai11BDE811IH2eShlR1G0fOflJx6da4PVfiFq/hLxr4q1NrpfEuladpFhLKiXhgibe+xpokAdNxJBIBUHnnoKAPoWivJrP4vy6h4zm0fS/CuqXlhb6ium3F5FHM7QkjmVlWIxiMHuZA2OduOa5XXvjFqPibwJr82k+H9Y02yl066ktdXh88eS8eQA7+UqIxwcbJHweDg8UAfQdFedfBbxvJ4y0OUG3aNNNSC1ea4nJuJ5PKUs7xFcopJ+ViSW5OBXotAAaKDQaAEPUVzGtJ5Ossx4EqBvx6f0rp3zjjrWfrll9stCYxmeL5k9/UVlWhzRsjSlLllqeeeJkKyRt/DmqekKJdTz1CR5rdv4V1CzKnr6+hrA0INbaxLBLwxX86887jpU6UvemqeTTh1rJmiHqKU0Kad1oQwUGvNdd8Taz4o1+fw74HdIIbY7b7VmGVi9VT36j1JzjAGa1Pizr9zo+gQ2Gk7jrGrSi0tQp+YZwGYfmB7Fga3/A/hm28K+HbbTbUKXUbppQOZZCPmY/09ABXv4SnTwOGWOrRUpybUE9VpvJrrbZJ6N3vsZN3dkc9oXwr8PWLm41OOXWdQc7pLi+YvuPc7en55PvXXwaDpEMYSLS7BEHRVt0AH4YrRxilFcGJzLF4qXNWqN/PT5LZfIailscnrvw48K61Cy3GkW8EhHEtqohcH1+Xg/iDXHXUfin4ZHzxcTeIfCqf6xZP+Pi1X1B7gfl7L1r1+msodSrAFSMEHvXVhs5rwj7HEfvaXWMtf/AXvF+a/ETit0cHrmi6f8Q9L0nWdD1aSzurZjJa3sC7imcblZcj06ZGPzqhF8LPt93HP4v8RajryxnKQPmGL8VDH9CKp2dv/wAK6+JcFjb5Tw14hJEUeflt7kYGB6ZyB9GA/hr1V+BXdi8bistjCGEq/upK8HZcyTbuua1007p2dr69RJKW+5QitreytY7azhjgt412pHGoVVHoAKZn0qaY5qFRk18vKTk23uzdbE0faqfidS3hbWQoJY2UwAHc7DV5eBUOqo0mj38a/eeCRR9SprbDPlrQfZr8yZbGB8FmDfDLQipyPLcceokeq3x3i8z4YasRnMbQvgDr+9Qf1pPgRIH+GGkKM5RplP185z/WtH4wx+b8NdeGcYgDfkyn+lfSt+y4hb7Vv/bzn+z8jR05/tGi2M3ynzLeN8r05UHiqNwuHNT+EGM3grQJCMF9Pt2x9Y1p13Hg181i4clacezf5nRB6FS3b5617VhgVjqcNWhZt0rCLLaNdOlSBaiiPFWFqzJgFp20YpRS1aIYwjimEVKelRNSY0RuKjYVI1RsakohaomqVzURoKEb7tc7cs0d5PEenUfSuhk6Cuc1uQJqp46xgVSJZe8OkmR/TNdNYoZNbtBj7pLH8BWD4bgKwmRxgHmur8NwmW7muyPkUeWh9T3rSkrzRlUdos6IdaKQd6WvSOAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACivEfHXwv8T+IfiEmu2s+gW8MF/aXdvPHGsFzsjwHWRxA0jkjgfvguAMr0xWsfhJ4lttd0xhe6UlhYa9e6qlzHNJ55SdQAPLMe0MpGfvkH8OQD2XW9B0fXoY4td0rT9SijO5EvLZJlU+oDA4NRT+GNAuFuFuNE0uVbiFLeYPaRsJIkxsRsjlVwMA8DHFfMGh/DXXNUvRo9lpUcMkWi31rca1Pa3Nsl5NM52PKZoUdn552+ZgDr2HY6z8DNVnsdbj01tDt7i5tNMFk+518i6gKedNkR/KWAYBhljnnGTQB7XceFPDtzq0WqXGg6TLqcTI0d3JZxtMhX7pDkbgRgY54xVLUvCvg+zTUNWvvDuiKfJke7uDp8bO8e0l9xC5YEZyOc15vN8JNaf4oT+I576O8t21VNQgm+2LbzwRjgwkfZpGeMDI2CVFI6gHms3wv8DNR0yw0C3u5NFDQ6TqGnanJCGb7S0zO0JwUHmBMqfmxgrx0FAHsnhWPw9fWUGv+HLSyWK/t49l3DaiJ5YVGEByobaAAAD0FOk8U6Qms6jpIuJZNS0+1F5cW0VtLI6xHOCoVTvJxwq5b2rxLUPgx4kuvA+j+HktPCFutpaTwTyxorSyzMoCziV7VmXJA3KoVvlGJPTRi+DusRXd1cyR6BeXl94XXR5bqZ3WW3uxbNEZkPlEuG4BYlW2k8HGCAe5Ws6XVrDcRiRY5UDqJY2jcAjI3KwDKfUEAjoRUjHArwDVfgx4huraOEXekTzHStNsYb2eWQS6RJbKoka1AjOQ5UnOUPP4VcX4PatH4gTWFuNLN8vi8a2Lre4mNiVw8WQn32IBK/dPrQB7pRVa/innspYrO5+y3DLhJtgfYfXaeDXPf2J4n/6G7/ymRf40AYl6H07xBcW7H9zIxdPbPP8AWsrWd1tq9ncovyn5WIpfGnh/xCk8U7+JvNfGQfsEa9PxqtDpWvXMCM3iQEdRnT4+P1rzakeWTO+ErxTOiU8mnE81zZ0nxAJCP+El/wDJCP8AxpDpXiDP/Izf+SEf+NYyS7myb7G7f6ja6ZbG5v50t7cMqGWQ4VSxCjJ7ckDJ9avIQwBByD0NeY/EbStb/wCEG1iObV5NRE0BgS0j09C0zv8AKqjByPmI5HTGe1Uvgl4L8Z+GrSH/AISHXitiF+XScCby/wDtofu4/urke9OMFy81xOT5rWNaRBrPx1ijmGYdF07zUU9PMcjn8nH/AHyK9RArzDST9h+POrxSDaNQ0xJY+fvFdq/+yt+VeojpXtZzo6EVsqcLfNXf/kzZMeo0rRin0leKMbSiikzzQM84+P0P/FDJfxcXGn3kNxE/dTnb/wCzD8q7xLpZ7aKZMbZEDjBzwRmuC+Plx5fw7uoQTuuZ4YlUfxHeGx/47XXQoLayggHHlxqmAc9BivYxTvlVBy356lvS0P1uKK95k8j56URjJqq0lXbQZUE14Zq9CZV4p5iEkTxvna6lTj3pRSiqi7O5DPPf2fHL/DqCNjzFcyoR3HzZwfzrpPinH5nw68QKTjFm7fkM/wBK5n4DN5Oha5ZtndbavOmD1AwnX8c10nxVlMfw68QMoGTaMvPvx/Wvq8av+F9uPWon97T/AFMF8Ivw+fzfAPh1iMYsIF/JAP6Vo3ce5Se9UfACLF4C8OqCSP7Pgbn3jU/1rXkGQa8DMUniqtv5pfmzaD0OclykuDVq0f5hzSalDj5x2qvbvhq8/Zm61R0lu3FWVPFZdrLwKvo+a0TMpIsZpd1RBqXNO5FhzNUTGlLUwmhsaQhNRueKcTUMhpFIjc8009aaT81KOaYxG+8KwLaEalrVzM3MSEKPeti6WWSOVICBIVIGaqaNZvplg7XBHmMSxqkZs1omV7m3sYTiSQheB0Hc13EEKW8CQxDCIMCuM8CW5uL+e/k5KrhPbP8Ak13Fd2HjaPMcdeV3YRRhQDS0UV0GAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABjnNNI4Ip1IaABfSlzR3ooA5vxrC7WsE6/dRijD2bHP5j9a5zSAywFW7Gu81W0F9p89vnBdeD6Ecg/nXC2k20GNxtkU7WHuK4cTG0r9zsoSvG3Ykl4mpM/NUV5KFmj54Jp7cNXJI6okyVZjAqrGasxmpQ2ec/Fu3n0fUtC8Z2UbO2ly+VdqvVoH4P82H/AAOvSdPvINQsYLyzlWW2nQSRuvRlIyDTbu1gvbSa1u4lmt5kMckbDIZSMEGvKLabVPhNeyQXMM+o+C5pC0U0Y3SWRJ6N7c/Q9Rg5B+joQWa4WGHi/wB9Tvyr+aLd+Vf3k7tLqnZbGL9136HsBOBTA1Z+i65puvWK3ekXsN3AepjblfZh1U+xq5uxXhVKc6UnCorNbp6MtakzNimB6jdxjJ4Arzbxb4+kubo6B4GUajrMgKvcR8xWw6Fi3QkfkPc8V1YLAVsdU5KS0W7eiiu7fRA2ktSp4vuB4u+JOlaFanzLDRn+237DlfMH3U+vb/gR9K7+Z/Wue8E+GYfCukG3Ehnvp2827uW5Mr/U84GTj8T3rXmfPStc2xVKpKGHw7vTpqyfd3vKXze3lYunFrVkM83zBQeScVsQTKkaqOwrn7oFHiY+tFzfm2t3lIJCjPFeRe5o43OmWcHvUqSA15IfiDcRzEGxRo88YfBxXV+HvE9rrCkQMyTLy0b8EVpZoy0ZmfCdhbeKfHtl0Eep+eB6CQuR+gra+MFx5Xw111srzCqc/wC06j+tcpoFz/Z3xm8QQn5Uv7OK4UepXav/AMUatfHDUM/D67gXO64mijAHf5w2P/Ha+vlH22dYafSfspfhG/4pmNrRfzOz8JDyPB+hw8/u7GBOevEair0s4A61jS30Wl6VEJnCxwxqmfoMVwt746u3uCtnBH5WeC2cmvlq9T2tWU11bZqko7npMriRWU85rIjbbIyf3TVTRNTlvrJJZo/Lc9RXE/F2OWTRoZ281tPiu4zdpGcFozx1+uB9SK1y/B/XsXDDuXLzO19/w0u3stdzRvljzHqls+B1rShk6V4ro2oXHgTWLO2uryS98KaiB9kupDnyGIyAT6fpjkdCK9dgfOK0zDL5YKUWpc0JK8ZbX7q3Rp6NdAUuc1lenbqqRvxUobNefclolLU3NMJpM0wsOY8VXlNSMeKrymgaGA809etRrUvARm9BTQmJbHdK5qrrD7gkA6uas2Ayhb1qtfwlrlXHLE4UepNWZHX+EIVi0slRwzED6Dj+ea3KradbCzsoLcHPloAfc9z+dWa9KEeWKR583zSbA0UGirJCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKRqM/NilNAAKKKachwex4oAUdcVg65oAvJDcWbJFcn7wb7r/XHQ+9b2Oc0d6mUFNWZUZOLujg5vC+puC80lsqxjdhXJJx+FVg24A16MeRg151Knl3E0eMbHZcfQ1wYmkoJWOyhUc27kkZq1FVOLrVuM1yo6WWl6Ukyq8bRyKrIwKsrDIIPY01DTnNaJkHnetfC3Rbi9N9ok13oV91ElhJsXP8Au9vopFU/+EU8c2o8u08cmSL7uZ7NS2Pqd3P416QxxUZPevWjn2NUVCpJTS/njGf4yTf4hyI82l+HOo6qceKPF2pahAfvW8I8mM/UZIP5Cuu0PQ9M8PWf2bR7OO2i6sV5Zz6sx5P41ru1VpTngVz4vNsXi4eyqT93+VJRj90Ul+BcYJakMrZPFJHFk5NSxxZNWUixXmMu5RubUSRlTWY8J2tFMuQePY10eyo3t1bqKm2oKRwN94ZgkJKKBntiqWi+Hp7DWFuEOEAxwau/FPxOfCel/arCfTJ7uE75dPuJdsssfcpg5BHXkEYz7VnfDDx7J49aX7N4fvLSCHiW5aVXiVsZ2g8En6D644zsoz5eboZuUObl6lbx5N/Y/jPw34hbi3DGyuWPRVbOCfpuY/hTviRKNS1zwtoifN514LmRR2RP/rF/yq/aAeMdQ8WaDqsMZsbKWOKJ48hsndk555BUH8eaw9a8Lz+BdFvvEMGoS6jqNtHHBA10uRDGXCkAZ9Dj86+1wSpxqUKVaVsRTXLFdJe0V6bv05XPXySsRJ722Oy8T2cupWXkxnBzWPpXhgRAG4AODmu20yIXtjbXGBiaNZBj3ANaiaenfmvi3Fwbi+hpdbnNwxFVEcK+2BV6fRYbzSbizvY98FwhSQeoI7VvQ2ccZ+VQKllT5CKIylCSlF2a2ByueG+HbJZYNW+H3iJsyQAvZTEctH1Vl9xnOPTI7Guh+F+tXJjuvDusnGraUfLyT/rYv4WHr2H0KnvU/wAVtCuJbS38QaQNur6QfNXA/wBZEOWU+vr+Y71y/iS8E9no3xA0FD5lvhLyIHloycMre6nIz6EHsK+19zNaHZVn/wCA10vwjVX4+hmnyv0/L/gHskbVaTmsbSdQg1Cyt7u1cSQToJEYdwRmjX/Eml+HLNLjVrpIvMYRwxDmSZz0RF6sSf8A6+BXxDhKMnFrVG0mkrm6RxUZ4qQHKg4x7U1xQSiJjVdzUz1A/WgYqU2+kEVjIx78U9a2PDkKzXzl0DKkZ6jIyeP5Zq4R5pJGdSXLG5zlpdbbYDvW94Z06S7u1vblCLePmIN/E3r9BXSDTLEMWFnb5P8A0zFZXiXxl4f8LX+kWOvailjPqshhs1eNysjAqCCwBVfvryxA5rthh7O8jjnXurI6Gisrw/4h0vxCuoNo919oFheSWFz+7ZPLnjxvT5gM4yORkehrVrpOcKKZPIIYZJWBKopY464HNZHgvxJZ+LvC+n69psdxFZ3qGSNLhQsgAYjkAkdvU0AbVFc/oniux1jxT4i0C2iuVvNCNuLl5FURv5yF12EEk4A5yBz61raffw34uDAlynkTNA/n20kOWXqV3qN688OuVPYmgC1RWF/wlFl/wnX/AAinlXP9o/2b/anmbV8ryvN8vGc53bu2MY79qhtfFtpeeNb/AMM2dpezXWnwxy3lyqoIYPMBKKSWDEkKfuqR6kUAdHRWD4s8UWXhj+xvt8VzJ/aupQ6XB5KqdssudpbJGF+U5IyfY03W/Fdjo/inw7oFzFctea6bgWzxqpjTyUDtvJIIyDxgHn0oA6CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooATHzZ9qHO1cgZo53e1LQAUUCigAo70UlAC1wutII9aulAwCwb8wDXdVyPiqPZqkb4wHjHPqQT/8AWrmxSvC50YZ2nYyE4NW4zVLOGqxG3Fead5bB4oZ+KYrcUHmncQxjmo2bFSFaxNa1/SNHZY9T1G1t5n+5E0g8x/8AdQfM34CnvsO6W5oO2aRFya5weIb29OND8P39yp6T3uLOL/x/95+UZqSPTPE1+P8AT9attNiP/LLTLcM4/wC2suQfwjFHL3Dn7HSu8VtC8txIkUSDLO7BVUepJrAk8aaTIxj0n7VrMoONumwNOmfQy8Rj8WFOtvBWiCVJr62fVLhTkTalK10QfVQ5Kr/wECtHxOoi8KasIhsCWU20LxjEZxj0q6VNVJxh3aRLbMee+8UXMUksdhp2i2yKWaW+lNzKoHU+VFhen/TQ1T0bTLfxJo8WrXniDVtWspVZljiY2cR2kgjZGFY8g8OzVF8Pst8HLQsST9imHP1epPg0/kfCbS5jj92lw/zdOJpDXr18tjQpVne8qdVQ7Jq07vq/srqRe9rjfC9hofiz4e3iaHp8Wj22pxTWsvlRIHAOUYkjqSDnJ9a7Pw7oNhoWk2+m6TbJbWduu1I1/mT3J6knrXHfAGHy/htZOc/vJpn5/wB8j+ldb401h9C8JapqNvG8s8MJ8pUXcd5+VTj0BIJ9s1GPwSjmVTB4fbncV99kJP3bnBfCYC8v/GWqJzDc6tIsZ9QuSP0cVtfEu0+0+A9djxnbavJ/3x83/stSfC/Q5NA8Caba3ClbqVTczg9Q7nOD7gbQfpW9qNmL7T7q0bhZ4niP0YEf1rox+MhHN3Xpv3YSVn5Qsk/wHFe7YofDqQXfgTQZ85Js4lJ91UKf1FdMq1wPwKuZJPh5BaXCMk+n3E1rIrDBBDbsfhvA/CvQBXHm9H2GOrU10k/uvp+Aou6DbimNUhqN680sqzRg54rx/TLOLwv451HwvdqP7D1tGms1b7oYjDR/jyPwX1r2U81w/wAWPDkmteGjc2AK6rprfa7R1+9leSo+oH5gV62TYiEassLVdoVdG+z3jL/t1/g2KXddDl/hvJNo2qar4OvpHD2jGazcnBeFvT3GQfqT6VzPi74Q6pF4nsvE2larf6t9nuI5pre5lzcqisCfKfoSB0XA9s9K1fEuqC/0Tw18QtOQfaLJ1hvo0/uk7WU+2SQPZwa9gsJo7i3ingYPDKgdGHRlIyDXXnlOpCpHGNWlO6mu1SOkvv0l8xKKmuV9NjLXwsCAf7e1/n1vMf8AstI3hXj/AJD2v/8AgZ/9aujU8U12r57mZfKjl38Lf9R3Xv8AwM/+tULeF+f+Q5rv/gX/APWrpXaogcmjmYcqMJfC/wD1HNd/8C//AK1dF4b8GF7aWU+IPEKbm2jbe4yB/wAB9zQOldnoUflaTbDuy7z+Jz/WunDXlMwxNlExP+EN/wCpj8S/+B3/ANjWB8TPhsPHGveFTeyRSaNp0N7DeLJIwnfzoVSNo8KQWVlDZJGMA89K9JorvOE+d9P+DPi218IHRru88O6k0+sXV/dzXUYkkkSSONVZHlgkEcmVYt8h6jDDrSW/wY8Ux2HhpZJ9Em1LS7ZbV7q8n+2wbBM0hCW01qcNtIUMsiHj8/omigDw+z+Euuw+L49Ra801THq1zqL6ukjm+uoZFwtrIuzAQdDhyMdFBrB1b4KeLbzwbomhLP4ab7BpjW3nlQJo7jzmcMszW7v5eCPlQxHJJyeh+jqKAPn/AFj4OeJNS8QavdNNogOoTaZKmptNIbuyNtEqyGNfK5LkHnevAGfabXPhH4lvYdXto5PDk9nqGu6hqbrcRq0qRTqgj2SSQShHBUlgq5PGHHUe9UUAeU/Db4e654c8TaLqesXtlcrZeGRospjld3aYXJkDDcoym3AySDnt3rI8V/B2+1fXvH2pWMulWr659iNk21g2Ix/pEcpC5VZSBkqTnqR2r22igDxG0+E+txvayxyaRYW6eKbTXF0q1kc21pBCrB1iPlrl2JBxsVeOtReEPhHrmjeN/Der3r6NN/Zl7qFxd6is0hu9QWdCse8GPgpnGC5GCce/udFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRXG/EDxjdeGL/w5Y6fpcGoXetXhs4xPdm3SM7d25mEbnHHYVwmn/G77Vr2iJdWCWWlTJqA1ApHLdvG9sR80TRjLR9ydnTPTFAHttFeUeN/izDp/h/Wb3wzJpl7JbaRFq1q0jTN5iSShAWTYqhevSTdkcqKsad8YdIGqeK7bXLa50208P+T5t79nnkSTeBkkCP5PmICgk7x8y5HNAHp/ek/iFcOfip4S/sZdYS/u5NHYsPt0Wm3TwLtbYd0ixlV+b+8R2PSn+EPFtzrvj3xlozLanTtIWxa0liB3yCeEyMWJJB5AxgDj1oA7aiuPf4jeGFj1OZb64ktNNEn2q7isLiS3jMY+cecsZjYj0DE1Qi+MPgWeyF3b659ohxIxMFnPIyrGAXdlVCVQBhlyAvvwaAO/orlI/iD4cn1T+zrK7ub66EcUrixsLi6WNJV3Rl3jRlQMpBG4jjmq3wr8eRfEDw/LqUen3Fg8U7wtFIshUhWKgrIyKGJxyBkr0PNAHZjOT6Vg+Los2sEwGfLfBPoD/wDXAqfXfE+h6BtGs6rZWcj/AHIpZQJH9lT7zH2ANYGoeJ7vWrKW38PeGdWvVkXC3N4gsYB6H97iQ846RmoqR5otF05cskzPYc5p7SxwxtJM6xxqMszHAA9zXNCw8T3wxf6ra6XGODFp8HmSj/trKCP/ACGK81l8MXfivxrq9ja6g8dvpJRXn1DN47u2SGVXO1Oh+6F6DvXPgcv+tubc1CMFeTd7JXS6Jt3bSVkei5tbI9Tbxto8jtHpck+sTKcFNMha4APoXX5F/wCBMKct74q1Ef6HpdjpEZ6SahN58o/7ZRHb/wCRa5RLb4ieHowbW503XrSMf6hoxDIF9FxgfqfpWr4f+Jml3l4NP1uCfQ9U6GC8G1SfZ8D9QK6qmS1uR1MM41Yrdwd2vWLSkv8AwGxPN30Ng+FJ74Z13XtUvgesMEn2OH6YiwxHsztWlpXh/StGVhpWnWloW+80UQVn92bqT7motT8VaJpU6295qMIu25W2izLO30jQFz+Aqmdd1rUABovhyaND0uNVlFsuPUIN0n4FV+teR7zHojfK1S1XVdO0iDztVv7Wyi7NcSqgPsMnk1ltoGt6hk614imjjP8Ay76VELZfoXYvIfqGX6Vc0vwtoulT/aLPToRdnrdS5lnP1kclz+dKyW7Hds8l+K3xC13w/cWOs+EJbq40u4kFtLDe6e4geXBKmJmCuchTnadvGRyTXYz6l4jn+EmuX/jCzsrG+msZQltbBsxqyFRvyThsnp27n06XxXbwvaW97Lpsupy6dMLu3to9uTKFZQwDYyQGYj36AnFeYD4k+IvE13c6dommadYlcrIt/JvcDofk4/H5TivdynL62JaxFOK5KbTk3JK1n9+vezM7NS1e522gWVyPgtBaWcfmXk2kMIkyFy0kZI68fxVm2+r6V4Q+GEGh6zqcFnqf2F4miU+bJHI4J+6mTwW+nvXIa1YaoNMnvPFniq9a0iXLW1goiQjoFGMA84Aytc9oei6jc7bnQtKtNMgPzR3N4PPnYf3huBA/AD6mvo6OFw1WnUq1q65HU520rLm105pauyf2aci3TkmlbX+v63Ot8G+I/E0XhbT9G8I6KFtoEIOo6iNisWYsSqZ9W7FvpWmfD3i3UD5mr+NruKT/AJ52CeWo/EFc/lXNz6PqT3Udtqni/UTcyjcsEcghLjvhd3P5fzpx8KyxnKeIddikHQm4PH8qzxGYYR1JToVYQcm237OU229X70137RXoaxoPqvxRvPqnjzwkGZzH4n08AhSV2zoexIHJ5/3vqKcmleNdaX7XrHieTS3flbSxjwIwexIIz+v1rD07XdZ8Na3ZWOr3/wDaWm3reXFO64kjfjAPr1HUn17Yr0BdViA+Zq4cdjquE5Z04U25q6qRiveW3wyVou9+a0U/1uGHUr76dDnRB8QNEOdM8QW2rwLz5N/FtY+2ev8A48KtQfFS/wBLbZ4t8N3lmo4NxbfvY/8AAfmavXOqhztiBP0qATzydI2IPtXn/wBrUq2mLoRl5x9yX/kun3xZbwq6O34nVaD4+8N63tFjqtsZW6RSN5b/APfLYJ/CukMqkcGvGtS8KaRqhY3mkosh6yRDy2z65XGfxzVCDwzrekc+GfEd/boPu290PNj/AMB/3zS+q5biP4NZ032mrr/wKP6xRlKhOPn6HuBYetJkYrxK++IXinwr5S+I7DT7uNzhJLefy3f32nJ/8dArrm8fix8O22sazo+o2VvNMsRBUMUB/jYZyF+oyfSorcP4ymoTglOM3aLjJO77JXv+BlzLZnNyadF4e8Y6t4XvAE8P+J43e0Y/dhnIwVHoc4x/wCui+C99Ld+Co7S5z9p02d7KQE8jacgfgGA/CtXxj4ftPG/hmNLe5VJfluLK7Q52N1BBHYj/ADxUPwx8L3vhjSr1NWuorq+vLprmV4s7ckAdwOeCenevQxmPoYvLJe1lateN463bjdc3zjZS8436kpNS02OwAwKjkqbtUMtfJmhVc01etPcUgHFMY8Kz4RPvMQo+pr0CGMRRJGvRFCj8K4rR4vP1W1QdA3mH6Lz/ADxXcV34SOjZxYp6pBRRRXWcoUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHMeNPA+j+MrjRpNdjaeLS7k3MduVRopiVxtkVlO5fbiq2p/DzQ77VdMvY0lsRp1lcWFvbWYSKFYpl2t8u3ggdMYHsa7Cvnbwb488ZX17BffbNW1O1t9UvU1OBtMjS0hsos4ZJhEuZeMBRIxPcUAd1/wAKU8Of2Tcad9t1fyJtJj0Zm82PcIUl80MP3eN+7gnGMdu9Wtb+Emjas3iRX1LV7e38QRQR30EMkWxjDtCOpaMsrYXscHJ46Y5ex+OV3c+HdS1w+DL9NMg09r+3ud0whlxJs8p5GgVVfB3fIZF6jORTrr4t6hpmpfbPEOhahpsC6FNqgsI7yCdZFWVVRjtj3BmDD/lphR1UnmgDpvHvwj0LxtfR3Oq3mpIyWX2ERxmF0CZzuUSRvsfP8abTjjpmt3wr4M0/w1rOralYzXck+pxWkMyzOpVRbxeWm3Cggkdck89MdK8/1X42XOkWerC/8NRtqdillMILXUfMiljuSAv70xLtYZ+6VwexxzS+JPjReeG2RNX8NwR3UJiGoWUOoSTz2IkfCFykBhGQVYAygndgCgDpl+FumxaLrOiWur6zb6Dqgm8zTkaAxxGX7xjZojIOeQC5GSeKZ4j+Efh3XpdGnujOl1pdmthFMYbe43wqOA6TxSISDk5Cg8mm/CXUL2+1n4gJfXlzcpa+IZoIFmlZxFGI0IRQT8q5J4HHNea+BPiZqekaFZvqM2pao6afrGous12m2X7PM+1GLRtJnAABDgAfwmgD0uX4SaJPr2karcXd202lNA9skVtZ2+PJQKgLxQJJt4zs3hewAAAG34Q8EWHhbSdQ0qxu7+bTLuWSUW08i4g8wsXEboqvg7v4mYjAwRXnl18dv7N0+7uNV8NtHIul2WqWyW14ZhKlyVVVcmNShBYZwG9ucA6kvxU1uLQpL2XwHq0csV79mkLx3KwLDs3faMm287ZwQf3PHegD0LQvDOiaCG/sbSrKzdvvyRRAO/uz/eY+5JrXrlLLxZNqHhXStX0nSpNXfUEDomnTqYlHqZJhEQv1UNnjbmozB411UHzrvSvD0B/htkN7cY7fO4SNT7bHHvQBH4ktxZai8rELBMDJuJwAR97/AB/GvCdW8U6Z4Y+J0mqWNymoadqUQgu1siJfKmUfLkg7QTgdSOrele46h8ONK1C1kOrzX2uXg+ZJNUuDLGGHIxCMRL+CCub8ReHLPXPD9xot3AsEYG1VRQPJcdCo7Y/l7GlhK0MJXaq/w6i5ZejtqvNNJrzR20pOcbdUURe+KNQ/489OstIiJ/1moSefKB/1yiO3/wAiVDqPgCz8QIv/AAll/eawyg7EJW3jjJH8KxgH/vpmrI+HWv3VreSeEvEh2avZDbBK3S5iHQg9yB+Y9wa9HjNcuMw9bLcRyXt1Ul1T2afZr/I3SUlqeVWnh3X/AIYvLP4WiXWPD7NvmsmQCeMeqkDn8P8AvnvXofg7xdpPiuyM2lz/AL1B+9t5PlliPuP6jIrYU1xPi/wBHqN4NZ8OXJ0jxDGdy3EXypKfSQD19fzBrvji8NmS5MalCp0qJaP/ABxX/pS17pi5XH4djvjTCK4Lwf48ln1EeH/F1t/ZniBPlG7iO59Ch6ZPp0Pb0HS6t4o0XSrgW17qMIuz0tY8yzt9IkBc/gK8zGYGtg6ns6q801qmu6fVMakmrmsUyK43xp4A03xG32pd1jqyYMd7Bw4I6bh/F/P0Iq6Ne1rUBjRPDk6RnpcarKLVPqEAaT8Cq/Wn/wBg63qAzrPiKWKM9bfSoRbL9DI2+Q/VWWlhcTWwdRVaM+WS7fk+68noJtPSx5F4pvr/AEbTJ9A+IKqlrdLst9XgGVJBBBZeM4IGeh9j1qjovxEu9K0zy9Q0ufUbSL9zBqVshSGXGAMswGfqM/SvcLbwX4ftt7LpVvNNIu157oG4lcejSSEsfxNcH4g+HV3o0s174JuhAsmTNplyd8Eo7gZ6fj+Yr6fC5jgcdB4bExVO7v2jzbNp68jasno46bIalUTun/X6nE/ESyvPGvgmW7hfS5zDLH9mtrENPN5juqAGRtu0fNyNnbrxXXfDjwJ/wiujqt7dzXmoSqPOLSM0af7KKeMD16n26VxO2xXU8KJ/B/iNP4TkW0v9AD/3z9a6u28WeKdNjWHVfDz374+W5snysg9cAHH6fSoxvD9SFo4aSs/syai7eTvyzXnF+qRpBxc/aS3+/wD4Yb8U7OOKz0Xy0AmfUogu3qRhs/riu1XSogc+UD9TmuO0yz1fxN4ks9Z8R2y2FjYHfaWW7cxf+830IB7dBx1z6CblPWvPzRxo0KGEUlKUFJys7pOT2utHZLW2l2dFNNtytuQRWSqOFVR7Cp/IQDk1UvNUt7SFpriaOGJfvPIwUD8TXF6h8QPtdwbPwvYzarddN6grEh9Sf/1D3riweXYnGt+xjdLd7RXq3ovmy5SUN2dzcyW9tE8s0iRxIMs7sFVR7k1xN541uNUum07wTYnULro9264gh9+evfrgemagg8Hahrc0d1401AzqDuSwtjtiX6kdfw59zXoWh6db2VvHb2VvHbwL0SNcAV3f7Bl+79vU+apr1ejn+C82YTqTl5L8f+AYXhHwBBZXo1bX7g6trbfMZpeUiPoin09fyArurqwgvbOa1u4Vmt5kKSRsOGB6ip7eLAFW1TivLxePxGLqqtVldrbol2SS0SXkYaLRHk3hGafwH4w/4RPUZWfRr8mXSp3P3WJ5iJ+v64P8VenX13Bp9nNd3b+XBCpd2wTgDqcDmud+KHhg+JPC00dqCNStD9ps3XhhIvO0H3HH1we1T/DvxEvijwlZ6gSBcgeTcqP4ZV+9+fB+hFelmNsfh45jFe/flqf4ukv+3le/95PuRHR8p5xJ8b9O1jxhp+i+Hg0di0pa61G4jP8Aq1G4rGmCfmxjLDjPTuPQH8beHz/zEP8AyDJ/8TUer+A9Gu/Elj4gtIFsdbtJhJ9pt1C+cDwyyAcNlSRnqPXselc140nDSyCKlrdnLt410DP/AB//APkGT/4mgeNNA/5//wDyDJ/8TXQnrUkETzSpFGMu5wBUqz6F6rqVvDPjPw3C81zNqOCR5aDyJenUn7v0/KumsvG/h6+vIbW11DfPMwRF8iQZJ6DJXFb1pAttbRwp91Bj6+9TV6tOHJFI82cueTZ5F4m+Ntl4c8deIvDmoaRN/wASy3je2uI5d32yd41dLcLt+Vm3EDk52nitjw/8V9IvPAOl+KNctr3S7a9ieZxFaXF5FAqyMnzzRxbV6Z+bHWtmPwDon/CT65rtxE13d6s1tI6XKpIkEkEZSN4gVyrAMeck56YrkL34DeGbvRtL0uXUNZNrp1nLZRBngkyjuzl8PEyrIC5w6BWAwM1ZBuap8W/CFpe3mmwaxby6xBatdrbvHMqMotzcAmRY2G3yxuyAx7YJwDP/AMLR8LW9rZPqOpxxSz2lveSmCGeaG3SYDYZJBGBGrE8GQITxwOlM0n4YaLpdl4ltbe61Fo9fsINOui8iEpHFbmBSmEGGKnJJyM9gOKzrv4M+Hri2e1W91aGzuLK0sb6COWPbfR2wAiMpMZIYBQCUKZoA21+JfhNtbGk/2o4vTfnSwDaTiP7UP+WXmFNm7nj5ue2aztZ+LnhaysNSksbx7+7tbe5mhhS3mVLtoFJdY5fLKNg/eKltoyTwDQvwm0FbgSpcaim3xAniNUWSMKLhRgIBs/1eO3X/AGqo6X8EvCulz3ZsxKlrcpcRtAba1JRZkZHVZzD54ADnH7zjpyMigCLTPjHaX2qeCbP+xdRT/hI7Nrln+z3B+zMEBCqPJ/erkkF1woGGPykGut0Lx/4Z13Vk03StT8+6lWR4cwSpHOqNtcxSMoSQA8HYTise0+F2n2v/AAi7R6zrJuPDkbwWU7G3LGB0VDC48ray7VxnAbn72eaTwX8JvD3g7WI7/Rd6CIyeXFJa2rFA+cgTeT55AycZkPHHTigChrPxKudG8XeLLC9j01dN0hNPMUkzTRlmuCVO5kSQnnGAEHuR1HQWvxJ8KXWsppUOpubx76XTV3Wk6xm5j+/EJCgTcPTdzkYzVTxJ8L9F8QX+uXd7daikmsfY/PEUiAL9mbcmzKHGT1zn2xUMPwo0KK6jnFzqLMmvS+IdrSRlTcSABkI2f6vjp196ANnQvH/hnXdWTTdK1Pz7qVZHhzBKkc6o21zFIyhJADwdhOK6ivPvBfwm8PeDtYjv9F3oIjJ5cUlrasUD5yBN5PnkDJxmQ8cdOK9BoAKKKKACiiigAooooAKKKKACiiigAooqhr+qQaHoWpatdrI9vYW0l1KsQBcqiliFBIGcDjJFAF+qum6bY6XA0OmWdtZwu7StHbxLGpdjlmIAHJPU96w/+EysD4R0jxEsUostTW3eFJZoIXUTAFdxkkVc8jIDEnsDV2y8VeHr/U/7Osde0m51DLD7LDeRvLlc7vkBzxg544waAK8fgjwpHJdSR+GNDWS6VkuGXT4gZlYgsHO35gSASD1IrSfRtLe4Wd9NsmnS3NoshgUsIT1iBxnYf7vSq+seJ9B0S6htta1zS9PuJhujiu7uOF3GcZUMQTzxxRc+JtBtXukutb0yF7V447hZLuNTC0gzGr5PylhyoPXtQBDb+D/DVtp8lhbeHdHhsZJFle3jsYljd15VioXBI7HtTtV8JeHNXvTe6roGkX14VCme5so5ZCByBuZScCg+LPDg1g6Sdf0gaqH8v7Gb2Pzt/Xbs3bs+2KrJ498HvG8ieK9AZETzGYajCQFzjcTu6Z4z60AbVlp1lYyXL2NnbWz3UpnnaGJUMshGC74HzNwOTzxWenhTw6sYRdB0kII5Ydos48eXISZExj7rEncOhzzmnX3inw/p8lml/rulWr3qh7VZryNDOpxgpk/MDkdM9aZ/wlvhz+0/7O/4SDSP7Q8xofsv22PzfMX7ybN2dw7jGRQBL/wjWhbXX+xdM2vbLZsPskfzQL92I8fcGBheg9Kz/wDhAPB32YW//CJ+H/s4fzBF/ZsO3djG7G3GcADNZfhn4r+Dtf0e51JNasbC2t7o2j/b7qGIhvm2n75G1wjFeeQpPY1LqHxN8LWXiPQNHbU7aV9aieW1uoriJrfapwNz7/4mBVcA5YEdqAOwtreG1t47e1ijhgiUIkcahVRR0AA4AqWuXtfHXh86Lb6pqep2Gk21xJJDGb2/tgGZGIIDpIyE8dAxI7gHirl94v8ADVhcLb33iHR7adgjLHNexIxD8oQC2fm7evagDcrG1/S/tMZuLVR9qQcgf8tB6fX0q5q2rado1obrV7+0sbZestzMsSD8WIFc6fHEV7lfDWjatrRPSWKD7Pb/AF82YorD/c3fQ1M4KasyoycXdHn3j3wpH4nsoriykNrrVmd1rcD5SrA52t7ZH4H8QYfAPjFtUE+l6+i2Ov2ORPE5CiQAffX2xyccd+hp/id/FUPiBnvriw0S2vP3hjtM3ci9jh3VVB7n5G61ieKfhjpviOx+2R311c6yuGivbyXzQ2OQjIMIFz/dUY9+laUMTTqUvqGMfup+7LrBvf1i+q76rqd6bkueKOufxroxmaDTpZdWuFODHpsTXG0+jOvyL/wJhTlvfFWo4+yabY6PEf8AlpqEv2iUf9soiF/8iVg+BPGHnT/8I9r9sml67bDYIdoSOYD+JO3PXA+o46d+r152MwdXA1fZVY67p7pro09mmWve1ucV4g+G1v4ntj/wk2r6hf3SqRDIoSBICe6IgBI6cMWrB8Eam3w/1KPwt4mtLS1glOLPVIIljjnHYSEAfN7nnJ59T6wGrN8SaFYeJNIm07VIRJBJyCPvI3ZlPYiuvA5hTUHhsZHmpP8A8Ci+8X+cdn66icNbrc2F5GRUgHFeI+GPHqeBdZl8KeI9QTUrWEYsru0PnOB0WJ1XJB7DPT/dwR6N/afifUhjTNFt9LiPSfVpgz49RDETn6GRTWGOwEsJU5VJSi9VJbNfo+63QlNM6Yiuc8Ua7o9hE9pe6rHbXkylY4oj5lxkjqkYDMxH+6RTD4Vub/nxDr2o3wJz9ntm+xwD2xHhyPZnYVr6RoemaNC0ek6fa2aMcsIIgm4+rEck+5riskPU+ZofFXijxH4pn8J6loGn6w8LkGa4t5LV44+CJH7x5Ug4wDzjk8V2jeB9W0fB8M65JAnU2t0N8We+Dg4H4Z969bsvD1hp99qV5awhbrUJRNcSnlnIUKBn0AHA+vqaLiw3dq9Khm+IwsfZ0n7nWLSlF/J3X3ahTjbWT1PIhd+Obb5JNG0+7xxvinCZ9/mb+lNZfHWofKIdO0pD1Yt5jj8tw/SvUJdOYdBUY0589K2/tpLWOGpp9+Vv8HJx/A35pfzM84tfh/DcTLceI9Su9VmHIR2KRj6AHP6j6V2On2NvYwLBY28cES9EjUKK249NY9RV6304DqK48ZmeLxqSrzbS2WyXolZL7gTUdjKtbRpGBYVvWdqEA4qxDbKg6VbRQBXCiJSuNVMU/FOppNBAhryvwyP+EX+LmtaIPlsNYi/tC2XsJBncB/4/+CivUGevN/iRZ3S+LfB2safbTTPb3ht5zEhYrHJgEnHQAbuTxzXtZNNSlVws37tSEl80uaL+9W+ZMl1O+leqrvk052zUeMtXiGqQ5Bmul8MWWA15IB83yx/Tuf6Vxus34sbYLHgzyEKg9zXpdnCLazt4SR+7RUz64FdeFgnK76HNiZ2jZdSeiiivQOEKKKKACiiigA70UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVl+KdJ/t7wxq+ked9n/tCzmtPN2b/AC/MQru25GcZzjIrUooA8tn+GmsXvgfSfC+o+IrB7LS2szbSwaU8chFuRgOTcMCWCgZAGDz7Vg/D74W60uq29/4kuUsrbTNevdUtLKKJWkmMpwrtMJGAXH8G0H1PTHsr6nYJqkemve2q6jJGZktTKolZAcFwmclc98YpNL1Ow1e1+06VfWt9bbinm20qypuHBGVJGR6UAcD8VfhtqPjyeWNPFNxYaXLZm2ewMUjxb924TYSWMM3QYcOvsDgjC1v4JTajcap5HiRIbbUjp0lwj6eZH8yzQIpVhKAAwzkEE5PWvZ6KAPALP4b+Ibfx9psNlbTr4ctNfudae7vVhVsyLjarJO7SA8Y3Rxkdye21o3wRGnaVo9kdfEv9n6Rf6VvNljzPtTOfMx5hxt34285x1Fej6j4w8P6fPDDc6rbGaW/j0sRxEyst1ICUicJnYSAfvYHrWppupWOqW7T6Ze215ArtGZLeVZFDKcMuVJGQeo7UAeN3fwFhljtFGtrOg0u30y7hu4bgw3AhxsYJDcxEfdB2sXGeRg81qJ8HFW8S4GtDcnilPEo/0TJwq48jJkJ567/0NetVleIfEOl+HYbOXWbr7NHeXUdlAfLZ980mQi/KDjODyePU0Aee2/ws1mw0W50nSPGMtlZPqrakgitZI5GV2ZnhlkjmR2UkrgoYzwc5yMQeF/g7N4Zl8KT6d4gja50Ga8YedYlkmjuT8yY80FSB0bceeSD0r11jtUmlHQUAeNWnwVm0+ysRp3iKNb2C3vrN5bjT/NieG6dnbEfmja67sbtxBxyO1RXHwHtzoms6Zba9IkGoaVaaYrS2vmNF5EgfzD843ZI6cY9TivU7jxBplr4ltNBnutuq3kL3EEHlsd6J947gNox6Eg1r0AYGm+D9Csb436aXaSameWvJY/Mlz32s2So/2QQBW/RVPVdU0/SLRrrVr61sbZestzKsaD8WIFAHG/FXTlksba8H3o5PLP0Yf/Wrz3S9Tm0ufa2TAT07V2vjPxbba14duY/D+larqwUCRbmO3MNsuD182XaGGM/c3V5fJZa/qUYNxc2emREfctVM8o/4G4Cj/vg/WvNxUPfud+GleFjqfFug6P4t0kTXUq2txAN8N6pCtAevX09j+h5ritA+Kb6JJJpfiMnVRE3l2+p6eVkjnPHDOSEBHclhjv6me38P2NpcJPexPqjocg37mYKfUIflU/QCu7KaZ4i0hrG+toprZgFMTDAXHTGOhHYjpXbhcyiqSwmKXPSvp/NHu4vz7PR9r6mri73WgyG68U6qiPbxaZo9s4yHlY3kxXsQqlUX67nFTr4PtbsBtfvtQ1pscpdTbYT/ANsYwsZH+8CfeuKOneI/h47S6J5mt+GwSz2bnM1uO5U9x9PfIHWu48J+LtI8T23maXcgyqMyW8nyyx/Vf6jIp4vLJ0af1jDS9pS/mXTykt4v10fRsSs9HuWde8JaPrPht9Fks4Le0xmEQRqnkt2ZABgH+fSub+G/iK+0/VJfBnilydVtBm0uGORdQ9sE9SB+gOeVNd6Hrivin4el1fSI9U0omLXNKP2m1kQfMwHJT36ZHuMdzWuV4mFaLy/FP3Jv3X/JLo/R7SXbXdBKNtUehg1S1vWNO0LTnvtXuo7W2Tgu56n0A6k+w5rF8K+K7TWPBkPiCZlhhWFpLn0jZAd4+mQce2K4zwhoknxG1Y+LPFKM2kq7Lpmmv9wIDjew78j8SPQAUsLlajKpPGtwhSdpW3cv5Y9Luz12S1JcuxaXxz4m8VOV8C+HSLPOBqOpfJGR0yoyM/gT7ipl8E+N9SG7W/G72xPWLToNgH0YbT+leowokaKiKqooACgYAHoKlwK2ebqlpg6MILu0py+bkn+CRNn1Z5WPhO7czeL/ABI8h5LfasZ/nSH4Xalb86Z44163YHOJnMq5913AHtXqmBSEVP8Ab2P6zT/7di191hWR5M9t8TPDvzpLpviW0XqhUQzY9ugz+LGtnwp8RdJ1q+/sy/hn0bWQdps70bSW9FJxk+xAPtXemua8a+ENI8W2Bg1OAecoxFcoMSRH2Pp7HiqWOwmL9zG0lF/zwVmvWPwteiT8yldbM6AikzXmfgPX9U0bXn8G+LpvOvETfp96c/6VHzwSepAB/Ig9Mn0rNebj8DPBVfZyaaaumtpJ7Nf1o9C4u44tUTvSO/FVpZK4SrCySVXds0jEk0oXNIZHz2qtqF9Fp9u0shGR0FO1G9hsoWeRgMDpXC311Nq1zufIhB4FAzS0aaTWfFGnPJnZ9pQ49gwNe6Ou4D65rxnwVGsXiDT8DH7wAV7RXfg/hZxYr4kFFFFdhyhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHlfx08L+I9Ti0bXvAcKyeJtMeaFB5iRloJoyj/ADMQMqdpGT64rlfEPw+8a6PpXhfRfCV7fpollpbQXA02YRzLeMSzT4NxAHBJJALsAc5Q5r36igDwmLwb8QLq68XX93rXiRJ00mGPRrdNRjhiubprBo5WeNXYRsJSGGHCh/mBYAGs3UPBvxKXR9TFjda99t/sXT2tc66xP9oqU+0ctLjGN+QfkPbJxX0RRQB4bqvhLxtqeuRzX0Fzc2sHjGw1OAS3iMsVnHGwkZFL/KAx+6Bk9gazm8NfE37HGNRbXby236ji3staWC4SV2P2aRpPNXMQGPk3HH909K+g6KAPn7VfCXxQurS/M+o6pJfx+HreO2kstV8iN9QWQF/lDqCdmQWYbW/Kuw+Lnh/XfEPgzwtFaWE1/qNlqlle3kMM8cUm2MEyFWZ1Xdk8YYcnj1r1GigDwa28OfERLKyOoDXLjSP7Uv5n0u31oLfpbOgFqjXJmG7YwYkeYeGH3sYEnhfwX8R7rxFoEninX9Xgt7HRUaaSz1FVhnvkumZIpk5LjyiodgPm243Hv7rRQB816X4H+I7anYajJDqEPiG30nULabU7/UkuI2uZGJiaJfMYomCAAEUAjlfWeLwp8Uf+ET1G3jv/ABImpT/YsI95GnlsjjznimN5K3K7iQQinso+7X0bRQBzkPhmaDwza6NF4i139yxL3zzo91OpLEq0jIcD5hyoBAUAEUaV4K8PaZeC9i05LjUB0vb12urgfSWUsw+gIFdHVLVtV0/RrRrrV761sbZestzKsa/mSKAE12H7Rot9FjO6BwPrg4rxe1GYR7V6Hd+MJNUtZY/C2h6lq29SouZE+yWw7Z8yXBYe8avXkOnaZrupJ/xMNVSwhycwadH8xHoZXBP/AHyqmuHFx1TO3CPRovavdWVhbme/uYLaLpvmcID7c1yl7qB1O3mt9L0m8vraZdrSTA20JHqGf5j7FVPqK7C08L6ZYT/aYLVXu/8An5nYzTH/AIG5LfrVmWHPUVxppbHW03ueQ/Ca08W3Hii5g1HxRqUOiWFw0LKbgyeeyn7ilxwo7nA9AM9PXvFHgHS9cuPt9k8ml6uDuW8tDtJb1YDGfrwfesyawSNSIFEfzFvlGOSck/iSTV3StensWEN2C8fTd6V10Mwr4ar7WhLlfl19Vs15PQzVJRVmZi63428KkR67pg16wXpeWP8ArQPVlxz+Q+pq/b/Fnwq8Rae8uLWQdYZrZ94Pp8oI/WuytLyG8iDwOGFNuLG1uH33FrBK4/ieMMf1rveYYHEa4rD2l3py5b/9utSX3W9B8slszw4z3Ft8I9YFvFJbWmsaxts0cbSYmwePY7Mfga+hNGtodN0y0sbcAQ20SxIAMcKMf0rzb40wyHwfFdwpu/s+8huio9Blf/Zq7zT76K8s4Lq2cPBMiyRsO6kZBrtzjGvG4OniIqylOba31tBK76vl69dSIxs7G8sgp4k96yVnI71Itz7180pFOJp76QvmqH2getH2getPmFylwvUbvVRp/eo2m9alyGonBfG+0YeHbXXrP5dQ0a5jnjkA52lgCPpnafwrrdQ8S6fp3h5da1CbyLAxLKX2s+AwyOFBJ61yvxmvUg+HeqCQ/NN5cSD1JdT/ACBP4V1Hh+B7bQdOtphiSK2jjcehCgGvZrvnyqhKe6nNL0tFv7m394re87HmOhfGiz8TeMxZWCtZaHbRPLNczoWkuG+6qqqg7Vyc5PJx26Huj400An/kIf8AkGT/AOJqO18CaPYeLIvEOkQLp96UaK5SBQsdwjf3lHAbcFOR6c57dLPcRwLlmAryZuD+FBFSW7OfHjPw8BzqH/kGT/4mqeo/EHw/BEfLvtz9h5T/APxNT6r4h5Mdty3rXPsst1L5k7Fj6GovEu0jGvPF2nahPvmvCFzwPLf/AAqzbeI9FUDN5j/tk/8AhW9DCBjAq9EnrSvEqzMvw74t0OHXbF5L7CLKCT5Un/xNerp4/wDDLuqrqeWY4A8iX/4muH09lg1exldtqJMhJ9BkV7DXfhGuV2OHFXurnC+OfFep6f4u8M+F9ASyTUdZ8+U3d6jSRQRQqGbEaspdjngbhjHNcn4j+IHiDwl8QobbXla/0y28Ozaje22kwRgMyTlfOHmsGUCMZKbzjnG7rXpviTwxpHiRbT+17VpZLSTzbaeKaSCaB+hKSRsrrnvgjPest/h14WkZ2k01nd9Pl0t3e6mZnt5WLSKxL5LMzElz82T1rrOU5a4+MWlWU2q3c63dzpkFvp1xDHBZKsu27GUJdpsP1GRsTb/tV2HgrxfZ+KZNYgt7W9s7vSrs2l1b3aoHR8Z4KMykHPBBqlL8MPCEtvLBJpG6KWK1gdftM3KWwxAPv/w4/Hvmt3SfDulaReardafaCKfVZvtF4xdnEr4xnDEgcdhgUAcP/wALp8OrqWqWE9tepdafYz37pHNa3G+OEEuoMMzhXwDhX2mkvfjX4ZsopHuLfVF26ba6mqiFC0iXBURxqN/MnzDIOAOea19O+FPgzTiv2bSG8tbee1SKS8nljSGbPmoqM5VVbJ4AHJJqnffCLwsdIvbXTdPiS4uLWOyEt/Nc3apFG4ZFwZlYbcfLtdSOMHAxQBA/xg0qOZ7afRdciv01eHRDastuX+0yoWUbhMU2/Lgnd1I+tN0/40eHbmSy+02erWFvdG7QXFzHF5cb2qlpkbZIxyFGcgEHPB60/wAJfCXTNKE02vXMmtX76tHrCTM0saxTxqVjI3SO7bQT993znmty3+G/hOBrNo9IQ/Y57i5hV5pHUSXA2zEgsQwYcYOQOwFAHH2v7QHhG507VLyOHUithZrftGogd5IWlWPKhZSFYM65RyrAHOKg8Z/GaSx0vUf7B0S8XVtN1Gzs7u31COPCpcAsjqUmwdyjjngkbgBXZD4Z+Fv7EudGa0v30i4iED2MmqXbwKgdXASMylUwVGNoGBkdCRU+ofDvwtqB1g3mlCRtWa3e8bz5QXaAYiZSGyhUd1wT3zQBj6/8WNI8Pa9YaRrOn31rd3kkEKr9os5HjeUAgPGk5kAB+UtsK5HBIIJ5vw38WdV1DwvFqer6d/Zzv4gTSFdLVZo5FaQpsCi5DK4wNznKjPyq/OOym+FvhGe+N3Np1w87SwTyM2oXJEssIAjkceZh3GPvMCTk5Jyc2E+HHhaNZUTTZFhkv01Mwi7n8pblGLCRU37UOSSQoAPGQcDABi2Pxh8P3k1qUtNUjsr37V9gvnjjEN4bcEyCPD7h0ON6qDVzwX8T9J8WaxZ6da2GqWc97pw1S1a7SILNBv2EgpI2CGyMNjp9Ku2nw28J2l611b6VtkPnbENzKYofOBEpijL7IywJyUAq1ongbw7od9p95peneRc2FidOtn8+RvLty2/ZhmIPzc5OT70AdLRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5v8AtF6je6T8GvEV7pV5c2V7EIPLuLaVo5EzcRg4ZSCMgkfQ16HdXENnazXN3NHBbwoZJZZWCoigZLMTwAAMkmsa28ZeGLqymvLXxHos1nC6xyTx30TRo7HCqzBsAnsD1oA8Ns9U8d+H/id4ZTxlqdwtlDp9/EkMEjTJex20BYXUkSN87uWztPzfJ2zVaT4/68NL8QXFpDo94tnYW99Zzm3MQcSXMcLLJGlzLg4ckAurAjlR0r6BuvFPh+0hvJrrXdKghs5RBcvJeRqsEh6I5J+VvY4NVn8b+FEtYbl/E+hrbTFxFKb+IJJsxv2ndg7cjOOmRmgDy/Vvit4i0mTXrG7i0bz9P1600o6m0MkdrbwTqWM8yGQkBcY++ASw6d+B8Ka7cWumSW0UsVzHqniDXllnhlmijcC2DhlRJNrAnkCTfgHjnmvpez8U+H7150std0q4aCH7RMIryNzHFjO9sHhcEcnioE8aeFpLEXqeJdEazMogE638RjMhBITduxuwCcdeKAPnv4f/ABP1vQvh/Dp+hR6VrEWmeGv7QzDDIzWcyybfKnKyEHK7mwNhHpgZqx8QviHc+MfDvizTs6dLpuntok9vPaZJdpnjaQFtxBAbIGAMYwcmvZNa+KXhPSb3QIJdWtJ4dZkkjgu7e5haBNnVnfeMLn5cjPPFadx468LQ/wBoKviDSZriwilluLaK9iaWMRgl8ruyMYwc4x3oA8t1P4zahb/EQaLYrY3dh9vn0+VZbT7PNA6IWU/8fDO65H3jEinBweuO0+DHiTxR4v8ACMWveJIdFhhvY1eyTT/NDcFg/mB8gcgYwT3zV3wr8SdC8UQaFNpL701YTBVe5t1kt2iQOySR+bvLYIOED4BBbaCDWvD4z8Lz215cQeJNFkt7PBuZUvoisGTgbyGwvPHOOaAM1tK8Wavg6rrdvotuetto8Ykl+huJV5H+7Gp9/S7o3grQdKvFvo7L7VqYGPt19I11cevEkhLAewIHtWlo+uaTrazto2qWOoLA/lym0uElEbf3W2k4Psa0aAEb7p+leL6YMA/WvaGO1ST0AzXjGnfMWOMAsTXDjfsnbg+pfIyKieEHtU4qVUzXAdpjT2/Xisy5tQ2ciuqkgyOlUZ7X2oA5aF7nTZTJaucd1rp9I8RQXeI5/wB1L6HvWfcWmc8Vk3Njk5wQfUUybHeXtrBqFlNbXKLLbzoY3U9GUjBFeYaZqV78M73+ydcE1z4akcmzvlXcYMnOxwPxP6j0GxZ6tf6awUkzRDsa6CHWdP1W1e3vY42jkG14pVDKw9CDXp4DMI4eMqFePPSnutmmtpRfRr7mtGRKN9Vuatje22oWqXNjPFcW7jKyRsGB/Kp91ed3Hw7gt7h7zwfrN3osznLRoxkhb225/mSPalEnxI035Wg0bWEH8St5Tn8yoH5V0vK8NX97CYiNu0/ckvm/dfykHM1uj0IyGgSGvPh4k8br8r+C1LDglb1Mfh1o/tzx/P8A8e/hK0gB7z3anH4Bgan+wsR1nTS/6+Q/+SDnXY9DyTVLWNWsNHtGudUu4raEfxSNjPsB1J9hXEtp/wARNUGLvV9K0iFuGFpGXfH4g/owp9j8PtDtbkX3iG9udcvR1e9kyn/fOensSRVLL8Fh9cViE/7tNOT+92ivvfoHNJ7IzoGufiZ4isbhbaW38KabL5oaYYN3IOmB6dvYZ7nA9XZ0jXLECubufEdrbxCKzQYQbVVRgAelYN1qN7fsdzFE9BXJmGPWKcYU48lOCtGO9urbfVt7v9EOMbbnT6n4hggBWNtz+1c3cXt1fMdxKqait7UDk8n1NX448cAV5xaRXtbML8x5PqauJBzU8acc1OiUh2IkjxUgGKdjFNagZFc/dzXsenTC50+2mU5Ekat+Yrx6UZUivSvA1x5/h2BSctEWjP55H6EV24OXvNHHi17qZv0UUV6BwBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBQ1+yudR0W+s7G/l066nhaOK7iUM0LEYDAHg4/yR1rx4/Ameez10X3iua4vtTjswbp7eSQrJbtkO3mzuz7gMEbgB2wOK9wooA8P1v4U6lYyza1bX02q62+vx63HHaWMaxJIqEENHLcoGX3EgYZ4zyaj8CfCPVvsWhah4gu49O1Gzl1WaSzSMTf8fqbAC4fAK9cDcDnGe9e6UUAeKSfAa3uNLtLC61+UwwaAdELQ2vls5+0ecJc7zgZABTnIzzzVix+CpguNPuZtYtzdW2rWOqSzx21yz3P2ZZFVHM11LjIfAZcYAxg8Y9jooA8ksvg/NpzaXPp+vxJe6drV1q8LS2BeIicYMTIJFPAAwwYfSmx/CC+n8Z2evaz4uu9R+yvehUlhk3mK4iaPywTKY02A5yka57g8Y9dooA8j0/4OypYeFrHUdfWe00G3v7OP7PZGGSWG6h8rljI2HXLHcBg8DAxk5t58CZL/RJbG98SoZE0aPRLSSDT/LEcCTLKGkXzT5jnbjOVHOcZr26igDj/AAh4KXw54t8Ua2l6Jhrf2T9wINnk+REY/vbju3Zz0GPfrXYUUUARXTbbWZumEY/pXjumLiIV6r4ll8jw/qD/APTBgPqRj+teY2i7Ylrgxj1SO7CLRssr1q3Guaqx9avQCuE6x2zIqOSDI6VdVKXy80xXMSa1z2qlNadeK6Z4aryW2e1AXOTnsgc8Vm3Gnc5C4PtXaSWntVWSz9qAucei3luf3MzqPTNWotW1KLAJDCt6Sz68VWeyH90UAUxr153QE0w6/fHIEYqybIZ+7SG0H92mMoS6lqE+cybB7VUaGWU5ldm/GtoWuOi0otz6UgsZcNmF7Yq3HCq9s1cFsT2qWO1PpQBVSPParEcXtVyO29qnWDHagZUSKplj9qtJD7VKYhjpSC5nulQMOa0pI+KqvEfSgLlXqK6/4cXIDXloScnEi/yP9K5UxkVo+Erj7J4ityfuyZjP4/8A18VtQlyzTMa0eaDR6jRRRXrnlhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzvjy5WHw/JET887rGo/HJ/QfrXCwj5AK6Px1MLi/hgBysK5P1P/1gKwYk6CvKxU+ap6HpYaPLD1JYlq9CvSoIUq9EmBXObsmjFTKlMjFWUWqRDZH5eaaYR6VaAoxVE3KDQe1RNbe1ae0U3ZRYLmQ9qD2qF7MHtW40YppiFKw7mAbEelN+xD0rf8n2phhHpQO5hGyHpTTZgHpW6Yh6Uwwg9qmw7mOtqPSpVtgO1aYh9qUxgCnYLmcIMU4RCrhUUm2iwXKuwCgrVhlqNhzQBXZM1GYauBeafspBcyZYapOGhmSVfvIwYVramWhtXkjA3DAyRkKCQCT7Ac/hWLdqqjMV+8sxGVQBWDfgozj3ovYpanrGkXq6hp8Vwn8Q+Yeh71crzzwTqptL0WlzlI5xlQ38Leleh169Gp7SKZ5VWnySsFFFFamYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUF5cpaW0k8p+VBnHr6Cp65DxVqIuJVtYGzGhy5Hdv/rVlWqezjc0pU/aSsc/dSNc3Ek0nLOxJpY05p0ceatRRV4+7uertoLClWlXilijqYLVWJbCMYqdaiAxUimmiGSUUgpaYgpKDTS2KBD6Ki304OKBjsU0ilzSE0ANxTSKeaaTSGNIFMfpTmNMNAyMjNJinmmmgBpFRlc1LikAoGIq1IBSqKdigRXkWsC5eHSpYogsKLPKWZiNgC47sTgnOPw7V0jDNUrm3WYLklWQ7lYdVPT+tSyos5y7uIri7EVofMZRv8yMgheuOR9K9I8Ka0NWstsg23UOFkHr7ivOdREmwSakkqrGQoaMonU/3t27H0APtWjb+bpl3FdWTEMnYnIYehrWhWdOWuxFakqkdNz1KiqOkajDqlms0PB6Mh6qfSr31r1k01dHmNNOzCiiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACikBycCloAKKKKACimSypEpaRwo9657VNZlcGO1BRf7/c/wCFZ1Ksaa1NKdOU3oT6/q/2dWt7Y/vT95h/D/8AXrkwhJyetTlSzEtyTUscXtXlVajqu7PRpwVNWQyKP2q3FHSxx4qwi4qUhtgi07bxTgKeBVWIuQEYpRT3FRtxSGPBpwqNTTgaYhx6VG/Sn5prc0AQk0m6nsKiNIZIHpd1Qg0ZoGSlvemlqYTSZoAdmim0tACGkpaMUAJ3oHvTsUYoAcKXNNpRQAjdKiZamNNIpDMzUbeWVA1tIsc6ZKFlyORjkVkWE8y3DwSpNI24eZuziM4z1OR/IegrpnWqV3Yw3GTJFG7lcZdM/n6j2qWikw0y7fTrtbm2O9Dw6g8MK72xu4r23WaBsq3buD6GvLIpEsb14W8wlzxGFGWPHzAYAxzjAz+hrdsbi4sZ/Mt2wD95D0aunD4h09HsY16PPqtzvqKp6dfR3sIYDY4+8h7Vcr001JXR5zTTswooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoopsn3DQAFx25pM561GtPFSmVYeowKWimsxHTk1RI6oZpCBhOvrR8xOWpSMipbuUkZs8TSHLEk+9UZrPPatwpTDEDWEqSkbRqWOca0IPSgQkdq6BoAe1QvbD0rnlQ7GyrXMlUqQCrb25HaojER2rJwaLU0yKlFKUPpSYqbDBhUTCpiKjYUMEQ9DTweKawpM4qSh+6nZzUdOWgBSuajZKmFKRmmIqbKNtWttIVpDuVitGKnIphFAEYWjFSAUEUAREUqrTiKcooGIFpCKkpDQBERSgU8LmnbaAuRYoxUu004RE9BQkK5WK0nl5q+lsT2qxHae1aKk2S6iRkNYrK6Oy/On3SDgj/63tVqKxyeRWtHaj0q1HCBW8MP3MZV+xRs7MxMGXgjvWqjHHzdaFUAUtdcIcq0OaUubcdRQOlFaEBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUj/dNLSMMjFAEOKenWl8v3pVXHfNQkU2LSgUYoqyRMUhFOopARkUlPK5pCnvSaKuNpr4HbNSeWfWk8s+tKzHci2q3A601oAe1WAmKXbS5L7hzdik1sD2qFrX2rT20bKh0UylUaMk2x9Kie3PpW0UpDED2qHh0UqzOfeBvSomhYdq6IwA9hTGtQe1ZvDGirnO7CO1OCmtxrIelN+xe1R9WkUq6McA04A1q/Yvag2XtR9XkHtomXg0hBrU+xn+6aPsZ9P0pewkP2sTHYGm7Tmtg2XsaT7F7UvYSD20TIwaCDWv9i9qPsQ9KPYSH7ZGPtPpTghrXFmPSnrZj0prDyF7ZGOIyaesJPatgWqjtTxbqO1WsMyXXRkLbn0qVbUntWqIQO1PEYq1h0Q6zMxLT2qdLUDtV7aKXFaqikZuq2VlhA7U9YwKmxRitFFInmY0LThRRTJDNIaQ0hNFxki9BS0ifdFLVEhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFGKKKADFJtFLRQAm0UmwU6ilYLgBgYooopgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42037=[""].join("\n");
var outline_f41_3_42037=null;
var title_f41_3_42038="Superficial veins of neck";
var content_f41_3_42038=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Superficial veins of the neck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 376px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The superficial temporal and maxillary veins merge, forming the retromandibular vein, the posterior division of which unites with the posterior auricular vein to form the external jugular vein. The facial vein receives the anterior division of the retromandibular vein before emptying into the internal jugular vein, deep to the sternocleidomastoid muscle. The anterior jugular veins may lie superficial or deep to the investing layer of the deep cervical fascia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Moore KL, Dalley AF. Clinically Oriented Anatomy, 5th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42038=[""].join("\n");
var outline_f41_3_42038=null;
var title_f41_3_42039="Drugs that should be avoided or used with caution in patients with heart failure";
var content_f41_3_42039=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Drugs that should be avoided or used with caution in patients with heart failure",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42039/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42039/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42039/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42039/contributors\">",
"     Stephen S Gottlieb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42039/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42039/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/3/42039/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of medications that are in common clinical use are relatively or absolutely contraindicated in patients with heart failure (HF), either because they can cause exacerbations of HF or because there is a higher risk of adverse reactions in such patients (",
"    <a class=\"graphic graphic_table graphicRef68838 \" href=\"mobipreview.htm?13/55/14205\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/1\">",
"     1",
"    </a>",
"    ]. Drug induced exacerbation or decompensation of established heart failure is a relatively common occurrence. Its prevention requires frequent reassessment and meticulous management of often complex medication regimens.",
"   </p>",
"   <p>",
"    Utilization of these drugs is common in patients with HF. In a study from Denmark, 34 percent received at least one nonsteroid antiinflammatory agent (NSAID) or cyclooxygenase-2 (COX-2) inhibitor after discharge for first hospitalization for HF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/2\">",
"     2",
"    </a>",
"    ]. Use of some of these drugs may be increasing. As an example, a review of Medicare beneficiaries hospitalized with the diagnoses of HF and diabetes mellitus found that the proportion using",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a thiazolidinedione increased from 13.5 percent in 1998 to 1999 to 24.4 percent in 2000 to 2001 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management of patients with heart failure is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7018?source=see_link\">",
"     \"Treatment and prognosis of diastolic heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;General principles for avoiding drug induced worsening of heart failure include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recognition of the basic mechanisms by which drugs can exacerbate heart failure including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Sodium retention",
"     </li>",
"     <li>",
"      Negative inotropic effect",
"     </li>",
"     <li>",
"      Direct cardiotoxicity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identification of significant drug interactions among medications used to treat HF and concomitant diseases. A complete and updated list of medications including non-prescription vitamins, supplements and remedies should be obtained at each encounter. Common HF drugs often affected by pharmacokinetic drug interactions include:",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"       digoxin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"       amiodarone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      and beta-blockers (via CYP 2D6 metabolism). Examples of significant pharmacodynamic interactions in HF can include: angiotensin converting enzyme",
"      <span class=\"nowrap\">",
"       inhibitor/angiotensin",
"      </span>",
"      II receptor",
"      <span class=\"nowrap\">",
"       blocker/",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?17/22/17767?source=see_link\">",
"        spironolactone",
"       </a>",
"      </span>",
"      combinations leading to hyperkalemia, digoxin toxicity with hypokalemia, additive QTc prolongation with QTc prolonging drugs and electrolyte disturbances (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/63/38906?source=see_link\">",
"       \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=see_link&amp;anchor=H10#H10\">",
"       \"Acquired long QT syndrome\", section on 'Risk factors'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Awareness that drug absorption, distribution and clearance can be significantly altered during acute overload state secondary to gut edema, hepatic congestion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      renal insufficiency.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    dose requirement is generally much lower in acute exacerbation versus chronic stable HF.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"     Digoxin",
"    </a>",
"    clearance may decrease and a trough should be checked during acute HF exacerbation to monitor for risk of toxicity. While",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    may be beneficial in selected patients with chronic stable heart failure, they may be harmful with acute HF exacerbation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surveillance for drug effects that are altered as chronic heart failure progresses. For example, the volume of distribution tends to decrease for certain HF drugs (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"       digoxin",
"      </a>",
"      ) as heart failure advances as well as with aging or renal failure. Lower load and maintenance dosing may be required to avoid an increase in risk of drug toxicity.",
"     </li>",
"     <li>",
"      Monitoring heart failure management involving frequent assessment and adjustment of several drugs with similar pharmacodynamic effects. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/63/38906?source=see_link\">",
"       \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consultation with a clinical pharmacist with cardiovascular expertise may be valuable in some instances.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should receive education about drugs they are prescribed. They should also receive information about drugs that should be avoided including non-prescription medications, alternative treatments, and dietary supplements.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Nonsteroidal antiinflammatory drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsteroidal antiinflammatory drug (NSAID) use is not associated with a first occurrence of heart failure (HF). However, administration of nonselective NSAIDs in HF patients (ejection fraction not reported) is associated with an increased risk of HF exacerbation, increased renal dysfunction, and impairment of responses to angiotensin converting enzyme (ACE) inhibitors and diuretics. Observational data in HF patients indicated an association between NSAID use and increased mortality. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=see_link&amp;anchor=H7#H7\">",
"     \"Nonselective NSAIDs: Adverse cardiovascular effects\", section on 'Heart failure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     COX-2 selective inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the risk of COX-2 selective inhibitors in patients with HF has not been established, in observational studies COX-2 use in patients with HF is associated with increased rate of HF exacerbation and increased mortality (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=see_link&amp;anchor=H8#H8\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\", section on 'Heart failure'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Aspirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;While patients with HF and vascular disease (including coronary disease)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cardiovascular risk factors may have indications for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    use, the risks and benefits of aspirin in patients with heart failure but without other indications, are not well established.",
"   </p>",
"   <p>",
"    A potential interaction between",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and ACE inhibitors has been investigated. While aspirin may attenuate some of the acute hemodynamic effects of ACE inhibitors, most of the available evidence does not support an inhibitory effect of aspirin on the long-term outcome benefits of ACE inhibitors in HF. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16090?source=see_link\">",
"     \"ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Limited data suggests that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    use may interfere with the beneficial effects of beta blocker therapy on left ventricular ejection fraction in patients with HF. This issue is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/27/36282?source=see_link&amp;anchor=H23#H23\">",
"     \"Rationale for and clinical trials of beta blockers in heart failure due to systolic dysfunction\", section on 'Use with aspirin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The comparative effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    on hospitalization for HF in patients with systolic dysfunction is uncertain. In the WASH trial and WATCH trials, hospitalization for HF occurred more frequently in patients treated with aspirin than in those treated with warfarin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In contrast, in the larger WARCEF trial, there was a nearly significant trend (p = 0.053) toward higher rate of hospitalization for heart failure in patients treated with warfarin as compared to those treated with aspirin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/6\">",
"     6",
"    </a>",
"    ]. Evidence on the effect of antithrombotic therapy in patients with heart failure is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7048?source=see_link\">",
"     \"Indications for antithrombotic therapy in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In summary, evidence is lacking to support a recommendation for or against",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy in patients with heart failure. The 2008 American College of Chest Physicians antithrombotic therapy guidelines recommend AGAINST routine use of aspirin (or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    ) in patients with HF due to a nonischemic etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/7\">",
"     7",
"    </a>",
"    ]. However, given the demonstrated value of aspirin in patients with atherosclerotic cardiovascular disease, it would be premature to modify recommendations for use of aspirin in such patients who have HF until further data are available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some initial studies suggested a possible deleterious effect of calcium channel blockers in patients with HF due to systolic dysfunction, while later trials with vasoselective calcium channel blockers",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/296?source=see_link\">",
"     amlodipine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/45/2775?source=see_link\">",
"     felodipine",
"    </a>",
"    showed a neutral effect on mortality. Thus, there is",
"    <strong>",
"     NO",
"    </strong>",
"    direct role for these drugs in the management of HF. However, amlodipine and felodipine appear to be safe in patients with HF and can be used if treatment with a calcium channel blocker is necessary for another indication, such as angina or hypertension. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30438?source=see_link\">",
"     \"Calcium channel blockers in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Antidepressants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depression is common in patients with HF and is associated with worse outcomes including increased mortality rates. While concern has been raised that certain antidepressants, particularly tricyclic antidepressants, may cause adverse cardiovascular effects, an analysis found that depression rather than antidepressant use was independently associated with worse outcomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/48/33546?source=see_link\">",
"     \"Predictors of survival in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Limited data are available on the safety and efficacy of antidepressants in patients with heart failure. A review of randomized controlled trials found that tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRI) were associated with similar rates of major adverse cardiovascular events (such as HF, myocardial infarction, stroke, or cardiovascular death) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/8\">",
"     8",
"    </a>",
"    ]. However, other cardiovascular side effects (particularly palpitations) were more common among patients taking TCAs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Oral hypoglycemic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oral hypoglycemic agents thiazolidinediones and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    pose particular risks in patients with HF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Thiazolidinediones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thiazolidinediones cause fluid retention which may precipitate HF. This issue is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28569?source=see_link&amp;anchor=H9#H9\">",
"     \"Heart failure in diabetes mellitus\", section on 'Thiazolidinediones'",
"    </a>",
"    .),",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Metformin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with HF who take",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    are at increased risk of potentially lethal lactic acidosis as discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28569?source=see_link&amp;anchor=H12#H12\">",
"     \"Heart failure in diabetes mellitus\", section on 'Metformin'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/26/38312?source=see_link&amp;anchor=H7#H7\">",
"     \"Metformin in the treatment of diabetes mellitus\", section on 'Lactic acidosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Phosphodiesterase inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concerns have been raised about the safety of phosphodiesterase-3 (PDE-3), phosphodiesterase-4 (PDE-4) and phosphodiesterase-5 (PDE-5) inhibitors in patients with HF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     PDE-3 inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with HF due to systolic dysfunction, chronic use of oral PDE-3 inhibitors for inotropic therapy have been associated with",
"    <strong>",
"     increased mortality",
"    </strong>",
"    compared to placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/37/7769?source=see_link&amp;anchor=H3#H3\">",
"     \"Inotropic agents in heart failure due to systolic dysfunction\", section on 'Phosphodiesterase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/38/38502?source=see_link\">",
"     Cilostazol",
"    </a>",
"    is a PDE-3 inhibitor approved by the FDA for the treatment of intermittent claudication. While it is not established that cilostazol impacts mortality in patients with HF, the Food and Drug Administration regards HF of any severity as a contraindication to the use of cilostazol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/37/7769?source=see_link&amp;anchor=H3#H3\">",
"     \"Inotropic agents in heart failure due to systolic dysfunction\", section on 'Phosphodiesterase inhibitors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/21/32090?source=see_link&amp;anchor=H451547835#H451547835\">",
"     \"Medical management of claudication\", section on 'Cilostazol'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     PDE-4 inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/19/6454?source=see_link\">",
"     Anagrelide",
"    </a>",
"    is a PDE-4 inhibitor used in the treatment of proliferative hematologic disorders such as essential thrombocythemia and polycythemia vera. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/28/32202?source=see_link\">",
"     \"Prognosis and treatment of essential thrombocythemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/56/28554?source=see_link\">",
"     \"Prognosis and treatment of polycythemia vera\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/19/6454?source=see_link\">",
"     Anagrelide",
"    </a>",
"    has positive inotropic and vasodilatory effects. The development of fluid retention, and less commonly heart failure with or without development of cardiomyopathy, has been reported with its use, although controlled data are lacking. It may also cause high-output heart failure. Anagrelide use should be avoided in patients with HF. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/28/32202?source=see_link&amp;anchor=H14#H14\">",
"     \"Prognosis and treatment of essential thrombocythemia\", section on 'Toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     PDE-5 inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phosphodiesterase-5 (PDE-5) inhibitors, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/40/21127?source=see_link\">",
"     vardenafil",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/4/19528?source=see_link\">",
"     tadalafil",
"    </a>",
"    , are widely used in the treatment of erectile dysfunction in men. These drugs are vasodilators that can lower pulmonary and systemic arterial pressure.",
"   </p>",
"   <p>",
"    The use of PDE-5 inhibitors with any form of nitrate therapy (regular or intermittent) is contraindicated.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/24/11656?source=see_link\">",
"     Nitroglycerin",
"    </a>",
"    is contraindicated after the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    within the previous 24 hours or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/4/19528?source=see_link\">",
"     tadalafil",
"    </a>",
"    within 48 hours and may have an augmented hypotensive effect beyond these time windows. An",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    expert consensus document concluded that the PDE-5 inhibitors are potentially hazardous in patients with HF who have borderline low blood pressure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    low volume status. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8442?source=see_link\">",
"     \"Sexual activity in patients with heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical data on use of these agents in patients with HF are limited. In a randomized comparison of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    to placebo in 35 patients with NYHA class II to III HF who were not taking nitrates, a single 50 mg dose of sildenafil caused an asymptomatic 6 mmHg decrease in mean systemic blood pressure at two hours that had resolved by four hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/11\">",
"     11",
"    </a>",
"    ]. Over a six-week course of therapy, no patient developed symptoms of hypotension or worsening of HF while taking sildenafil. In another trial of 34 HF patients randomly assigned to receive either sildenafil or placebo, no significant difference in incidence of symptomatic hypotension was observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preliminary studies suggest that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    may be a useful treatment for HF complicated by pulmonary hypertension. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18809?source=see_link\">",
"     \"Possibly effective emerging therapies for heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Antiarrhythmic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most antiarrhythmic drugs have some negative inotropic activity and, in patients with reduced LV function, can precipitate HF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/1\">",
"     1",
"    </a>",
"    ]. The further reduction in LV function can also impair the elimination of these drugs, resulting in drug toxicity. In addition, some antiarrhythmic drugs exert a possible proarrhythmic effect, particularly class I agents and the class III agents",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/32/13829?source=see_link\">",
"     ibutilide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/13/21721?source=see_link\">",
"     sotalol",
"    </a>",
"    . HF is a risk factor for torsades de pointes in patients receiving the class III agents ibutilide, sotalol and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/2/6183?source=see_link\">",
"     dofetilide",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     Amiodarone",
"    </a>",
"    is generally considered to be less proarrhythmic than other antiarrhythmic agents and is generally the preferred drug for treatment of arrhythmias in HF. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/30/24042?source=see_link\">",
"     \"Atrial fibrillation in patients with heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/55/19322?source=see_link&amp;anchor=H22#H22\">",
"     \"Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy\", section on 'Antiarrhythmic drugs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Chemotherapy agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiotoxic chemotherapeutic agents should be avoided in patients with HF. Cardiotoxic agents include anthracyclines, high-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41706?source=see_link\">",
"     \"Cardiotoxicity of anthracycline-like chemotherapy agents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40138?source=see_link\">",
"     \"Cardiotoxicity of nonanthracycline cancer chemotherapy agents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42232?source=see_link\">",
"     \"Cardiotoxicity of trastuzumab\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Androgens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data are available on the impact of androgen therapy on cardiovascular function. Although disorders including sudden death, hypertension, and left ventricular hypertrophy have been reported in individuals taking androgens, a causal relationship has not been established. United States Food &amp; Drug Administration approved labeling for the testosterone patch includes a warning that edema, with or without heart failure, may be a complication of androgen treatment in patients with preexisting cardiac, renal, or hepatic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21050?source=see_link\">",
"     \"Use of androgens and other hormones to enhance athletic performance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2010 Endocrine Society guidelines on testosterone therapy for men with androgen deficiency recommended against testosterone therapy in patients with uncontrolled or poorly controlled HF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In men with HF, deficiency in anabolic hormones, including androgens (testosterone, dehydroepiandrosterone), is common and is an independent marker of poor prognosis. However, the nature of the relationship between androgen deficiency and HF severity is not known. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/48/33546?source=see_link\">",
"     \"Predictors of survival in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Available data are insufficient to recommend androgen therapy in patients with HF as discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18809?source=see_link&amp;anchor=H5577859#H5577859\">",
"     \"Possibly effective emerging therapies for heart failure\", section on 'Testosterone'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     TNF-alpha inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tumor necrosis factor-alpha (TNF-alpha) inhibitors may be associated with new onset or worsening of pre-existing heart failure. US product information includes heart failure as a warning for these agents as a class and a specific contraindication for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    dosed over 5",
"    <span class=\"nowrap\">",
"     mg/kg.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/55/40825?source=see_link&amp;anchor=H18#H18\">",
"     \"Tumor necrosis factor-alpha inhibitors: An overview of adverse effects\", section on 'Heart failure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Sodium-containing preparations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some drug preparations contain clinically significant quantities of sodium. For example,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    and Fleet PhosPho soda include one and two grams of sodium, respectively, per dose.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Antihistamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long QT syndrome has been reported with some second generation antihistamines (terfenadine and astemizole) but not others (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/33/35350?source=see_link\">",
"     fexofenadine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36390?source=see_link\">",
"     cetirizine",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Theophylline",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a narrow therapeutic index for methylxanthines such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    in treating chronic airway disease. During acute decompensation of HF, theophylline serum levels may increase, causing toxicity. Tachycardia and atrial arrhythmias may occur at serum concentrations considered therapeutic, particularly among patients with heart disease. If this drug cannot be avoided in heart failure, dosage reduction with monitoring of levels or discontinuation of medication may be required. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/57/11161?source=see_link\">",
"     \"Theophylline use in asthma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/28/25031?source=see_link\">",
"     \"Role of methylxanthines in the treatment of COPD\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     \"Natural\" remedies and supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Naturoceutical products or dietary supplements may be construed by some patients as benign although they are not of proven benefit and some may pose health risks. For example, ephedra (also called Ma huang) is a plant source of ephedrine that is contained in some products promoted for athletic performance enhancement or weight loss. Case reports suggest that ephedra may cause HF and left ventricular systolic dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42039/abstract/16\">",
"     16",
"    </a>",
"    ]. The FDA has banned dietary supplements containing ephedra since 2004.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8052714\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A number of medications that are in common clinical use are relatively or absolutely contraindicated in patients with heart failure (HF), either because they can cause exacerbations of HF or because there is a higher risk of adverse reactions in such patients (",
"      <a class=\"graphic graphic_table graphicRef68838 \" href=\"mobipreview.htm?13/55/14205\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      General principles for avoiding drug-induced exacerbation of HF include recognition of the basic mechanisms by which drugs can exacerbate HF, identification of significant drug interactions, awareness of potential alterations in pharmacokinetics in the setting of HF, surveillance for changes in drug effects with changes in HF status, and monitoring the pharmacodynamic effects of HF management. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NSAID use in HF patients is associated with increased risk of HF exacerbation, increased renal dysfunction, and impairment of responses to angiotensin converting enzyme inhibitors and diuretics. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Nonsteroidal antiinflammatory drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Data are lacking on the safety and efficacy of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      &nbsp;in patients with heart failure. While patients with vascular disease (including coronary disease) or cardiovascular risk factors may have indications for aspirin use, the risks and benefits of aspirin in patients with heart failure with or without vascular disease are not well established. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Aspirin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The oral hypoglycemic agents thiazolidinediones and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      pose particular risks in patients with HF. Thiazolidinediones cause fluid retention and may precipitate HF. Patients with HF who take metformin are at increased risk of potentially lethal lactic acidosis. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Oral hypoglycemic agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Concerns have been raised about the safety of PDE-3 and PDE-4 inhibitors in patients with HF. Use of a PDE-5 inhibitor is contraindicated in any patient taking nitrate therapy. Limited safety and efficacy data are available on use of PDE-5 inhibitors in patients with HF. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Phosphodiesterase inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most antiarrhythmic agents have some negative inotropic activity and some have proarrhythmic effects.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"       Amiodarone",
"      </a>",
"      is generally considered less proarrhythmic than other antiarrhythmic agents and is generally the preferred drug for treatment of arrhythmias in HF. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Antiarrhythmic agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Drug list review should include any naturoceutical products or dietary supplements. Although these may be construed by some patients as benign, some may pose health risks. (See",
"      <a class=\"local\" href=\"#H23\">",
"       '\"Natural\" remedies and supplements'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/1\">",
"      Amabile CM, Spencer AP. Keeping your patient with heart failure safe: a review of potentially dangerous medications. Arch Intern Med 2004; 164:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/2\">",
"      Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009; 169:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/3\">",
"      Masoudi FA, Wang Y, Inzucchi SE, et al. Metformin and thiazolidinedione use in Medicare patients with heart failure. JAMA 2003; 290:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/4\">",
"      Cleland JG, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004; 148:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/5\">",
"      Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009; 119:1616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/6\">",
"      Homma S, Thompson JL, Pullicino PM, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/7\">",
"      Becker RC, Meade TW, Berger PB, et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:776S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/8\">",
"      Swenson JR, Doucette S, Fergusson D. Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials. Can J Psychiatry 2006; 51:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/9\">",
"      Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325:1468.",
"     </a>",
"    </li>",
"    <li>",
"     www.fda.gov/cder/news/cilostazol/default.htm (Accessed on February 18, 2004).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/11\">",
"      Webster LJ, Michelakis ED, Davis T, Archer SL. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial. Arch Intern Med 2004; 164:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/12\">",
"      Lewis GD, Shah R, Shahzad K, et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007; 116:1555.",
"     </a>",
"    </li>",
"    <li>",
"     file://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4241 / (Accessed on May 7, 2009) file://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4241. (Accessed on May 07, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/14\">",
"      Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95:2536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/15\">",
"      Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91:1995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42039/abstract/16\">",
"      Peters CM, O'Neill JO, Young JB, Bott-Silverman C. Is there an association between ephedra and heart failure? a case series. J Card Fail 2005; 11:9.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3499 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-617C8121F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42039=[""].join("\n");
var outline_f41_3_42039=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8052714\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DRUGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Nonsteroidal antiinflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - COX-2 selective inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Aspirin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Antidepressants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Oral hypoglycemic agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Thiazolidinediones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Metformin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Phosphodiesterase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - PDE-3 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - PDE-4 inhibitor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - PDE-5 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Antiarrhythmic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Androgens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      TNF-alpha inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Sodium-containing preparations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Antihistamines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Theophylline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      \"Natural\" remedies and supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8052714\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/3499\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3499|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/55/14205\" title=\"table 1\">",
"      Adverse drug effects in HF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16090?source=related_link\">",
"      ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/30/24042?source=related_link\">",
"      Atrial fibrillation in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=related_link\">",
"      COX-2 selective inhibitors: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30438?source=related_link\">",
"      Calcium channel blockers in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41706?source=related_link\">",
"      Cardiotoxicity of anthracycline-like chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40138?source=related_link\">",
"      Cardiotoxicity of nonanthracycline cancer chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42232?source=related_link\">",
"      Cardiotoxicity of trastuzumab",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28569?source=related_link\">",
"      Heart failure in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7048?source=related_link\">",
"      Indications for antithrombotic therapy in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/37/7769?source=related_link\">",
"      Inotropic agents in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/21/32090?source=related_link\">",
"      Medical management of claudication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/26/38312?source=related_link\">",
"      Metformin in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=related_link\">",
"      Nonselective NSAIDs: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18809?source=related_link\">",
"      Possibly effective emerging therapies for heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/48/33546?source=related_link\">",
"      Predictors of survival in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/28/32202?source=related_link\">",
"      Prognosis and treatment of essential thrombocythemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/56/28554?source=related_link\">",
"      Prognosis and treatment of polycythemia vera",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/27/36282?source=related_link\">",
"      Rationale for and clinical trials of beta blockers in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/28/25031?source=related_link\">",
"      Role of methylxanthines in the treatment of COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/55/19322?source=related_link\">",
"      Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8442?source=related_link\">",
"      Sexual activity in patients with heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/57/11161?source=related_link\">",
"      Theophylline use in asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7018?source=related_link\">",
"      Treatment and prognosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/55/40825?source=related_link\">",
"      Tumor necrosis factor-alpha inhibitors: An overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21050?source=related_link\">",
"      Use of androgens and other hormones to enhance athletic performance",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_3_42040="Transesophageal echocardiography in the evaluation of mitral valve disease";
var content_f41_3_42040=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Transesophageal echocardiography in the evaluation of mitral valve disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42040/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42040/contributors\">",
"     Elyse Foster, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42040/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42040/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42040/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42040/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42040/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/3/42040/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 13, 2005.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     MITRAL STENOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transthoracic echocardiography (TTE) is the established method for detecting, quantifying, and judging the severity of mitral stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32409?source=see_link\">",
"     \"Echocardiographic evaluation of the mitral valve\"",
"    </a>",
"    .) However, transesophageal echocardiography (TEE) has a growing role in mitral stenosis, paralleling the growth in catheter-based palliative interventions. These interventions require a transseptal puncture to deliver a dilating balloon along the path of blood flow and across the obstructed mitral orifice. When successful, these techniques offer dramatic relief of symptoms and may help a patient avoid the need for thoracotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Use in percutaneous balloon valvotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transesophageal echocardiography is used in patients with mitral stenosis prior to percutaneous balloon valvotomy in order to identify atrial spontaneous echo contrast; atrial appendage thrombus, which is a contraindication to valvuloplasty due to an increased risk of stroke from catheter dislodgement of thrombus; and poor atrial appendage function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. TEE can establish the likelihood of success by evaluating the morphology of the mitral valve and its supporting apparatus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/5\">",
"     5",
"    </a>",
"    ]. Most authors, however, recommend relying on transthoracic echocardiography to judge the degree of mobility, calcification, subvalvular disease, and mitral regurgitation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/45/33497?source=see_link\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TEE has been used during the procedure to guide transseptal puncture and balloon placement. It has also been used after the procedure to allow for prompt recognition of major complications (left ventricular or left atrial perforation with tamponade, and severe mitral regurgitation and creation of a large atrial septal defect) and to assess the following parameters of response to the procedure:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The resolution of spontaneous echo contrast in response to relief of obstruction",
"     </li>",
"     <li>",
"      The hemodynamic impact of the residual atrial septal defect resulting from the transseptal puncture",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Possible disappearance of atrial thrombi can also be documented.",
"   </p>",
"   <p>",
"    TEE may be particularly beneficial when there is a desire to limit fluoroscopic exposure, as in pregnancy, or when interatrial septal puncture is initially unsuccessful. To date, there are no data to suggest that TEE can reduce the complications associated with percutaneous valvotomy.",
"   </p>",
"   <p>",
"    A number of studies have emphasized the importance of residual atrial septal defects after the transseptal procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Although these defects are small and usually insignificant, the left-to-right jet provides a convenient means of obtaining a Doppler gradient between the atria. Using the inferior vena cava response to respiration as a guide to right atrial pressure, the sum of the transseptal pressure difference and right atrial pressure provides a measure of left atrial pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Spontaneous echo contrast",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous echo contrast in the left atrium is a dramatic finding on TEE. It is a phenomenon associated with blood stasis within a cardiac chamber or vessel. In its obvious form, it appears as smoke-like, slowly swirling patterns in the left atrium. Its appearance is similar to that of agitated saline contrast within a chamber. However, saline microbubbles appear much coarser, less concentrated, and lack the characteristic gentle swirling motion.",
"   </p>",
"   <p>",
"    Spontaneous echo contrast is, however, difficult to quantitate because it depends upon transducer frequency and gain settings of the instrument. When frequencies higher than 5 MHz are used, low-intensity contrast can be seen in normal subjects without mitral regurgitation who have normal or slightly reduced cardiac output. When gain settings are too low or when there is bright light in the examination setting, such as the operating room, higher grades of spontaneous contrast can be missed. The presence of spontaneous echo contrast should be sought with 5 MHz frequency, with the gains high enough to create uniform, low-level background noise throughout the atrium.",
"   </p>",
"   <p>",
"    Spontaneous echo contrast is seen commonly in patients with mitral stenosis. In one study of 47 patients in sinus rhythm, 47 percent had this finding, which was associated with a smaller mitral valve area and a higher gradient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/11\">",
"     11",
"    </a>",
"    ]. In another series of 128 patients with mitral valve disease or a mitral valve prosthesis, one-third demonstrated spontaneous echo contrast; those with this abnormality had larger left atria, more frequent atrial fibrillation, and, most importantly, a higher incidence of left atrial thrombi (60 versus 28 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/12\">",
"     12",
"    </a>",
"    ]. Interestingly, pure mitral regurgitation was never associated with spontaneous contrast in this report; however, others have noted spontaneous echo contrast in occasional patients with moderate or moderately severe mitral regurgitation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In its more intense forms, spontaneous echo contrast has important implications in mitral stenosis and in chronic atrial fibrillation of nonvalvular origin, primarily because of its associated embolic potential. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/50/2856?source=see_link\">",
"     \"Role of echocardiography in atrial fibrillation\"",
"    </a>",
"    .) In one study of 400 patients, spontaneous echo contrast was found in 19 percent; 95 percent of these patients had either atrial fibrillation or mitral stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/16\">",
"     16",
"    </a>",
"    ]. In patients with mitral stenosis or nonvalvular atrial fibrillation, spontaneous contrast was the only independent predictor of embolism, stroke, or both. Another report compared 42 patients with spontaneous echo contrast, most of whom had mitral stenosis or atrial fibrillation, to 40 control patients with atrial fibrillation or mitral stenosis who did not have this finding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/17\">",
"     17",
"    </a>",
"    ]. The presence of spontaneous echo contrast was associated with a significantly increased risk for stroke or peripheral embolism (relative risk ratio 10.6); among those patients with nonvalvular atrial fibrillation, the relative risk ratio for an embolism was 27. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Even recognizing the inherent bias in the many studies now published on the subject, the strong association of spontaneous echo contrast and embolization cannot be dismissed. The incidence of emboli in patients with this finding may be as high as 45 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/13,16,18\">",
"     13,16,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spontaneous echo contrast is believed to be the result of erythrocyte rouleaux formation (ie, red cell aggregation) in the setting of sluggish blood flow and low shear rate conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/19\">",
"     19",
"    </a>",
"    ]. Erythrocyte aggregation is mediated by plasma proteins, especially fibrinogen, which promotes red cell rouleaux formation by moderating the normal electrostatic forces (due to negatively charged membranes) that keep erythrocytes from aggregating [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/20\">",
"     20",
"    </a>",
"    ]. One study of 185 patients with valvular or nonvalvular AF found that spontaneous echo contrast was related to the presence of anticardiolipin antibody, a high erythrocyte sedimentation rate, and increased fibrinogen levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Left atrial appendage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Determination of left atrial appendage function has a complementary role to spontaneous echo contrast in assessing embolic risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/22\">",
"     22",
"    </a>",
"    ]. Those in atrial fibrillation at highest risk had maximum left atrial appendage contractile velocities below 0.25",
"    <span class=\"nowrap\">",
"     m/second.",
"    </span>",
"    These patients also tended to have appendage thrombi. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/50/31528?source=see_link\">",
"     \"Echocardiographic evaluation of the atria and appendages\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Other causes of spontaneous echo contrast",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although spontaneous echo contrast is located most commonly in the left atrium as a result of mitral stenosis or nonvalvular atrial fibrillation, it can also be found in each of the other chambers and in other pathologic states:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spontaneous echo contrast is seen in the left ventricle when systolic function is severely reduced or in the presence of an aneurysm.",
"     </li>",
"     <li>",
"      Spontaneous echo contrast is seen in the right atrium and right ventricle in patients with right heart failure.",
"     </li>",
"     <li>",
"      Right atrial spontaneous echo contrast is seen in patients with atrial fibrillation, native tricuspid valve disease, prosthetic tricuspid valves, and Fontan operations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Spontaneous echo contrast can be visualized in the lumen of the descending aorta of patients with severely reduced cardiac output (eg, severe mitral regurgitation), in the false lumen of an aortic dissection, and in the vicinity of a true aortic aneurysm.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, TEE is an integral part of modern diagnosis and treatment of mitral stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     MITRAL REGURGITATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mitral valve may become regurgitant within each of the major categories of heart disease, either as the primary target of the disease or as a physiologic consequence of diseases that primarily affect the left ventricle. Defining the morphology of the valve (",
"    <a class=\"graphic graphic_figure graphicRef79932 \" href=\"mobipreview.htm?5/22/5476\">",
"     figure 1",
"    </a>",
"    ) and the precise etiology of regurgitation have gained new importance in the era of surgical mitral valve repair. Three dimensional reconstructions of transesophageal images of the mitral valve may, in the future, provide additional morphological clues to the nature of the underlying pathology.",
"   </p>",
"   <p>",
"    While the etiology and severity of mitral stenosis can usually be discerned by transthoracic echocardiography, the extent of mitral regurgitation is often less evident. The important role TEE plays in the evaluation of mitral regurgitation is due to the proximity of the transesophageal transducer to the left atrium; from this vantage point, the mitral regurgitation jet is generally axial or parallel to the ultrasound beam. In situations that frustrate transthoracic echocardiography (eg, acoustic shadowing from calcium or prosthesis), TEE provides an unimpeded view.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Etiology of mitral regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral regurgitation may be primary, as a result of disease of the valve itself, or secondary to another disease process that affects the left ventricle or atrium and therefore mitral valve function.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Minor grades of mitral regurgitation are detected in nearly 90 percent of normal individuals. These tiny jets arise from the center of the valve coaptation point and penetrate into the receiving chamber (ie, the left atrium) for a short distance; their spectral Doppler envelopes are incomplete and of low density.",
"     </li>",
"     <li>",
"      Functional mitral insufficiency can be inferred when the valve is morphologically normal but the left ventricle is either globally or segmentally abnormal. The color flow jet is usually central, occurring at a coaptation point that is marked by decreased contact area and displacement toward the left ventricle apex, a direction that is the opposite of prolapse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemic syndromes cause intermittent severe mitral regurgitation in association with segmental wall motion abnormalities. Dyskinesis of the muscle supporting one of the papillary muscles undermines the mitral apparatus, and mitral regurgitation results from systolic papillary muscle displacement and incomplete coaptation of the mitral leaflets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/23\">",
"     23",
"    </a>",
"    ]. Papillary muscle rupture occurs most commonly in conjunction with myocardial infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/24\">",
"     24",
"    </a>",
"    ] and rarely in endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/25\">",
"     25",
"    </a>",
"    ]. This dramatic complication, readily identified on TEE, should be suspected when a new murmur is audible in a patient with cardiogenic shock postinfarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39225?source=see_link\">",
"     \"Mechanical complications of acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/6/11369?source=see_link\">",
"     \"Role of echocardiography in acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Myxomatous disease/prolapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Degenerative changes in the mitral valve are manifested most commonly by myxomatous change that thickens and elongates the leaflets and chordae and enlarges the annulus. This may occur as an isolated lesion, in association with multivalvular involvement, or as a part of a connective tissue disease syndrome (Marfan syndrome or Ehlers&ndash;Danlos syndrome). Mitral prolapse of one or more of the three scallops of the posterior leaflet or of both leaflets is the hallmark of this condition, but its precise features have not been well studied by TEE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/24/13705?source=see_link\">",
"     \"Definition and diagnosis of mitral valve prolapse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common complication of mitral prolapse is ruptured chordae tendineae, which is the leading cause of severe nonrheumatic mitral regurgitation. On transthoracic echocardiography, the condition usually can be diagnosed by observing a flail portion of the mitral valve protruding into the left atrium in systole. A remnant of the severed chord can often be seen as a filamentous structure, moving with the flail portion of the leaflet. When the sickle-shaped scallop can be recognized, the diagnosis is clear; however, if, as is often true, the mass is poorly defined, it can be impossible to differentiate between a liberated scallop and a vegetation. TEE makes this differentiation with increased, but by no means absolute, certainty. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/37/2648?source=see_link\">",
"     \"Nonarrhythmic complications of mitral valve prolapse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TEE is also more precise in determining which of the three scallops of the posterior leaflet are involved. Such information is of importance in planning mitral valve repair. In the relatively common association between prolapse and the vegetation of infective endocarditis, it can be difficult by transesophageal echocardiography to distinguish among the components of the prolapsing mass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Rheumatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postinflammatory (ie, rheumatic) changes in the mitral valve are recognized by the same features in both TEE and transthoracic echocardiography. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32409?source=see_link\">",
"     \"Echocardiographic evaluation of the mitral valve\"",
"    </a>",
"    .) Valve thickening, immobility, doming into the ventricle, chordal foreshortening, and calcification support this diagnosis. Mitral regurgitation in this condition is characterized by malcoaptation.",
"   </p>",
"   <p>",
"    Valve lesions related to systemic lupus erythematosus have been related to antiphospholipid antibodies, but this association is controversial; antiphospholipid antibodies can also occur in patients without lupus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/28\">",
"     28",
"    </a>",
"    ]. These lesions cause focal areas of thickening, which concentrate on the atrial aspect of the valve toward the tips of the leaflets, creating a club-like appearance. Occasionally, the lesions are associated with severe mitral regurgitation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/59/22456?source=see_link\">",
"     \"Non-coronary cardiac manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Congenital abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other than mitral valve prolapse, the most common congenital etiology of mitral regurgitation encountered in the adult is a partial or previously repaired complete atrioventricular septal defect (\"so-called\" endocardial cushion defect). The bridging anterior and inferior leaflets appear \"cleft\" and are frequently incompetent. TEE may be useful in defining both the site of regurgitation and the presence of residual septal defects. Other congenital causes of mitral regurgitation include the isolated cleft mitral valve and mitral valve fenestrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Infective endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A common acquired cause of mitral regurgitation is endocarditis, either complicating an underlying valve lesion (eg, mitral valve prolapse with regurgitation) or causing primary destruction of a normal mitral valve, usually in the presence of a virulent organism such as Staphylococcus aureus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=see_link\">",
"     \"Complications and outcome of infective endocarditis\"",
"    </a>",
"    .) The mechanisms for mitral regurgitation in endocarditis include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Primary leaflet destruction",
"     </li>",
"     <li>",
"      Chordal rupture",
"     </li>",
"     <li>",
"      Papillary muscle rupture (rarely)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    TEE not only has superior sensitivity in identifying vegetations and elucidating the mechanism for valve dysfunction, but also in detecting the presence of a perivalvular abscess (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76481 \" href=\"mobipreview.htm?3/25/3487\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61434 \" href=\"mobipreview.htm?0/47/754\">",
"     image 2",
"    </a>",
"    ). In a patient with severe mitral regurgitation due to endocarditis who is referred for surgery, it is critical to diagnosis this complication and to exclude multivalvular involvement. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/8/20617?source=see_link\">",
"     \"Role of echocardiography in infective endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Marantic or nonbacterial endocarditis is most often associated with systemic lupus erythematosus, but is also seen in the antiphospholipid syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The typical lesion is characterized by focal areas of thickening concentrated on the atrial aspect of the valve toward the tips of the leaflets. Occasionally, severe mitral regurgitation is associated with these lesions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=see_link\">",
"     \"Clinical manifestations of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Degenerative calcific disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elderly patients with severe degenerative calcific mitral valve disease infrequently have severe mitral regurgitation, occasionally due to ruptured chordae tendinae and sometimes in association with hypertrophic cardiomyopathy. Calcification often obscures the presence of mitral regurgitation on surface Doppler imaging because of acoustic \"shadowing\" in the posteriorly located left atrium. TEE may be necessary to confirm the presence of mitral regurgitation in this condition, which can also rarely cause hemodynamically significant mitral stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Dilated cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dilated cardiomyopathy usually results in mild to moderate mitral regurgitation due to ventricular dilatation with displacement of the papillary muscles and mitral annular dilatation; severe regurgitation is unusual in this setting. Transthoracic echocardiography is usually adequate to evaluate mitral regurgitation in patients with dilated cardiomyopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Hypertrophic cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In hypertrophic cardiomyopathy, the mechanism of mitral regurgitation may be better elucidated by TEE imaging. The mitral regurgitation usually results from systolic anterior motion of the mitral valve. Associated mitral annular calcification may cause the mitral regurgitation to be underestimated by transthoracic echocardiography. TEE may better characterize the degree of mitral regurgitation and exclude chordal rupture, a rare complication that causes acute severe mitral regurgitation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/59/28600?source=see_link\">",
"     \"Types and pathophysiology of obstructive hypertrophic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Severity of mitral regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are more than 20 variables that can be examined to judge the severity of mitral regurgitation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/31\">",
"     31",
"    </a>",
"    ]. Using this approach, severe lesions are readily recognized, but distinguishing between mild and moderate or moderate and severe mitral regurgitation can be difficult.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Color flow Doppler",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to proximity of the targets and the use of higher frequencies, color flow signals into the left atrium resulting from MR are particularly well-resolved in a transesophageal echocardiography examination. Most of the examinations listed below are conducted in one of the long axis views between longitudinal and transverse (zero to 110 degrees).",
"   </p>",
"   <p>",
"    Features of severe mitral regurgitation by TEE color flow Doppler imaging arise from the high-energy transfer of a large volume of blood into the left atrium. However, even when imaging is optimized (shallow depth, narrow sector angle, low velocity filters on), the appearance of the regurgitant jet on color flow Doppler provides only an estimate of regurgitation severity. To recognize severe MR, the following color jet characteristics should be sought during a TEE examination:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The proximal isovelocity acceleration of the jet (PISA)",
"     </li>",
"     <li>",
"      The jet size, especially the magnitude of the aliased portion",
"     </li>",
"     <li>",
"      The distance the jet penetrates to the posterior wall of the left atrium",
"     </li>",
"     <li>",
"      The eccentricity (wall hugging) of the jet",
"     </li>",
"     <li>",
"      Jet height measured at its origin or vena contracta",
"     </li>",
"     <li>",
"      The jet entering the left atrial appendage or pulmonary veins",
"     </li>",
"     <li>",
"      The jet encircling the left atrium",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One color Doppler sign usually present in severe mitral regurgitation is a characteristic proximal acceleration of the regurgitant jet appearing as a series of \"hemispheric bands of changing colors\" on the ventricular surface of the valve. The proximal acceleration isovelocity surface area (PISA) can be used to calculate both the regurgitant volume and regurgitant orifice area. In vivo and in vitro, this method has proved to be an accurate measure of mitral regurgitation severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/32-34\">",
"     32-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of PISA to calculate orifice area has been shown to have prognostic value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/35\">",
"     35",
"    </a>",
"    ]. However, the method requires accurate measurement of both the radius of the PISA and the peak velocity of the regurgitant jet (CW Doppler). These requirements are usually met by transthoracic but not by transesophageal echocardiography.",
"   </p>",
"   <p>",
"    In severe MR, at a Nyquist setting (aliasing velocity) of around",
"    <span class=\"nowrap\">",
"     55m/sec,",
"    </span>",
"    the diameter of the PISA ring closest to the regurgitant orifice is measured and usually approaches 1 cm. As the color jet crosses the defect in the valve, the width of the jet exceeds 5 mm, and as the jet enters the left atrium, the jet becomes eccentric and hugs the wall of the chamber (Coanda effect) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Once entrained on the wall, the wall jet may completely circle the chamber. The jet also tends to penetrate the atrial appendage and one or more of the pulmonary veins.",
"   </p>",
"   <p>",
"    In severe MR, the color flow pattern in the receiving chamber (left atrium) is agitated and multidirectional; spontaneous echo contrast is usually absent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. During most of its passage around the atrium, the jet is broad and aliased or mosaic. It must be emphasized that any aliased wall-hugging jet, however small in apparent area, should be considered as representing hemodynamically significant mitral regurgitation until proven otherwise through careful evaluation of the multiple parameters discussed here.",
"   </p>",
"   <p>",
"    Some researchers have found the jet area in the left atrium on TEE to be an excellent guide to mitral regurgitation severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/40\">",
"     40",
"    </a>",
"    ]. However, since the entire left atrium cannot be seen at one time on TEE, the measurement of total jet size is problematic. Furthermore, careful study of most jets with appropriate frame rates and Nyquist limits reveal that they are not central jets, but entrained wall jets that do not lend themselves to \"jet area measurement.\" On a technical note, we have observed that failure to carefully limit the area of color flow mapping results in low frame rates, low resolution, and excessive errors. The color flow examination should be directed only at the region of interest and cover as small a portion of the image fan as possible.",
"   </p>",
"   <p>",
"    The eccentricity and width of the jet have proved more accurate than either the depth or area of the jet. Importantly, severe eccentric jets, such as those due to a flail leaflet, have smaller jet areas than central jets of equal severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/41\">",
"     41",
"    </a>",
"    ]. Using TEE, one study found that a jet height of greater than 5.5 mm at its origin had a positive predictive value of 88 percent for grade 3 or 4 mitral regurgitation by angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/37\">",
"     37",
"    </a>",
"    ]. A second study found similar results using transthoracic imaging; a jet height less 5.5 mm corresponded to a regurgitant fraction of less than 25 percent while a height greater than 8 mm corresponded to a regurgitant fraction of greater than 45 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Pulsed-wave Doppler",
"    </span>",
"    &nbsp;&mdash;&nbsp;Color flow Doppler characteristics of the mitral regurgitant jet should not be used as the sole indicator of the severity of the regurgitation; spectral flow Doppler provides complementary information.",
"   </p>",
"   <p>",
"    In the four chamber TEE view, color flow should be used to identify the most well resolved inflow diastolic signal. The pulsed wave Doppler sample volume should be placed between the tips of the leaflets from where the early diastolic mitral inflow pulsed-wave Doppler signal (E wave) obtained. In severe MR, the velocity at peak inflow is almost always increased to greater than 1.4",
"    <span class=\"nowrap\">",
"     m/sec.",
"    </span>",
"    A velocity of less than 1.0",
"    <span class=\"nowrap\">",
"     m/sec",
"    </span>",
"    virtually excludes severe MR.",
"   </p>",
"   <p>",
"    In addition to increased inflow velocity, the pattern is strongly E wave dominant, with a small A wave",
"    <span class=\"nowrap\">",
"     (E/A",
"    </span>",
"    ratio &gt;2). This pattern is identical to the restrictive inflow pattern and, in fact, has a similar origin in that filling pressures may be elevated in both situations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Continuous wave Doppler",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several features are seen in severe mitral regurgitation upon study of the continuous wave Doppler systolic patterns of regurgitant mitral flow. If the flow signal can be aligned parallel to the beam, which is especially difficult in TEE, the jet will have the following characteristics:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Appear highly and uniformly dense throughout its duration",
"     </li>",
"     <li>",
"      Have a well-defined envelope",
"     </li>",
"     <li>",
"      May, in its late phases, show evidence of a \"v-wave cutoff sign;\" this sign results from a rapid decrease in the ventriculoatrial gradient as the large volume of regurgitant blood abruptly raises pressure in the left atrium",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In severe decompensated mitral regurgitation, the tricuspid regurgitation peak velocity will be increased as the result of pulmonary hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Evaluation of pulmonary veins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the pulmonary veins by TEE has provided insight into hemodynamics. In mitral regurgitation, this evaluation is a standard part of the examination and usually includes the left upper pulmonary vein, from which flow into the left atrium is usually axial to the beam of interrogation. In hemodynamically severe mitral regurgitation, the flow in one or more pulmonary veins usually demonstrates systolic flow reversal, depending upon jet direction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. Normally, pulmonary venous flow into the left atrium is predominantly systolic; thus, systolic reversal is paradoxical.",
"   </p>",
"   <p>",
"    Mitral regurgitation jet flow may enter the pulmonary veins of only one lung and result in unilateral or unilobar pulmonary edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/45\">",
"     45",
"    </a>",
"    ]. Patients who have this finding may be misdiagnosed as having lobar pneumonia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Two-dimensional echocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;TEE two-dimensional imaging of the left ventricle and atrium contains numerous clues to severe mitral regurgitation:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The left ventricle is spherically dilated and hyperdynamic.",
"     </li>",
"     <li>",
"      The left atrium is enlarged at peak systole and has an unusually pronounced change in volume that is visible during the cardiac cycle.",
"     </li>",
"     <li>",
"      The mitral valve itself may have one of the lesions consistent with severe mitral regurgitation, such as a flail leaflet. In a situation analogous to the wall-hugging jet, evidence of valve disruption obligates the echocardiographer to seriously consider and exclude severe mitral regurgitation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Role of intraoperative echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative guidance of mitral valve repair in severe mitral regurgitation is an established indication for TEE; few, if any, centers performing valve repair undertake this procedure without intraoperative TEE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Intraoperative transesophageal echocardiography can enhance the success of valve repair and can reliably predict early and late mitral valve dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study of 143 patients undergoing mitral valve repair, 11 patients had grade 3 or greater mitral regurgitation on intraoperative TEE after discontinuation of cardiopulmonary bypass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/46\">",
"     46",
"    </a>",
"    ]. Of these 11 patients, five underwent mitral valve replacement, five underwent revision of the mitral repair, and one was managed with observation only. A predischarge TTE was performed in 132 patients; when compared to the intraoperative TEE, there was a discrepancy of 1 grade or greater in the estimated severity of MR in only 17 patients (13 percent).",
"   </p>",
"   <p>",
"    The environment in the cardiovascular surgical suite imposes unique demands on the cardiologist or the cardiovascular anesthesiologist-echocardiographer. The window of time in which an estimation of the importance of a lesion must be made is narrow, the working space crowded, and the ambient light excessive. No decision is more challenging than the one to put a patient back on cardiopulmonary bypass after an apparently unsuccessful mitral valve repair.",
"   </p>",
"   <p>",
"    In addition to methodically and efficiently evaluating the variables enumerated above, it is essential that the echocardiographer be aware of the hemodynamic state of the patient at the moment of imaging. Postpump hypotension may lead to an erroneous conclusion about the presence of mitral regurgitation after repair, and blood pressure should be normalized before surgical decisions are made. On the one hand, important regurgitation may be missed because of low afterload in the presence of low systemic vascular resistance. On the other hand, paradoxically significant mitral regurgitation may resolve once hypotension is corrected; in this case, the hypotension is usually due to decreased left ventricular contractility and will respond to inotropic agents.",
"   </p>",
"   <p>",
"    In the course of restoring blood pressure by volume and pharmacologic perturbations, heart size may decrease and contractility may improve. At this point, the enlarged mitral apparatus, particularly if it is myxomatous, is confined in the ventricle by the annuloplasty ring. During systole, this redundant tissue develops systolic anterior motion and creates a dynamic gradient in the left ventricular outflow tract. In our experience, this situation responds to decreasing catecholamines and increasing preload and rarely, if ever, requires further surgical intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42040/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/1\">",
"      Hatle L. Doppler echocardiographic evaluation of mitral stenosis. Cardiol Clin 1990; 8:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/2\">",
"      Kronzon I, Tunick PA, Glassman E, et al. Transesophageal echocardiography to detect atrial clots in candidates for percutaneous transseptal mitral balloon valvuloplasty. J Am Coll Cardiol 1990; 16:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/3\">",
"      Goldstein SA, Campbell AN. Mitral stenosis. Evaluation and guidance of valvuloplasty by transesophageal echocardiography. Cardiol Clin 1993; 11:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/4\">",
"      Manning WJ, Reis GJ, Douglas PS. Use of transoesophageal echocardiography to detect left atrial thrombi before percutaneous balloon dilatation of the mitral valve: a prospective study. Br Heart J 1992; 67:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/5\">",
"      Levin TN, Feldman T, Bednarz J, et al. Transesophageal echocardiographic evaluation of mitral valve morphology to predict outcome after balloon mitral valvotomy. Am J Cardiol 1994; 73:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/6\">",
"      Palacios IF, Block PC, Wilkins GT, Weyman AE. Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis. Circulation 1989; 79:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/7\">",
"      Marwick TH, Torelli J, Obarski T, et al. Assessment of the mitral valve splitability score by transthoracic and transesophageal echocardiography. Am J Cardiol 1991; 68:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/8\">",
"      Kronzon I, Tunick PA, Goldfarb A, et al. Echocardiographic and hemodynamic characteristics of atrial septal defects created by percutaneous valvuloplasty. J Am Soc Echocardiogr 1990; 3:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/9\">",
"      Rittoo D, Sutherland GR, Shaw TR. Quantification of left-to-right atrial shunting and defect size after balloon mitral commissurotomy using biplane transesophageal echocardiography, color flow Doppler mapping, and the principle of proximal flow convergence. Circulation 1993; 87:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/10\">",
"      Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 66:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/11\">",
"      Bernstein NE, Demopoulos LA, Tunick PA, et al. Correlates of spontaneous echo contrast in patients with mitral stenosis and normal sinus rhythm. Am Heart J 1994; 128:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/12\">",
"      Michalis LK, Thomas MR, Smyth DW, et al. Left atrial spontaneous echo contrast assessed by TEE in patients with either native mitral valve disease or mitral valve replacement. J Am Soc Echocardiogr 1993; 6:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/13\">",
"      Castello R, Pearson AC, Labovitz AJ. Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography. Am J Cardiol 1990; 65:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/14\">",
"      Tsai LM, Chen JH, Fang CJ, et al. Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol 1992; 70:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/15\">",
"      Hwang JJ, Kuan P, Chen JJ, et al. Significance of left atrial spontaneous echo contrast in rheumatic mitral valve disease as a predictor of systemic arterial embolization: a transesophageal echocardiographic study. Am Heart J 1994; 127:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/16\">",
"      Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol 1991; 18:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/17\">",
"      Chimowitz MI, DeGeorgia MA, Poole RM, et al. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke 1993; 24:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/18\">",
"      Daniel WG, Nellessen U, Schr&ouml;der E, et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988; 11:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/19\">",
"      Fatkin D, Loupas T, Low J, Feneley M. Inhibition of red cell aggregation prevents spontaneous echocardiographic contrast formation in human blood. Circulation 1997; 96:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/20\">",
"      Peverill RE, Gelman J, Harper RW, Smolich JJ. Stability of left atrial spontaneous echo contrast at repeat transesophageal echocardiography in patients with mitral stenosis. Am J Cardiol 1997; 79:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/21\">",
"      Fatkin D, Herbert E, Feneley MP. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 1994; 73:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/22\">",
"      M&uuml;gge A, K&uuml;hn H, Nikutta P, et al. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994; 23:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/23\">",
"      Kaul S, Spotnitz WD, Glasheen WP, Touchstone DA. Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation 1991; 84:2167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/24\">",
"      Kranidis A, Koulouris S, Filippatos G, et al. Mitral regurgitation from papillary muscle rupture: role of transesophageal echocardiography. J Heart Valve Dis 1993; 2:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/25\">",
"      Habib G, Guidon C, Tricoire E, et al. Papillary muscle rupture caused by bacterial endocarditis: role of transesophageal echocardiography. J Am Soc Echocardiogr 1994; 7:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/26\">",
"      Goldman AP, Glover MU, Mick W, et al. Role of echocardiography/Doppler in cardiogenic shock: silent mitral regurgitation. Ann Thorac Surg 1991; 52:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/27\">",
"      Schl&uuml;ter M, Thier W, Hinrichs A, et al. [Clinical use of transesophageal echocardiography]. Dtsch Med Wochenschr 1984; 109:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/28\">",
"      Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/29\">",
"      Jafar MZ, Morgan MC, Gorcsan J 3rd. Transesophageal echocardiographic detection of multiple mitral valve masses in primary antiphospholipid syndrome with stroke. Am Heart J 1994; 127:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/30\">",
"      Zhu WX, Oh JK, Kopecky SL, et al. Mitral regurgitation due to ruptured chordae tendineae in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1992; 20:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/31\">",
"      Schiller NB, Foster E, Redberg RF. Transesophageal echocardiography in the evaluation of mitral regurgitation. The twenty-four signs of severe mitral regurgitation. Cardiol Clin 1993; 11:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/32\">",
"      Rivera JM, Vandervoort PM, Thoreau DH, et al. Quantification of mitral regurgitation with the proximal flow convergence method: a clinical study. Am Heart J 1992; 124:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/33\">",
"      Schwammenthal E, Chen C, Benning F, et al. Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing. Circulation 1994; 90:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/34\">",
"      Mele D, Vandervoort P, Palacios I, et al. Proximal jet size by Doppler color flow mapping predicts severity of mitral regurgitation. Clinical studies. Circulation 1995; 91:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/35\">",
"      Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005; 352:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/36\">",
"      Grayburn PA, Fehske W, Omran H, et al. Multiplane transesophageal echocardiographic assessment of mitral regurgitation by Doppler color flow mapping of the vena contracta. Am J Cardiol 1994; 74:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/37\">",
"      Tribouilloy C, Shen WF, Qu&eacute;r&eacute; JP, et al. Assessment of severity of mitral regurgitation by measuring regurgitant jet width at its origin with transesophageal Doppler color flow imaging. Circulation 1992; 85:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/38\">",
"      Hwang JJ, Shyu KG, Hsu KL, et al. Significant mitral regurgitation is protective against left atrial spontaneous echo contrast formation, but not against systemic embolism. Chest 1994; 106:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/39\">",
"      Movsowitz C, Movsowitz HD, Jacobs LE, et al. Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography. J Am Soc Echocardiogr 1993; 6:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/40\">",
"      Castello R, Lenzen P, Aguirre F, Labovitz AJ. Quantitation of mitral regurgitation by transesophageal echocardiography with Doppler color flow mapping: correlation with cardiac catheterization. J Am Coll Cardiol 1992; 19:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/41\">",
"      Chen CG, Thomas JD, Anconina J, et al. Impact of impinging wall jet on color Doppler quantification of mitral regurgitation. Circulation 1991; 84:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/42\">",
"      Klein AL, Bailey AS, Cohen GI, et al. Importance of sampling both pulmonary veins in grading mitral regurgitation by transesophageal echocardiography. J Am Soc Echocardiogr 1993; 6:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/43\">",
"      Klein AL, Obarski TP, Stewart WJ, et al. Transesophageal Doppler echocardiography of pulmonary venous flow: a new marker of mitral regurgitation severity. J Am Coll Cardiol 1991; 18:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/44\">",
"      Klein AL, Stewart WJ, Bartlett J, et al. Effects of mitral regurgitation on pulmonary venous flow and left atrial pressure: an intraoperative transesophageal echocardiographic study. J Am Coll Cardiol 1992; 20:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/45\">",
"      Roach JM, Stajduhar KC, Torrington KG. Right upper lobe pulmonary edema caused by acute mitral regurgitation. Diagnosis by transesophageal echocardiography. Chest 1993; 103:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/46\">",
"      Freeman WK, Schaff HV, Khandheria BK, et al. Intraoperative evaluation of mitral valve regurgitation and repair by transesophageal echocardiography: incidence and significance of systolic anterior motion. J Am Coll Cardiol 1992; 20:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/47\">",
"      Maurer G, Siegel RJ, Czer LS. The use of color flow mapping for intraoperative assessment of valve repair. Circulation 1991; 84:I250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42040/abstract/48\">",
"      Saiki Y, Kasegawa H, Kawase M, et al. Intraoperative TEE during mitral valve repair: does it predict early and late postoperative mitral valve dysfunction? Ann Thorac Surg 1998; 66:1277.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5329 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-91.202.164.29-FFA7B79098-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42040=[""].join("\n");
var outline_f41_3_42040=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      MITRAL STENOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Use in percutaneous balloon valvotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Spontaneous echo contrast",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Left atrial appendage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Other causes of spontaneous echo contrast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      MITRAL REGURGITATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Etiology of mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Ischemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Myxomatous disease/prolapse",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Rheumatic disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Congenital abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Degenerative calcific disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Severity of mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Color flow Doppler",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Pulsed-wave Doppler",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Continuous wave Doppler",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Evaluation of pulmonary veins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Two-dimensional echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Role of intraoperative echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/5329\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5329|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?3/25/3487\" title=\"diagnostic image 1\">",
"      TEE mitral valve vegetations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?0/47/754\" title=\"diagnostic image 2\">",
"      Transthoracic v transesophageal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5329|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?5/22/5476\" title=\"figure 1\">",
"      Mitral valve structure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=related_link\">",
"      Complications and outcome of infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/24/13705?source=related_link\">",
"      Definition and diagnosis of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/50/31528?source=related_link\">",
"      Echocardiographic evaluation of the atria and appendages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32409?source=related_link\">",
"      Echocardiographic evaluation of the mitral valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39225?source=related_link\">",
"      Mechanical complications of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/59/22456?source=related_link\">",
"      Non-coronary cardiac manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/37/2648?source=related_link\">",
"      Nonarrhythmic complications of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/45/33497?source=related_link\">",
"      Percutaneous mitral balloon valvotomy for mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/6/11369?source=related_link\">",
"      Role of echocardiography in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/50/2856?source=related_link\">",
"      Role of echocardiography in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/8/20617?source=related_link\">",
"      Role of echocardiography in infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/59/28600?source=related_link\">",
"      Types and pathophysiology of obstructive hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_3_42041="Prevention of acute graft-versus-host disease: Trials of pharmacologic therapy";
var content_f41_3_42041=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention of acute graft-versus-host disease: Trials of pharmacologic therapy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42041/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42041/contributors\">",
"     Nelson J Chao, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42041/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42041/contributors\">",
"     Robert S Negrin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/3/42041/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/3/42041/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/3/42041/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically significant acute graft-versus-host disease (GVHD) occurs in 9 to 50 percent of patients who receive an allogeneic bone marrow graft from a genotypically HLA-identical sibling, despite intensive prophylaxis with immunosuppressive agents, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , corticosteroids, or antithymocyte globulin. Acute GVHD is also common in matched unrelated donors and in haploidentical related donors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/38/26218?source=see_link\">",
"     \"Donor selection for hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Development of moderate (grade II) or severe (grade III or IV) acute GVHD after marrow transplantation is associated with a significant decrease in survival. Various methods to prevent GVHD have been developed. The mainstay of prophylaxis remains a combination of drugs that individually have been shown to prevent GVHD (",
"    <a class=\"graphic graphic_table graphicRef78611 \" href=\"mobipreview.htm?10/62/11243\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This topic will review the clinical trials that have evaluated pharmacologic therapy for the prevention of acute GVHD. The trials evaluating T cell depletion and recommendations for the prevention and treatment of acute GVHD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24792?source=see_link\">",
"     \"Prevention of acute graft-versus-host disease: Trials of T cell depletion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=see_link\">",
"     \"Prevention and treatment of acute graft-versus-host disease: Recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SINGLE DRUG PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention of GVHD is an important contributor to improved outcome following allogeneic marrow grafting. Before reviewing the data on the efficacy of different regimens, it is useful to review three small trials reported in which GVHD prophylaxis was not used (",
"    <a class=\"graphic graphic_table graphicRef78611 \" href=\"mobipreview.htm?10/62/11243\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, the incidence of GVHD was much higher in the 15 patients receiving no prophylaxis than in those treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      or methotrexate and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (67 versus 25 to 26 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/3\">",
"       3",
"      </a>",
"      ]. Similar findings were noted in a series from Seattle in which all 15 evaluable patients developed grade II or greater GVHD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The results were different in another nonrandomized study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/2\">",
"       2",
"      </a>",
"      ]. The incidence of GVHD was the same in 34 patients given",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      and 21 patients receiving no prophylaxis (59 versus 52 percent); the severity of GVHD was also similar in the two groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Such differences may be due to patient selection and the small numbers of patients studied. Furthermore, these trials did not demonstrate any differences in overall survival or in the incidence of chronic GVHD (although there may have been a difference in the severity of chronic GVHD)",
"   </p>",
"   <p>",
"    There is no doubt, however, that the occurrence of GVHD can have a devastating effect, and subsequent studies have shown that a clear impact on overall survival. Given the advances in GVHD prophylaxis to date, it is unlikely that clinical investigators would consider not using GVHD prophylaxis following hematopoietic cell transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Methotrexate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial studies in animals and humans used a single drug for the prophylaxis of GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/4-8\">",
"     4-8",
"    </a>",
"    ]. In a study in dogs, for example, the administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    resulted in a greater than 90 percent disease-free survival following BMT from DLA-identical litter mates compared with a 55 percent incidence of acute GVHD and a 45 percent survival in dogs not receiving any GVHD prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/5\">",
"     5",
"    </a>",
"    ]. A subsequent study in rats documented the efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    for the prevention and treatment of GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These two agents were then the mainstay in clinical trials for the prevention of GVHD. However, GVHD still occurred in up to 55 to 70 percent of patients until the introduction of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Antithymocyte globulin (ATG) was also evaluated with conflicting results. Two studies that compared the addition of ATG to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    versus methotrexate alone did not find a decrease in the incidence of GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In comparison, a third study found that the addition of ATG and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    to methotrexate was associated with a significant reduction in the incidence of acute GVHD (21 versus 48 percent with methotrexate alone) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/11\">",
"     11",
"    </a>",
"    ]. However, there was no difference in survival. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Antithymocyte globulin'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cyclosporine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    binds to cyclophilin, a cytosolic transporter protein; this complex is then carried into the nucleus where it can bind to the interleukin (IL)-2 promoter region preventing IL-2 gene expression and therefore activation of T-lymphocytes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=see_link&amp;anchor=H3#H3\">",
"     \"Pharmacology and side effects of cyclosporine and tacrolimus\", section on 'Mechanism of action'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initial studies in animals and in humans demonstrated that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    was a potent agent to prevent GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. For the purposes of most trials, prevention of GVHD is primarily defined as the prevention of significant (&gt;grade II) GVHD. Grade I GVHD does not carry a clinically adverse outcome unless it progresses to more extensive GVHD. These studies and the subsequent trials described below primarily involved patients with matched related BMT.",
"   </p>",
"   <p>",
"    Controlled follow-up studies of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    showed that cyclosporine was not superior to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/7,8,15,16\">",
"     7,8,15,16",
"    </a>",
"    ]. In an analysis of 179 patients who were transplanted for leukemia and given either cyclosporine or methotrexate prophylaxis, for example, there was no significant difference in the incidence of acute GVHD (40 versus 55 percent with methotrexate) or chronic GVHD (42 versus 48 percent) at three to six-year follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subsequent report evaluated these patients at 8 to 11 years with no difference in conclusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/17\">",
"     17",
"    </a>",
"    ]. This long-term follow-up also allowed analysis of disease-free survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/17\">",
"     17",
"    </a>",
"    ]. The rates of relapse of leukemia, GVHD, and interstitial pneumonitis were similar with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    for all three underlying diseases (advanced stage leukemia, acute myeloid leukemia in first complete remission, and chronic myeloid leukemia).",
"   </p>",
"   <p>",
"    Although patients with advanced disease receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    had a trend toward higher relapse rates, this difference did not reach statistical significance. A similar finding was noted in a smaller study of 59 patients in whom the incidence of relapse was higher in those treated with cyclosporine compared with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (42 versus 10 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another approach has been a prolonged course of GVHD prophylaxis with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and early treatment of acute GVHD with high-dose corticosteroids&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/19\">",
"     19",
"    </a>",
"    ]. Under this regimen, cyclosporine was tapered very slowly after 12 months. Acute GVHD was treated at the first clear sign of the disease with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    at 10 to 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day divided into four doses. In one series of 45 patients, this regimen was associated with a low incidence of both severe and chronic GVHD (5 and 9 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cyclophosphamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Earlier studies had shown that high-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    given post-transplantation along with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil was safe and effective in preventing graft rejection and GVHD after nonmyeloablative conditioning and transplantation of T cell replete bone marrow from partially HLA-mismatched related donors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These results suggested the feasibility of a phase",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    study to evaluate the effectiveness of single agent high-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    in reducing the incidence of acute and chronic GVHD following myeloablative allogeneic HCT. All patients (78 HLA-matched related and 39 HLA-matched unrelated donors) received conventional myeloablation using",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/10/10408?source=see_link\">",
"     busulfan",
"    </a>",
"    plus cyclophosphamide conditioning and T cell replete bone marrow, followed by 50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day of cyclophosphamide on days 3 and 4 post-transplantation. Results included [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidences of grades II through IV and grades III through IV acute GVHD were 43 and 10 percent, respectively and the day 100 and two-year nonrelapse mortalities were 9 and 17 percent, respectively.",
"     </li>",
"     <li>",
"      At a median follow-up of 26 months among surviving patients, the cumulative incidence of chronic GVHD was 10 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that, in the majority of patients, this use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    after transplantation results in selective removal of alloreactive donor T cells, with the most dramatic effect being the low incidence of chronic GVHD. Clearly, these results need to be expanded and repeated in other centers for a more definitive conclusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     COMBINATION DRUG PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The equivalent efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    for GVHD prophylaxis led to studies evaluating these drugs in combination. Initial animal studies showed an improvement in survival in favor of those receiving cyclosporine and a short course of methotrexate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observations have been confirmed in initial clinical trials which demonstrated a survival advantage in patients who received the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    compared with either drug alone (",
"    <a class=\"graphic graphic_table graphicRef78611 \" href=\"mobipreview.htm?10/62/11243\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/25-30\">",
"     25-30",
"    </a>",
"    ]. The following summary of some of the randomized trials illustrates the range of findings that have been described:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One trial compared the combination of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      to methotrexate alone in 46 patients with severe aplastic anemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/28\">",
"       28",
"      </a>",
"      ]. Grade II or worse acute GVHD was much less frequent with combination therapy (18 versus 53 percent, P = 0.012).",
"     </li>",
"     <li>",
"      In three different trials that compared",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      to cyclosporine alone, combination therapy was associated with a significant reduction in acute GVHD (25 to 32 percent versus 51 to 55 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/26,29,30\">",
"       26,29,30",
"      </a>",
"      ]. In one of these trials, the benefit was more pronounced in patients transplanted for aplastic anemia compared with those transplanted for leukemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/30\">",
"       30",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      At long-term follow-up of these trials, there was no effect on the rate of development of chronic GVHD (26 versus 24 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/31\">",
"       31",
"      </a>",
"      ]. There was a trend towards improved event-free survival in the subgroup of patients with chronic myeloid leukemia. However, in patients with acute myeloid leukemia, the early survival benefit was offset by an increase in the relapse rate.",
"     </li>",
"     <li>",
"      A comparison of three regimens &mdash;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      alone, T cell depletion, and the combination of cyclosporine and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      &mdash; was studied in 140 consecutive patients with chronic myeloid leukemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/32\">",
"       32",
"      </a>",
"      ]. The combination of cyclosporine and methotrexate was significantly better than T cell depletion in terms of disease-free survival at two years (68 versus 40 percent) and hematologic relapse (6 versus 41 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At present, the combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    is the most widely used regimen for the prophylaxis of acute GVHD (",
"    <a class=\"graphic graphic_table graphicRef60951 \" href=\"mobipreview.htm?8/19/8509\">",
"     table 2",
"    </a>",
"    ). Dose adjustments need to be made according to the serum creatinine and bilirubin concentrations (",
"    <a class=\"graphic graphic_table graphicRef79917 \" href=\"mobipreview.htm?24/26/25004\">",
"     table 3",
"    </a>",
"    ). Various modifications of the basic regimen developed in Seattle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/28-31\">",
"     28-31",
"    </a>",
"    ] have been investigated. None of these studies has compared the efficacy of modified therapy to standard cyclosporine and methotrexate in a prospective randomized fashion.",
"   </p>",
"   <p>",
"    One of the concerns with the use of combination regimens containing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    is hepatotoxicity. One study compared 20 patients who received methotrexate and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    with 67 historical controls treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    and cyclosporine for GVHD prophylaxis after a preparative regimen consisting of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/10/10408?source=see_link\">",
"     busulfan",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/33\">",
"     33",
"    </a>",
"    ]. The patients receiving methotrexate and cyclosporine had a marked increase in the incidence of sinusoidal obstruction syndrome (SOS) of the liver (70 versus 18 percent) and in death from SOS (25 versus 5 percent). It was suggested that administering methotrexate and busulfan led to combined toxicity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/4/40009?source=see_link\">",
"     \"Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another approach to decrease the toxicity of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    is to decrease the dose. The regimen developed at MD Anderson utilized half of the traditional doses of methotrexate (so called \"minidose\" methotrexate) combined with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/34\">",
"     34",
"    </a>",
"    ]. The overall incidence of acute GVHD was similar to that of standard doses with less systemic toxicities.",
"   </p>",
"   <p>",
"    Another issue with combination regimens containing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    is the value of measuring cyclosporine blood levels. In one study from a single institution, four different methods of GVHD prophylaxis were evaluated:",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , cyclosporine, methotrexate and cyclosporine, and T cell depletion and cyclosporine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/35\">",
"     35",
"    </a>",
"    ]. Using four different assays for measurement of cyclosporine blood levels, no correlation was detected by any method that correlated with the clinical outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another study monitored blood",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    levels in patients also treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/36\">",
"     36",
"    </a>",
"    ]. This approach permitted a 60 percent reduction in the cyclosporine dose by day +50 compared with the Seattle protocol without an increased incidence of acute GVHD or a higher relapse rate. We monitor plasma cyclosporine levels as a guide to dosing until about day +120, when the dose begins to be tapered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Role of prednisone",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     Prednisone",
"    </a>",
"    is the most effective drug for the",
"    <strong>",
"     treatment",
"    </strong>",
"    of acute GVHD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/32/6666?source=see_link\">",
"     \"Treatment of acute graft-versus-host disease: Clinical trials\"",
"    </a>",
"    .) It may also be effective for reducing the incidence of acute GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/37\">",
"     37",
"    </a>",
"    ], such as when given in combination with other agents (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ) (",
"    <a class=\"graphic graphic_table graphicRef78611 \" href=\"mobipreview.htm?10/62/11243\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/8,11,34,38-41\">",
"     8,11,34,38-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A trial evaluated whether the addition of three doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    to the combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    could further decrease the incidence of acute GVHD in 150 patients transplanted for leukemia or lymphoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients receiving cyclosporine, methotrexate, and prednisone had a significantly lower incidence of grade II-IV acute GVHD than those receiving only cyclosporine and prednisone (9 versus 23 percent, p = 0.02) (",
"    <a class=\"graphic graphic_figure graphicRef79413 \" href=\"mobipreview.htm?27/49/28432\">",
"     figure 1",
"    </a>",
"    ). The lower incidence of acute GVHD did not result in a higher relapse rate, as the disease-free survival at three years was the same in the two groups (64 versus 59 percent). A similar incidence of acute GVHD in patients treated with cyclosporine and prednisone (20 percent) was noted in another trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to these results, a previous study from Seattle found that the addition of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    was not beneficial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/43\">",
"     43",
"    </a>",
"    ]. The incidence of acute GVHD was actually higher with triple therapy when high dose prednisone (2",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    was begun on day +1 after allografting; if, however, prednisone was begun on day +15, there was no difference in the incidence of acute GVHD compared with patients not receiving prednisone.",
"   </p>",
"   <p>",
"    In support of the delayed use of corticosteroids are the results noted in a prospective randomized study comparing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    (MP) versus cyclosporine and methotrexate in patients receiving BMT from an HLA-identical sibling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/44\">",
"     44",
"    </a>",
"    ]. Methotrexate was given in four doses (days 1, 3, 6, and 11), and MP was not begun until day 14. Acute GVHD was more common in the patients treated without MP. However, a second randomized study found no difference between these two regimens in preventing either acute or chronic GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/45\">",
"     45",
"    </a>",
"    ]. A third, non-randomized study concluded that the addition of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    to the combination of cyclosporine and methotrexate delayed the onset of early acute GVHD, but had no impact on the overall incidence of GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/46\">",
"     46",
"    </a>",
"    ]. Based on these data, our current recommendation is to save the use of corticosteroids for the treatment of acute GVHD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Tacrolimus plus methotrexate",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     Tacrolimus",
"    </a>",
"    (FK506), which is at least as effective as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    for the prevention of rejection of cell or organ allografts, has been evaluated in combination with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    for the prevention of GVHD. In a multicenter trial, 329 recipients of HLA-identical marrow transplants were randomized to receive a short course of methotrexate plus either tacrolimus or cyclosporine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/47\">",
"     47",
"    </a>",
"    ]. Although a significantly greater proportion of patients with advanced disease were randomized to tacrolimus, the incidence of grade II-IV acute GVHD was significantly lower in patients who received tacrolimus (32 versus 44 percent with cyclosporine). This difference was largely due to a reduction in grade II disease. The incidence of chronic GVHD was similar in the two groups (56 and 49 percent), but severe chronic disease was more likely with cyclosporine.",
"   </p>",
"   <p>",
"    There were, however, several adverse findings in the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    group:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A lower rate of two-year survival (41 versus 50 percent with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      ) and overall survival (47 versus 57 percent with cyclosporine) that was largely due to poorer survival of patients with advanced disease (25 versus 42 percent). Nonadvanced disease was defined as chronic myeloid leukemia in chronic or accelerated phase, myelodysplasia, or disease in remission; all other patients (35 percent) were categorized as having advanced disease.",
"     </li>",
"     <li>",
"      A higher incidence of regimen-related adverse events which predominantly occurred in patients with advanced disease (eg, 19 versus 8 percent incidence of hemodialysis within eight weeks post-transplant).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It was concluded that, among patients with nonadvanced disease,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    was more effective than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    plus methotrexate in the prevention of acute GVHD with no difference in disease-free or overall survival. The survival disadvantage in patients with advanced disease warranted further study. Another unexplained finding was that the survival of patients with advanced disease who received cyclosporine was much better than in other studies reported in the literature. Furthermore, patients with nonadvanced disease who were treated with cyclosporine had a much higher incidence of fatal regimen-related toxicity than those with advanced disease (26 versus 7 percent).",
"   </p>",
"   <p>",
"    Another randomized trial compared",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and methotrexate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/48\">",
"     48",
"    </a>",
"    ]. Tacrolimus was more effective than cyclosporine for the prophylaxis of acute GVHD but there was no difference in patient survival or relapse. Although these trials were performed in patients with HLA-identical marrow transplants, uncontrolled [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/34,49\">",
"     34,49",
"    </a>",
"    ] and controlled [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/50\">",
"     50",
"    </a>",
"    ] observations indicate that tacrolimus also has activity against acute GVHD in recipients of matched",
"    <strong>",
"     unrelated",
"    </strong>",
"    donor transplants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Tacrolimus plus sirolimus",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     Tacrolimus",
"    </a>",
"    has been employed in combination with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    and low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    for GVHD prophylaxis in mismatched related donor and mismatched unrelated donor HCT with a low rate of acute GVHD in these historically high-risk populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/51\">",
"     51",
"    </a>",
"    ]. In an attempt to minimize the toxicity of methotrexate, subsequent trials employed tacrolimus plus sirolimus without methotrexate in matched related donor (MRD) and matched unrelated donor (URD) HCT, with the following results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No overall differences between the 53 MRD and 30 URD transplants were noted. Engraftment was rapid, with median times to neutrophil and platelet engraftment of 14 and 12 days, respectively.",
"     </li>",
"     <li>",
"      The incidences of grade II-IV and grade III-IV acute GVHD were 20 and 5 percent, respectively; the cumulative incidence of chronic GVHD was 59 percent.",
"     </li>",
"     <li>",
"      Thirty-day and 100-day treatment-related mortalities were zero and 4.8 percent, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This regimen will be tested formally in a randomized phase III study in the MRD population comparing",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"      tacrolimus",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"      sirolimus",
"     </a>",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     tacrolimus/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"      methotrexate",
"     </a>",
"    </span>",
"    in a trial conducted by the Bone Marrow Transplant Clinical Trials Network (BMT CTN) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Toxicity of other sirolimus combinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A retrospective review of 488 patients studied the effect of treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    on the incidence of hepatic sinusoidal obstruction syndrome (SOS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/55\">",
"     55",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When used with",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"        cyclophosphamide",
"       </a>",
"       /total",
"      </span>",
"      body irradiation",
"      <span class=\"nowrap\">",
"       (Cy/TBI)",
"      </span>",
"      conditioning,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      was associated with a significantly increased incidence of SOS (OR 2.35).",
"     </li>",
"     <li>",
"      The concomitant use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      further increased this rate (OR 3.23), while",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      without methotrexate was not associated with a significantly increased risk of SOS (OR 1.55). Overall treatment-related mortality was lowest when sirolimus was used without methotrexate.",
"     </li>",
"     <li>",
"      When used with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/10/10408?source=see_link\">",
"       busulfan",
"      </a>",
"      -based conditioning,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      was associated with an even higher rate of SOS (OR 8.8).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that myeloablative doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/10/10408?source=see_link\">",
"     busulfan",
"    </a>",
"    should not be used with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    -based immunosuppression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Antibodies and antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antithymocyte globulin (ATG) and antibodies directed against the interleukin (IL)-1, IL-2, and IL-7 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/57\">",
"     57",
"    </a>",
"    ] receptors have been evaluated for the prophylaxis of acute GVHD in both experimental animals and man.",
"   </p>",
"   <p>",
"    The rationale for the use of murine monoclonal anti-IL-2 receptor antibodies is provided by the observation that there is an increase in the expression of IL-2 receptors as T cells become activated by histocompatibility antigens that differ between the host and the donor. The IL-2 receptor is composed of at least two chains, a heavy chain (75 kD) and a light chain (55 kD) that combine form a molecular complex with high affinity to IL-2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/58\">",
"     58",
"    </a>",
"    ]. The binding of IL-2 to its receptor is an essential requirement for T cell proliferation.",
"   </p>",
"   <p>",
"    Monoclonal antibodies that bind to the human IL-2 receptor light chain block IL-2 binding and may also allow selective targeting and destruction of activated T cells. Such a murine monoclonal IgG1 antibody (2A3) has been evaluated for prophylaxis of acute GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/59\">",
"     59",
"    </a>",
"    ]. In this study, 11 patients received standard therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    plus the 2A3 antibody: 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    on day -1, and 0.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day from day 0 through day 19. Although there was no appreciable toxicity or adverse effect on engraftment, 70 percent of patients developed grade II-IV acute GVHD, suggesting lack of elimination of alloantigen-specific T cells even though activation of these cells may have been delayed.",
"   </p>",
"   <p>",
"    Newer agents directed against human IL-2 receptors may be more immunosuppressive and more effective for prophylaxis against acute GVHD. There have been many other antibody targets, but nearly all the attempts have focused on the treatment, not prevention, of acute GVHD.",
"   </p>",
"   <p>",
"    In a randomized, double-blind, placebo-controlled trial, use of a recombinant human IL-1 receptor antagonist during conditioning and 10 days immediately following allogeneic hematopoietic cell transplantation did not reduce GVHD or toxicity, and did not improve survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Antithymocyte globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antithymocyte globulin (ATG) is a polyclonal immunoglobulin directed against human T lymphocytes. The interest in ATG for GVHD prophylaxis is based upon the understanding that GVHD is caused by donor T lymphocytes. The addition of ATG to other GVHD prophylaxis regimens decreases the rate of acute GVHD, but has not demonstrated a survival benefit. In addition, the use of ATG after HCT has been associated with an increase in post-transplant lymphoproliferative disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/1/34842?source=see_link&amp;anchor=H16#H16\">",
"     \"Overview of immunosuppressive agents used for prevention and treatment of graft-versus-host disease\", section on 'Antithymocyte globulin'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23338?source=see_link\">",
"     \"Treatment and prevention of post-transplant lymphoproliferative disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prospective and retrospective studies have had mixed results regarding the efficacy and safety of various ATG preparations for the prevention of GVHD. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report of 109 patients enrolled in two randomized trials from Italy, use of rabbit ATG in patients undergoing unrelated donor transplants reduced the incidence of both severe acute and extensive chronic GVHD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/62\">",
"       62",
"      </a>",
"      ]. However, this did not translate into a reduction of treatment-related mortality because of an increase in fatal infections in the ATG treatment arm.",
"     </li>",
"     <li>",
"      Another trial randomly assigned 202 patients undergoing allogeneic HCT from matched unrelated donors to receive GVHD prophylaxis with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , with or without rabbit ATG [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/63\">",
"       63",
"      </a>",
"      ]. The addition of ATG significantly reduced the overall incidence of acute and chronic GVHD, without an increase in relapse or non-relapse mortality, and without compromising overall survival. However, addition of ATG did not significantly reduce the incidence of grade III-IV acute GVHD or death within 100 days, the primary endpoints of the study. A subsequent report of this study demonstrated a lower incidence and severity of chronic GVHD without increasing the risk of relapse [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/64\">",
"       64",
"      </a>",
"      ]. Patients treated with ATG were more likely to have undergone successful taper of other immunosuppressants.",
"     </li>",
"     <li>",
"      A retrospective analysis of 1676 adults undergoing reduced intensity HCT for hematologic malignancy compared outcomes among patients who underwent in vivo T cell depletion with ATG (584 patients) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/25/26008?source=see_link\">",
"       alemtuzumab",
"      </a>",
"      (213 patients) with those of patients who did not undergo T cell depletion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/65\">",
"       65",
"      </a>",
"      ]. When compared with T cell replete transplantation, ATG resulted in similar rates of acute GVHD, lower rates of chronic GVHD (40 versus 52 percent), higher rates of relapse (49 versus 38 percent) and lower overall survival (38 versus 50 percent) at three years.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A 2012 Cochrane meta-analysis investigating the use of ATG for GVHD prophylaxis included data from six randomized trials with a total of 568 patients who underwent allogeneic HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/66\">",
"     66",
"    </a>",
"    ]. The addition of ATG did not improve overall survival (hazard ratio 0.88; 95% CI 0.67-1.15) or increase the incidences of relapse (RR 1.13; 95% CI 0.75-1.68) and non-relapse mortality (HR 0.82; 95% CI 0.55-1.24). While the overall incidence of GVHD was not significantly different, patients who received ATG had a lower incidence of severe (grade II to IV) GVHD (RR 0.68; 95% CI 0.55-0.85) with a number needed to treat of eight patients. The incidence of chronic GVHD could not be assessed.",
"   </p>",
"   <p>",
"    These studies suggest that ATG is effective in decreasing the rate of acute and chronic GVHD in patients undergoing HCT, but that these benefits do not translate as yet into a survival benefit. The efficacy and safety of ATG is likely affected by the intensity of the preparative regimen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Intravenous immune globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum immunoglobulin concentrations fall dramatically after marrow transplantation. Under normal circumstances, serum IgG and IgM concentrations return to normal at approximately three to four months following allogeneic transplantation, while serum IgA levels may remain low for up to two years. However, normal serum total IgG levels may be associated with marked subclass deficiencies of IgG2 and IgG4 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. This abnormality may predispose to certain bacterial infections, such as Streptococcus pneumoniae and Haemophilus influenzae type B.",
"   </p>",
"   <p>",
"    Initial studies of intravenous immunoglobulin (IGIV, IVIG) following BMT were performed with the goal of reducing the incidence and severity of cytomegalovirus infections. However, IGIV also appears to reduce the risk of acute GVHD. The potential benefit of this approach was illustrated in a randomized trial of 382 allogeneic bone marrow transplant recipients who were given intravenous immune globulin (IGIV) (500",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    weekly to day 90, then monthly to day 360) or no IGIV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/3/42041/abstract/69\">",
"     69",
"    </a>",
"    ]. Compared with the controls, patients given IGIV had a significantly lower incidence of interstitial pneumonia among patients seropositive for CMV (13 versus 22 percent, p = 0.02), a reduced risk of Gram negative septicemia (relative risk 0.38) and local infections, and, in patients more than 20 years of age, a lower incidence of acute GVHD (34 versus 51 percent, p = 0.005).",
"   </p>",
"   <p>",
"    As a result of these findings, many groups, including ours, use biweekly infusions of IGIV (500",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    until day 100 following allogeneic transplants. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/54/34664?source=see_link\">",
"     \"Hematopoietic support after hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121886080\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Graft-versus-host disease (GVHD) occurs when immune cells transplanted from a non-identical donor (the graft) recognize the transplant recipient (the host) as foreign, thereby initiating an immune reaction that causes disease in the transplant recipient. The pathogenesis of GVHD is a complex, multistep process, but is primarily a T cell mediated process. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/24/18826?source=see_link\">",
"       \"Pathogenesis of graft-versus-host disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Development of moderate (grade II) or severe (grade III or IV) acute GVHD after marrow transplantation is associated with a significant decrease in survival. Pharmacologic agents used for the prevention and treatment of GVHD include non-specific immunosuppressive drugs, such as corticosteroids and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , as well as more specific T cell immunosuppressive drugs, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Initial studies investigating single-agent",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , single-agent",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      , and single-agent",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      suggested that these agents appear to be equally effective in preventing acute GVHD. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Single drug prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Subsequent studies demonstrated a survival advantage in patients who received both",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      compared with either drug alone. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Combination drug prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      At present, the combination of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      is the most widely used regimen for the prophylaxis of acute GVHD (",
"      <a class=\"graphic graphic_table graphicRef60951 \" href=\"mobipreview.htm?8/19/8509\">",
"       table 2",
"      </a>",
"      ). Dose adjustments need to be made according to the serum creatinine and bilirubin concentrations (",
"      <a class=\"graphic graphic_table graphicRef79917 \" href=\"mobipreview.htm?24/26/25004\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=see_link\">",
"       \"Prevention and treatment of acute graft-versus-host disease: Recommendations\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/1\">",
"      Sullivan KM, Deeg HJ, Sanders J, et al. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood 1986; 67:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/2\">",
"      Lazarus HM, Coccia PF, Herzig RH, et al. Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients. Blood 1984; 64:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/3\">",
"      Elfenbein G, Goedect T, Graham-Pole J, et al. Is prophylaxis against acute graft-versus-host disease necessary if treatment is effective and survival is not impaired? (abstract). Proc Am Soc Clin Oncol 1986; 5:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/4\">",
"      Uphoff DE. Alteration of homograft reaction by A-methopterin in lethally irradiated mice treated with homologous marrow. Proc Soc Exp Biol Med 1958; 99:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/5\">",
"      Storb R, Epstein RB, Graham TC, Thomas ED. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 1970; 9:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/6\">",
"      Santos GW, Owens AH. Production of graft-versus-host disease in the rat and its treatment with cytotoxic agents. Nature 1966; 210:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/7\">",
"      Storb R, Deeg HJ, Fisher L, et al. Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood 1988; 71:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/8\">",
"      Santos G, Tutschka PJ, Brookmeyer R, et al. Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: A randomized double-blind study in patients undergoing allogeneic marrow transplantation. Clin Transplant 1987; 1:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/9\">",
"      Weiden PL, Doney K, Storb R, Thomas ED. Antihuman thymocyte globulin for prophylaxis of graft-versus-host disease. A randomized trial in patients with leukemia treated with HLA-identical sibling marrow grafts. Transplantation 1979; 27:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/10\">",
"      Doney KC, Weiden PL, Storb R, Thomas ED. Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients. Transplantation 1981; 31:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/11\">",
"      Ramsay NK, Kersey JH, Robison LL, et al. A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med 1982; 306:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/12\">",
"      Tutschka PJ, Beschorner WE, Allison AC, et al. Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature 1979; 280:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/13\">",
"      Tutschka PJ, Beschorner WE, Hess AD, Santos GW. Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. Blood 1983; 61:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/14\">",
"      Powles RL, Clink HM, Spence D, et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1980; 1:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/15\">",
"      Deeg HJ, Storb R, Thomas ED, et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 1985; 65:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/16\">",
"      Santos G, Brookmeyer R, Saral R, et al. Cyclosporine (CsA) versus cyclophosphamide (CY): Prevention of graft-versus-host disease (GVHD). Exp Hematol 1985; 13:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/17\">",
"      Storb R, Martin P, Deeg HJ, et al. Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia. Blood 1992; 79:3091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/18\">",
"      B&auml;ckman L, Ringd&eacute;n O, Tollemar J, L&ouml;nnqvist B. An increased risk of relapse in cyclosporin-treated compared with methotrexate-treated patients: long-term follow-up of a randomized trial. Bone Marrow Transplant 1988; 3:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/19\">",
"      Ruutu T, Volin L, Elonen E. Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroids. Transplant Proc 1988; 20:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/20\">",
"      O'Donnell PV, Luznik L, Jones RJ, et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2002; 8:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/21\">",
"      Luznik L, O'Donnell PV, Symons HJ, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/22\">",
"      Luznik L, Bola&ntilde;os-Meade J, Zahurak M, et al. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood 2010; 115:3224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/23\">",
"      Deeg HJ, Storb R, Appelbaum FR, et al. Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates. Transplantation 1984; 37:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/24\">",
"      Deeg HJ, Storb R, Weiden PL, et al. Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance. Transplantation 1982; 34:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/25\">",
"      Ringd&eacute;n O, Klaesson S, Sundberg B, et al. Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings. Bone Marrow Transplant 1992; 9:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/26\">",
"      Mrsi M, Labar B, Bogdani V, et al. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1990; 6:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/27\">",
"      Gluckman E, Horowitz MM, Champlin RE, et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 1992; 79:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/28\">",
"      Storb R, Deeg HJ, Farewell V, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/29\">",
"      Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/30\">",
"      Storb R, Deeg HJ, Whitehead J, et al. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease. Transplant Proc 1987; 19:2608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/31\">",
"      Storb R, Deeg HJ, Pepe M, et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 1989; 73:1729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/32\">",
"      Marks DI, Hughes TP, Szydlo R, et al. HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome. Br J Haematol 1992; 81:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/33\">",
"      Essell JH, Thompson JM, Harman GS, et al. Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide. Blood 1992; 79:2784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/34\">",
"      Przepiorka D, Ippoliti C, Khouri I, et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. Blood 1996; 88:4383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/35\">",
"      Atkinson K, Downs K, Ashby M, Biggs J. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays. Transplant Proc 1990; 22:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/36\">",
"      Hunter AE, Bessell EM, Russell NH. Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A. Bone Marrow Transplant 1992; 10:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/37\">",
"      Quellmann S, Schwarzer G, H&uuml;bel K, et al. Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation. Cochrane Database Syst Rev 2008; :CD004885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/38\">",
"      Forman SJ, Blume KG, Krance RA, et al. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone. Transplant Proc 1987; 19:2605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/39\">",
"      Chao NJ, Schmidt GM, Niland JC, et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 1993; 329:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/40\">",
"      Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991; 77:1821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/41\">",
"      Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/42\">",
"      Blume KG, Kopecky KJ, Henslee-Downey JP, et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study. Blood 1993; 81:2187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/43\">",
"      Storb R, Pepe M, Anasetti C, et al. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 1990; 76:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/44\">",
"      Ruutu T, Volin L, Parkkali T, et al. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study. Blood 2000; 96:2391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/45\">",
"      Chao NJ, Snyder DS, Jain M, et al. Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial. Biol Blood Marrow Transplant 2000; 6:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/46\">",
"      Hoyt R, Ritchie DS, Roberts AW, et al. Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants. Bone Marrow Transplant 2008; 41:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/47\">",
"      Ratanatharathorn V, Nash RA, Przepiorka D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 1998; 92:2303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/48\">",
"      Hiraoka A, Ohashi Y, Okamoto S, et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/49\">",
"      Nash RA, Pi&ntilde;eiro LA, Storb R, et al. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood 1996; 88:3634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/50\">",
"      Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96:2062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/51\">",
"      Antin JH, Kim HT, Cutler C, et al. Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. Blood 2003; 102:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/52\">",
"      Cutler C, Kim HT, Hochberg E, et al. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2004; 10:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/53\">",
"      Cutler C, Li S, Ho VT, et al. Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. Blood 2007; 109:3108.",
"     </a>",
"    </li>",
"    <li>",
"     BMT CTN Protocol 0402: A phase III randomized multicenter trial comparing sirolimus/tacrolimus with tacrolimus/methotrexate as GVHD prophylaxis after HLA-matched related peripheral blood stem cell transplantation. Available at the BMT CTN website at: https://web.emmes.com/study/bmt/protocol/protocol.html (Accessed on April 19, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/55\">",
"      Cutler C, Stevenson K, Kim HT, et al. Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood 2008; 112:4425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/56\">",
"      Rodriguez R, Nakamura R, Palmer JM, et al. A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. Blood 2010; 115:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/57\">",
"      Chung B, Dudl EP, Min D, et al. Prevention of graft-versus-host disease by anti IL-7Ralpha antibody. Blood 2007; 110:2803.",
"     </a>",
"    </li>",
"    <li>",
"     Smith K. The interleukin-2 receptor. In: Advances in Immunology, Academic Press, New York 1988. Vol 42, p.165.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/59\">",
"      Anasetti C, Martin PJ, Storb R, et al. Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3. Bone Marrow Transplant 1991; 7:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/60\">",
"      Antin JH, Weisdorf D, Neuberg D, et al. Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation. Blood 2002; 100:3479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/61\">",
"      Bhatia S, Ramsay NK, Steinbuch M, et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87:3633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/62\">",
"      Bacigalupo A, Lamparelli T, Bruzzi P, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98:2942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/63\">",
"      Finke J, Bethge WA, Schmoor C, et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009; 10:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/64\">",
"      Soci&eacute; G, Schmoor C, Bethge WA, et al. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 2011; 117:6375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/65\">",
"      Soiffer RJ, Lerademacher J, Ho V, et al. Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood 2011; 117:6963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/66\">",
"      Theurich S, Fischmann H, Shimabukuro-Vornhagen A, et al. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults. Cochrane Database Syst Rev 2012; 9:CD009159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/67\">",
"      Sheridan JF, Tutschka PJ, Sedmak DD, Copelan EA. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. Blood 1990; 75:1583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/68\">",
"      Aucouturier P, Barra A, Intrator L, et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/3/42041/abstract/69\">",
"      Sullivan KM, Kopecky KJ, Jocom J, et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990; 323:705.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3539 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.1.191.153-863D5741FF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42041=[""].join("\n");
var outline_f41_3_42041=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H121886080\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SINGLE DRUG PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Methotrexate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cyclosporine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cyclophosphamide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      COMBINATION DRUG PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Role of prednisone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Tacrolimus plus methotrexate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Tacrolimus plus sirolimus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Toxicity of other sirolimus combinations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Antibodies and antagonists",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Antithymocyte globulin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Intravenous immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H121886080\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/3539\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/3539|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/49/28432\" title=\"figure 1\">",
"      GHVD rates with prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/3539|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/62/11243\" title=\"table 1\">",
"      Prevention of GVHD with drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/19/8509\" title=\"table 2\">",
"      CYE MTX regimen prevent GVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/26/25004\" title=\"table 3\">",
"      Dose adj prevention GVHD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/38/26218?source=related_link\">",
"      Donor selection for hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/54/34664?source=related_link\">",
"      Hematopoietic support after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/1/34842?source=related_link\">",
"      Overview of immunosuppressive agents used for prevention and treatment of graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/4/40009?source=related_link\">",
"      Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/24/18826?source=related_link\">",
"      Pathogenesis of graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=related_link\">",
"      Pharmacology and side effects of cyclosporine and tacrolimus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=related_link\">",
"      Prevention and treatment of acute graft-versus-host disease: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24792?source=related_link\">",
"      Prevention of acute graft-versus-host disease: Trials of T cell depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23338?source=related_link\">",
"      Treatment and prevention of post-transplant lymphoproliferative disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/32/6666?source=related_link\">",
"      Treatment of acute graft-versus-host disease: Clinical trials",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_3_42042="Mucous membrane pemphigoid lip";
var content_f41_3_42042=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F52208%7EDERM%2F63997%7EDERM%2F75723%7EDERM%2F54207%7EDERM%2F77654&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F52208%7EDERM%2F63997%7EDERM%2F75723%7EDERM%2F54207%7EDERM%2F77654&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Mucous membrane pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Irregular erosions and a blister on the mucosal surface of the lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Mucous membrane pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucosal erosions on the gingiva and palate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucous membrane pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erosions are present on the genital mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Stage 3 ocular cicatricial pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the symblepharon bridging between the eyeball and the eyelid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cicatricial pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erosions are present on the gingiva in this patient with cictricial pemphigoid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42042=[""].join("\n");
var outline_f41_3_42042=null;
var title_f41_3_42043="Blood replacement products";
var content_f41_3_42043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F53854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F53854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Blood replacement products: Recommended uses and effects in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"20%\">",
"     </colgroup>",
"     <colgroup width=\"60%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Product (mL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contents",
"       </td>",
"       <td class=\"subtitle1\">",
"        Uses and effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Whole blood (1 unit = 500 mL)",
"       </td>",
"       <td>",
"        All components",
"       </td>",
"       <td>",
"        Rarely required. Consider when massive bleeding requires transfusion of &gt;5 to 7 units of packed red cells.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Red cells + additive solution (1 unit = 350 mL)",
"       </td>",
"       <td>",
"        Red cells",
"       </td>",
"       <td>",
"        One unit increases hematocrit by 3 percentage points and hemoglobin by 1 g/dL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frozen plasma (1 unit = 200 to 300 mL)",
"       </td>",
"       <td>",
"        All clotting factors, but no platelets",
"       </td>",
"       <td>",
"        Best used to correct deficiencies of multiple coagulation factors (eg, DIC, liver disease, warfarin overdosage). One unit FFP increases fibrinogen by 7 to 10 mg/dL. Usual dose is 10 to 15 mL/kg.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cryoprecipitate (1 unit = 10 to 20 mL)",
"       </td>",
"       <td>",
"        Fibrinogen, factors VIII, XIII, VWF",
"       </td>",
"       <td>",
"        Typical dose consists of two bags of prepooled cryoprecipitate (total of 10 units), which will raise plasma fibrinogen by 70 mg/dL in a 70 kg recipient.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Whole blood-derived and apheresis-derived platelets (1 unit = 50 mL)",
"       </td>",
"       <td>",
"        Platelets",
"       </td>",
"       <td>",
"        Six units of whole blood-derived or one unit of apheresis-derived platelets will raise the platelet count by approximately 30,000/microL in an average sized adult.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Frozen blood products (plasma, cryoprecipitate) take 35 to 45 minutes to thaw. It may take the same amount of time to perform an uncomplicated crossmatch.",
"    <div class=\"footnotes\">",
"     DIC: disseminated intravascular coagulation; FFP: fresh frozen plasma; VWF: von Willebrand Factor; kg: kilograms.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42043=[""].join("\n");
var outline_f41_3_42043=null;
var title_f41_3_42044="Skin tumors after OLT";
var content_f41_3_42044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72557&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72557&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Skin tumors after liver transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Tumor",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Squamous cell and basal cell carcinomas",
"       </td>",
"       <td>",
"        Squamous cell carcinomas are more frequent than basal cell carcinomas, in contrast to the non-transplantation context where basal cell carcinomas are 5 times more frequent than squamous cell. The risk increases with the length of the immunosuppression. After 15 years, they can be found in more than 50 percent of the recipients of a liver transplantation, particularly in regions exposed to sunlight. Regular use of sunscreens may prevent the development of squamous cell carcinoma and to a lesser degree basal cell carcinoma [1]. The use of topical diclofenac 3 percent&nbsp;gel may improve post-liver transplantation actinic keratosis and decrease the risk of squamous cell carcinoma [2]. These cancers are also frequent in the anogenital region where they may indicate the presence of another pathogen, human papilloma virus. They are often multiple and aggressive with rapid recurrence after excision, early metastases, or coexistence with a sarcomatous component.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cutaneous lymphomas",
"       </td>",
"       <td>",
"        Primary lymphomas of the skin are rare after liver transplantation. When present, they appear as nodules and tumors that are necrotic or ulcerative, more often on the face. They typically occur about 3 years after transplantation and are a sign of an infection with Epstein Barr virus and/or strong immunosuppression. T-cell lymphoma/S&eacute;zary syndrome are rare after liver transplantation [3].",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Melanomas",
"       </td>",
"       <td>",
"        Melanomas are 2.5 to 4 times more frequent after liver transplantation than in a non-transplanted population. A history of a melanoma before the transplantation is a risk factor for a subsequent melanoma. Melanomas can appear de novo after transplantation (mean time 5 years after), be a recurrence or, rarely, be transferred by the graft. Remission has been described after kidney transplantation after removal of the graft.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kaposi's sarcoma",
"       </td>",
"       <td>",
"        The risk of developing a Kaposi's sarcoma after liver transplantation increases 400 to 500 times. The lesions can appear in the first six months following the transplantation. Late presentations are also possible (more than 10 years after transplantation). Infection with herpes virus 8 and the immunosuppression have a pathogenic role. The lesions are limited to the skin in 50 percent of the cases. They appear as violaceous plaques or nodules accompanied by lymphedema. They are most frequently seen on the inferior extremities, but can occur anywhere. They may display Koebner's phenomenon (occur in areas of trauma). The evolution is usually indolent, but fulminant forms have been reported.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Merkel's cell tumors",
"       </td>",
"       <td>",
"        The frequency of these tumors, which have been associated with the Merkel cell polyoma virus, is increased after liver transplantation. The clinical presentation is usually a firm and inflammatory nodule. These tumors can be aggressive with local diffusion, metastasis, and rapid recurrence after excision.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     1.&nbsp; Ulrich C, Jurgensen JS, Degan A, et al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009; 161 Suppl 3:78.",
"     <br>",
"      2. Ulrich C, Johannsen A, Rowert-Huber J, et al. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses. Eur J Dermatol 2010; 20:482.",
"      <br>",
"       3. Al Ajroush N, Rafique Sheikh K, Kadry R, et al. T-cell lymphoma/S&eacute;zary syndrome in a liver transplant recipient. J Cutan Med Surg 2012; 16:68.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42044=[""].join("\n");
var outline_f41_3_42044=null;
var title_f41_3_42045="Stimulation tests for adrenal insufficiency";
var content_f41_3_42045=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Stimulation tests for adrenal insufficiency: Protocols and normal blood and urinary steroid hormone levels",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Adrenal capacity (ACTH stimulation tests)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Rapid IV ACTH test*:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <p>",
"         Intravenous Cortrosyn:&nbsp;15 micrograms/kg in neonates, 125 micrograms up to 2 years, 250 micrograms over 2 years of age. Dose is infused IV over one minute.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Sample blood for serum cortisol and ACTH at baseline and for cortisol at one hour after infusion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Normal response: Serum cortisol at 1 hour is 7 to 10 micrograms/dL over baseline level and &gt;18 micrograms/dL.",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Prolonged ACTH test*: The response can either be measured as a change in urinary steroid concentrations or a change in serum cortisol levels.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Prior to starting ACTH, obtain baseline (8:00 AM) ACTH and cortisol levels,&nbsp;or obtain two consecutive days of 24 hour urine collections for 17-hydroxycorticosteroids (17OHCS) and free cortisol, ending at 8:00 AM on the morning of ACTH administration.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Give 20 U/m",
"        <sup>",
"         2",
"        </sup>",
"        Acthar gel IM every 12 hours for 3 days,&nbsp;or give 250 micrograms/1.73 m",
"        <sup>",
"         2",
"        </sup>",
"        Cortrosyn IV over 8 to 12 hours beginning at 8:00 AM for 3 consecutive days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Measure serum cortisol at the end of the ACTH treatment (after 3 days of Acthar gel,&nbsp;or once daily for three days at the end of the Cortrosyn infusion). If measuring urinary steroids, continue 24 hour urine collections for 17-OHCS and free cortisol during the three days of ACTH treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Normal responses: Serum cortisol increases to &gt;36 micrograms/dL. Urinary 17-OHCS and free cortisol show a three- to five-fold increase over baseline.",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        ACTH secretory ability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Insulin-induced hypoglycemia:",
"        <sup>",
"         [1,2]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        After fasting since midnight, the test is performed in the morning. Obtain baseline 8:00 AM serum cortisol and glucose levels.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Give 0.05 units/kg of regular insulin IV, and measure cortisol and glucose levels at 15, 30, 45, and 60 minutes. If desired, samples for growth hormone can be obtained at the same time points to screen for growth hormone deficiency. Blood sugar levels should drop by 50 percent or to &lt;45 mg/dL. If this does not occur by 45 minutes, the dose of insulin can be repeated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Normal response: The cortisol level should increase to twice the baseline level or above 20 micrograms/dL.",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Glucagon stimulation test:",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        After fasting since midnight, the test is performed in the morning. Obtain baseline 8:00 AM serum cortisol and glucose.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Give glucagon 0.1 mg/kg IM and obtain blood samples at 15, 30, 45, 60, 90, 120, 150 and 180 minutes for glucose and cortisol levels. If desired, samples for growth hormone measurement can be obtained at the same time points to screen for growth hormone deficiency.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Normal response: The cortisol level normally decreases during the first 60 to 90 minutes, and then reaches a peak of &gt;20 micrograms/dL by 180 minutes. Hypoglycemia is a risk during the second half of the test.",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Single dose Metyrapone Test* (this test should be performed in the hospital):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Obtain baseline blood sample for ACTH, cortisol, and 11-deoxycortisol levels at 8:00 AM.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Give 30 mg/kg (up to 3.0 g) metyrapone orally at midnight with food.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Obtain blood for ACTH, cortisol and 11-deoxycortisol levels at 8:00 AM the following morning.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Normal response: ACTH level rises to over 100 pg/mL, 11-deoxycortisol rises to &gt;7 micrograms/dL, and cortisol drops to &lt;5 micrograms/dL if there has been adequate suppression of 11-hydroxylase activity.",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Prolonged Metyrapone Test* (this test should be performed in the hospital):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Obtain baseline blood sample for ACTH, cortisol, and 11-deoxycortisol at 8:00 AM.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Give 15 mg/kg or 300 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        every 4 hours for six doses at 8:00 AM, 12:00 noon, 4:00 PM, 8:00 PM, 12:00 midnight, and 4:00 AM.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Four hours after the last dose, at 8:00 AM, obtain blood for ACTH, cortisol, and 11-deoxycortisol.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Normal response: ACTH level rises to over 100 pg/mL, 11-deoxycortisol rises to &gt;7micrograms/dL, and cortisol drops to &lt;5 micrograms/dL if there has been adequate suppression of 11-hydroxylase activity.",
"        </em>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ACTH: adrenocorticotropic hormone.",
"     <br>",
"      * Normal ranges and protocols are from Esoterix Laboratories, Calabasas Hills, California, and are used with permission.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Donohoue PA. The Adrenal Gland and its Disorders. Kappy MS, Allen DB, Geffner, ME (eds). Principles and Practice of Pediatric Endocrinology, Charles C. Thomas Publisher, Springfield, IL, 2005, p381.",
"       </li>",
"       <li>",
"        Schmidt IL, et al. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. J Clin Endocrinol Metab 88:4193, 2003.",
"       </li>",
"       <li>",
"        Vanderschueren-Lodeweyckx M et al. The glucagon stimulation test: Effect on plasma growth hormone and on immunoreactive insulin, cortisol, and glucose in children. J Pediatr 1974;85:182-187.",
"       </li>",
"      </ol>",
"      <p>",
"       &nbsp;",
"      </p>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42045=[""].join("\n");
var outline_f41_3_42045=null;
var title_f41_3_42046="Fusarium cutaneous nodule";
var content_f41_3_42046=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cutaneous nodule in a patient with disseminated fusariosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A cutaneous nodule with central necrosis on the chest of a 15-year-old patient with aplastic anemia who had disseminated fusariosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Nucci M, Spector N, Lucena S, et al. Three cases of infection with Fusarium species in neutropenic patients. Eur J Clin Microbiol Infect Dis 1992; 11:1160, with kind permission from Springer Science and Business Media.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42046=[""].join("\n");
var outline_f41_3_42046=null;
var title_f41_3_42047="Normal postoperative UGI series after gastric bypass";
var content_f41_3_42047=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F57009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F57009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal postoperative upper gastrointestinal (UGI) series after gastric bypass",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 351px; height: 468px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Postoperative upper GI study showing gastric pouch and gastrojejunal anastomosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_3_42047=[""].join("\n");
var outline_f41_3_42047=null;
